Sentence,class,file
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/34/d8/ndt-11-311.PMC4327563.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/d8/ndt-11-311.PMC4327563.pdf
Available from: http://www.drugbank.ca/drugs/ DB0030 7.,Non-OADS,/arxiv_data1/oa_pdf/34/d8/ndt-11-311.PMC4327563.pdf
Available from: http://investor.mylan.com/releasedetail.,Non-OADS,/arxiv_data1/oa_pdf/34/d8/ndt-11-311.PMC4327563.pdf
Available from: http://clinicaltrial.gov/ct2/ show/NCT01782742.,Non-OADS,/arxiv_data1/oa_pdf/34/d8/ndt-11-311.PMC4327563.pdf
Available from: http://clinicaltrial.gov/ct2/show/NCT0206187 8.,Non-OADS,/arxiv_data1/oa_pdf/34/d8/ndt-11-311.PMC4327563.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/31/ijn-10-1119.PMC4327564.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1119–1129International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1119OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7184 7Dimensionality reduction, and function  approximation of poly(lactic-co-glycolic acid)  micro- and nanoparticle dissolution rate Varun Kumar Ojha1,2  Konrad Jackowski3 ajith abraham1,4 Václav snášel1,2 1IT4Innovations, VŠB – Technical  University of Ostrava, Ostrava,   czech republic; 2Department of  computer science, VŠB – T echnical  University of Ostrava, Ostrava, czech  republic; 3Department of systems  and Computer Networks, Wrocław  University of T echnology, Wrocław,   Poland; 4Machine Intelligence research  labs, auburn, W a, UsaAbstract:  Prediction of poly(lactic-co-glycolic acid) (PLGA) micro- and nanoparticles’  dissolution rates plays a significant role in pharmaceutical and medical industries.",Non-OADS,/arxiv_data1/oa_pdf/3d/31/ijn-10-1119.PMC4327564.pdf
"Several regression models were employed to evaluate the relationship between the  obtained input variables (features) and output variable.correspondence: Varun Kumar Ojha  IT4Innovations, VŠB – Technical  University of Ostrava, 17 listopadu  15/2172, 708 33 Ostrava – Poruba,  Ostrava, czech republic Tel +420 777 880431  email varun.kumar.ojha@vsb.c z Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ojha et al Running head recto: Function approximation of PLGA micro and nanoparticle dissolution rate DOI: http://dx.doi.org/10.2147/IJN.S71847",OADS,/arxiv_data1/oa_pdf/3d/31/ijn-10-1119.PMC4327564.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3d/31/ijn-10-1119.PMC4327564.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/31/ijn-10-1119.PMC4327564.pdf
Available from: http://www.cs.helsinki.fi/u/ahy - varin/presentations/Berlin05.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/31/ijn-10-1119.PMC4327564.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/ijn-10-1109.PMC4327565.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1109–1118International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1109OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7283 5effects of homogenization process parameters  on physicochemical properties of astaxanthin  nanodispersions prepared using a solvent-   diffusion technique Navideh anarjan1 hoda Jafarizadeh-Malmiri2 Imededdine arbi Nehdi3 hassen Mohamed sbihi3 saud Ibrahim al-resayes3 chin Ping Tan4 1Young researchers and elite  club, Tabriz Branch, Islamic azad  University, Tabriz, Iran; 2Department  of chemical engineering, Faculty of  Food engineering, sahand University  of T echnology, Tabriz, Iran; 3King  saud University, college of science,   chemistry Department, riyadh,   saudi arabia; 4Department of Food  Technology, Faculty of Food science  and Technology, Universiti Putra  Malaysia, selangor, MalaysiaAbstract:  Nanodispersion systems allow incorporation of lipophilic bioactives, such as  astaxanthin (a fat soluble carotenoid) into aqueous systems, which can improve their solubil - ity, bioavailability, and stability, and widen their uses in water-based pharmaceutical and food  products.",Non-OADS,/arxiv_data1/oa_pdf/f4/c5/ijn-10-1109.PMC4327565.pdf
"Nanodispersion systems have received much attention recently because of their  considerable potential for food and pharmaceutical applications.6 The development correspondence: chin Ping Tan Department of Food Technology,  Faculty of Food science and Technology,  Universiti Putra Malaysia, 43400 UPM  serdang, selangor, Malaysia Tel +603 8946 8418 Fax +603 8942 3552 email tancp@upm.edu.m y Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Anarjan et al Running head recto: Effect of homogenization parameters on characteristics of astaxanthin nanodispersions DOI: http://dx.doi.org/10.2147/IJN.S72835",Non-OADS,/arxiv_data1/oa_pdf/f4/c5/ijn-10-1109.PMC4327565.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f4/c5/ijn-10-1109.PMC4327565.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/ijn-10-1109.PMC4327565.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/01/ijn-10-1131.PMC4327566.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1131–1143International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1131OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7287 2Positive impact of IgF-1-coupled nanoparticles  on the differentiation potential of human  chondrocytes cultured on collagen scaffolds Juliane Pasold1 Kathleen Zander1 Benjamin heskamp1 cordula grüttner2 Frank lüthen3 Thomas Tischer1 anika Jonitz-heincke1 rainer Bader1 1Department of Orthopaedics,   Biomechanics and Implant Technology  laboratory, University Medicine  rostock, rostock, germany;   2Micromod Particletechnology gmbh,   rostock, germany; 3Institute of cell  Biology, University Medicine rostock,   rostock, germanyPurpose:  In the present study, silica nanoparticles (sNP) coupled with insulin-like growth  factor 1 (IGF-1) were loaded on a collagen-based scaffold intended for cartilage repair, and the  influence on the viability, proliferation, and differentiation potential of human primary articular  chondrocytes was examined.",Non-OADS,/arxiv_data1/oa_pdf/1f/01/ijn-10-1131.PMC4327566.pdf
"The main goal  is to rebuild hyaline cartilage and thus induce and improve the self-healing process.2 correspondence: Juliane Pasold Department of Orthopaedics,  Biomechanics and Implant Technology  laboratory, University Medicine rostock,  Doberaner strasse 142, 18057 rostock,  germany Tel +49 381 494 9306 Fax +49 381 494 9308 email juliane.pasold@med.uni-rostock.d eJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Pasold et al Running head recto: Positive impact of IGF-1-coupled nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S72872",Non-OADS,/arxiv_data1/oa_pdf/1f/01/ijn-10-1131.PMC4327566.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/01/ijn-10-1131.PMC4327566.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/01/ijn-10-1131.PMC4327566.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/40/ijn-10-1077.PMC4327567.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1077–1093International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1077OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7651 7sustained-release nanoar T formulation for  the treatment of neuroaIDs rahul Dev Jayant Venkata sr atluri Marisela agudelo Vidya sagar ajeet Kaushik Madhavan Nair center for Personalized  Nanomedicine, Department of  Immunology, herbert Wertheim  college of Medicine, Florida  International University, Miami,   Fl, UsaAbstract:  A novel approach was developed for the coencapsulation of an anti-HIV drug (teno - fovir) and a latency-breaking agent (vorinostat), using magnetically guided layer-by-layer (LbL)  assembled nanocarriers for the treatment of neuroAIDS.",Non-OADS,/arxiv_data1/oa_pdf/32/40/ijn-10-1077.PMC4327567.pdf
"Despite all the best intentions and efforts  on the part of health care professionals, a patient’s noncompliance in the case of HIV  therapy (HAART) is very high.4 As per clinical trial data on HIV drugs, results show  that missed doses of antiretroviral agents were most likely to occur because of forget - ting (43%), sleeping through a dose (36%), being away from home (32%), changing correspondence: rahul Dev Jayant   center for Personalized Nanomedicine,  Department of Immunology, herbert  Wertheim college of Medicine,  Florida International University,   11200 sW 8th st., University Park,  ahc-1, Miami, Fl-33199, Usa email rjayant@fiu.ed u  Madhavan Nair center for Personalized Nanomedicine,  Department of Immunology, herbert  Wertheim college of Medicine,  Florida International University,   11200 sW 8th st., University Park,  ahc-1, Miami, Fl-33199, Usa  Tel +1 305 348 1493 Fax +1 305 348 6021 email nairm@fiu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Jayant et al Running head recto: Sustained-release nanoART formulation for the treatment of neuroAIDS DOI: http://dx.doi.org/10.2147/IJN.S76517",Non-OADS,/arxiv_data1/oa_pdf/32/40/ijn-10-1077.PMC4327567.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/32/40/ijn-10-1077.PMC4327567.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/40/ijn-10-1077.PMC4327567.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/39/ijn-10-1095.PMC4327568.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1095–1107International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1095OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7355 7Titanium dioxide nanoparticles enhance  production of superoxide anion and alter the  antioxidant system in human osteoblast cells Karolina Niska1 Katarzyna Pyszka1 cecylia T ukaj2 Michal Wozniak1 Marek Witold radomski3–5 Iwona Inkielewicz-stepniak1 1Department of Medical chemistry,   2Department of electron Microscopy,   Medical University of gdansk, gdansk,   Poland; 3school of Pharmacy and  Pharmaceutical sciences, Trinity  Biomedical sciences Institute, The  University of Dublin Trinity college,   Dublin, Ireland; 4Kardio-Med silesia,   5silesian Medical University, Zabrze,   PolandAbstract:  Titanium dioxide (TiO2) nanoparticles (NPs) are manufactured worldwide for a  variety of engineering and bioengineering applications.",Non-OADS,/arxiv_data1/oa_pdf/5a/39/ijn-10-1095.PMC4327568.pdf
"Wang et al6 indicated that TiO2NPs correspondence: Iwona Inkielewicz- stepniak Department of Medical chemistry,  Medical University of gdansk, Debinki  street, 80-211 gdansk, Poland Tel +48 58 349 1450 email iinkiel@gumed.edu.p l Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Niska et al Running head recto: TiO2NPs alter the antioxidant system in osteoblast cells DOI: http://dx.doi.org/10.2147/IJN.S73557",OADS,/arxiv_data1/oa_pdf/5a/39/ijn-10-1095.PMC4327568.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5a/39/ijn-10-1095.PMC4327568.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/39/ijn-10-1095.PMC4327568.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/04/ijn-10-1061.PMC4327569.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1061–1075International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1061OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7267 0A living thick nanofibrous implant bifunctionalized  with active growth factor and stem cells for   bone regeneration sandy eap1,2,* laetitia Keller1–3,* Jessica schiavi1,2 Olivier huck1,2 leandro Jacomine4 Florence Fioretti1,2 christian gauthier4 Victor Sebastian1,3,5 Pascale schwinté1,2 Nadia Benkirane-Jessel1,2 1INserM, UM r 1109, Osteoarticular  and Dental regenerative  Nanomedicine Laboratory, FMTS,  Faculté de Médecine, Strasbourg,  France; 2Faculté de chirurgie Dentaire,  Université de Strasbourg, Strasbourg,  France; 3Department of chemical  engineering, aragon Nanoscience  Institute, University of Zaragoza,  Zaragoza, Spain; 4cNrs (National  center for scientific research), I cs  (Charles Sadron Institute), Strasbourg,  France; 5Networking research center  of Bioengineering, Biomaterials and  Nanomedicine, Zaragoza, Spain *These authors contributed equally  to this workAbstract:  New-generation implants focus on robust, durable, and rapid tissue regeneration to  shorten recovery times and decrease risks of postoperative complications for patients.",Non-OADS,/arxiv_data1/oa_pdf/f7/04/ijn-10-1061.PMC4327569.pdf
"The common bone regeneration techniques used today include the implantation of free  fibula vascularized grafts, autologous bone grafts, allograft implantations, and use of  growth factors, scaffolds, and osteoprogenitor cells, but all of these are limited.1 The  tissue engineering approach is a promising strategy in the field of bone regenerative  medicine which aims to generate new functional tissues, rather than just to implant  nonliving scaffolds.2 This alternative could overcome the limitations of current thera - pies, by combining the knowledge in orthopedic surgery with materials science and correspondence: Nadia Benkirane-Jessel UMr 1109, INserM, Faculté de  Médecine, Université de Strasbourg,  11 Rue Humann, 67085, Strasbourg, France Tel +33 3 68 85 33 76 email nadia.jessel@inserm.f r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Eap et al Running head recto: Nanofibrous implants for bone regeneration DOI: http://dx.doi.org/10.2147/IJN.S72670",Non-OADS,/arxiv_data1/oa_pdf/f7/04/ijn-10-1061.PMC4327569.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f7/04/ijn-10-1061.PMC4327569.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/04/ijn-10-1061.PMC4327569.pdf
We remind all the readers that the articles published in years not covered  by MEDLINE are also freely available at the SciELO website at: http://www.scielo.br/jaos.,Non-OADS,/arxiv_data1/oa_pdf/36/c3/1678-7757-jaos-17-02-000i.PMC4327580.pdf
Available from: http://people.umass.edu/aizen/pdf/tpb.measurement.pdf.,OADS,/arxiv_data1/oa_pdf/46/2d/1678-7757-jaos-17-02-0097.PMC4327584.pdf
"Available from: http://www.tanzania.go.tz/vission_2025f.html.DENTAL PRACTITIONERS’ ATTITUDES, SUBJECTIVE NORMS AND INTENTIONS TO PRACTICE ATRAUMATIC RESTORATIVE TREATMENT (ART) INTANZANIA 102",Non-OADS,/arxiv_data1/oa_pdf/46/2d/1678-7757-jaos-17-02-0097.PMC4327584.pdf
"(http://www.ncbi.nlm.nih.gov/PubMed)ESTRELA C, SYDNEY G B, FIGUEIREDO J A P , ESTRELA C R de A 3",Non-OADS,/arxiv_data1/oa_pdf/04/04/1678-7757-jaos-17-01-0001.PMC4327605.pdf
Available from: <http://www.seade.gov.br.> 16- São Paulo.,Non-OADS,/arxiv_data1/oa_pdf/21/92/1678-7757-jaos-17-01-0008.PMC4327606.pdf
"Available from: <http://www.saude.sp.gov.br/saude_bucal/html/saude_bucal_est_epide.html> 17- Shah N, Sundaran KR.",Non-OADS,/arxiv_data1/oa_pdf/21/92/1678-7757-jaos-17-01-0008.PMC4327606.pdf
Available from URL: <http://www.neuro.pucpr.br/ >.,Non-OADS,/arxiv_data1/oa_pdf/e1/ad/1678-7757-jaos-17-01-0013.PMC4327608.pdf
Available from: http://bvsms.saude.gov.br/bvs/publicacoes /projeto_sb2004.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ab/de/1678-7757-jaos-17-01-0039.PMC4327612.pdf
I take advantage of this message to invite you to visit our free complete online  collection at http://www.scielo.br/scielo.php.,Non-OADS,/arxiv_data1/oa_pdf/7c/a7/1678-7757-jaos-16-02-000i.PMC4327624.pdf
"Please, also send your suggestions and comments to improve the quality of our online submission system(http://submission.scielo.br/index.php/jaos/login).",Non-OADS,/arxiv_data1/oa_pdf/7c/a7/1678-7757-jaos-16-02-000i.PMC4327624.pdf
Available from: http://www.abep.org.,Non-OADS,/arxiv_data1/oa_pdf/4d/d9/1678-7757-jaos-17-05-0397.PMC4327663.pdf
Revised Edition October 2004 Availablefrom: http://www.acpa-cpf.org/teamcare/Parameters04rev.pdf.,Non-OADS,/arxiv_data1/oa_pdf/26/f6/1678-7757-jaos-16-03-0181.PMC4327691.pdf
ISO 4049:2000.Available at: http://www.iso.ch/iso/en/prods-services/ISOstore/store.html.,Non-OADS,/arxiv_data1/oa_pdf/ad/dd/1678-7757-jaos-16-03-0189.PMC4327692.pdf
2012. http://www.alz.co.uk/research/world- report-2012.,Non-OADS,/arxiv_data1/oa_pdf/1f/e3/dee-0005-0001.PMC4327701.pdf
"We also invite all readers, contributors and reviewers to visit our free complete online collection and our online submission system at http://www.scielo.br/jaos.",Non-OADS,/arxiv_data1/oa_pdf/5b/61/1678-7757-jaos-16-06-000i.PMC4327703.pdf
"Risk differences of included studies were combin ed as generic inverse variance data type (Review Manager Version 5.0 – Cochrane Collaboration, http://www.cc-ims.net, accessed 15May 2008), taking into account the separate tracking of positive and negative cultures/PCR.",OADS,/arxiv_data1/oa_pdf/15/47/1678-7757-jaos-16-06-0364.PMC4327704.pdf
"Risk differences of included studies werecombined as generic inverse variance data type (ReviewManager Version 5.0 – Cochrane Collaboration, http://www.cc-ims.net, accessed 15 May 2008), taking into accountthe separate tracking of positive and negative cultures/PCR.The level of statistical significance was set at p<0.05.",OADS,/arxiv_data1/oa_pdf/15/47/1678-7757-jaos-16-06-0364.PMC4327704.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/2c/main.PMC4327758.pdf
"Western immunoblotting utilized antibodies to STAT3 (#9139), pY705-STAT3 (#9131), MCL-1 (#5453) and GAPDH (#2118) (CellContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.12.001 2213-0489/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a8/2c/main.PMC4327758.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/2c/main.PMC4327758.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/b6/main.PMC4327759.pdf
"Case 3 had a signi ﬁcant CR2 for over 3 years and responded well to reinduction with a single course of FLAG and remains in CR3, with a very good self-reportedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2015.01.001 2213-0489/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ce/b6/main.PMC4327759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/b6/main.PMC4327759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/21/main.PMC4327760.pdf
"Nonetheless, the 3-month treatment by the demethy- lating agent 5-azacitytine failed to restore or increase the expres- sion of the NK activating molecules NCRs, NKG2D and 2B4/CD244, the expression of the later being on the contrary signi ﬁcantlyContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.09.004 2213-0489/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/21/main.PMC4327760.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/21/main.PMC4327760.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/0a/main.PMC4327761.pdf
Laboratory data September 2013 WBC (103/mL) 10.6 RBC (106/mL) 4.4 Hemoglobin (g/dl) 12.7HCT (%) 40MCV ( ﬂ)9 1 RDW (%) 15.7Platelet count (10 3/mL) 254 Differential Neutrophils # 8.1 Lymphocytes # 1.3Monocytes # 0.4Eosinophils # 0.2Basophils # 0.3 http://dx.doi.org/10.1016/j.lrr.2014.12.002 2213-0489/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/44/0a/main.PMC4327761.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/0a/main.PMC4327761.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/3c/main.PMC4327762.pdf
Erythroid and megakaryocytic dysplasia with a mye- loid: erythroid (M:E) ratio of 10:1 consistent with RCMD by WHOContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.11.001 2213-0489/ &2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/11/3c/main.PMC4327762.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/3c/main.PMC4327762.pdf
http://www.cdc.gov/getsmart/campaign-materials/ info-sheets/adult-acute-pharyngitis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/aa/10.1177_0046958015571130.PMC4327773.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/a8/main.PMC4327846.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/a8/main.PMC4327846.pdf
"http://dx.doi.org/10.1016/j.jbo.2012.12.005 nCorresponding author at: Division of Hematology and Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160,USA.",OADS,/arxiv_data1/oa_pdf/d7/a8/main.PMC4327846.pdf
http://dx.doi.org/10.1016/j.jare.2012.09.005,OADS,/arxiv_data1/oa_pdf/7d/35/main.PMC4327850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/09/main.PMC4327909.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.01.0012211-3355/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/09/main.PMC4327909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/09/main.PMC4327909.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/d8/09/main.PMC4327909.pdf
"http://www.cdph.ca.gov/ data/surveys/Pages/ MaternalandInfantHealthAssessment(MIHA)survey.aspx (Accessed July 27, 2013).",OADS,/arxiv_data1/oa_pdf/d8/09/main.PMC4327909.pdf
"Cancer Preven- tion Research Center, Rhode Island ( http://www.uri.edu/research/cprc/Measures/ Weight01.htm.",Non-OADS,/arxiv_data1/oa_pdf/d8/09/main.PMC4327909.pdf
"Once the RMP is approved, SCEM studies are registered on the European Network of Centres for Pharmacoepidemiologyand Pharmacovigilance (ENCEPP) e-register of studies (http://www.encepp.eu ).",Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
2007. https://www.rcplondon.ac.uk/ sites/default/ﬁles/documents/guidelines-practice-ethics- committees-medical-research.pdf .,Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
2013. http://www.gmc-uk.org/ Prescribing_Guidance__2013__50955425.pdf .,Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
2002. http://www.cioms.ch/ publications/layout_guide2002.pdf .,Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
London: Department of Health; 2013.http://www.crn.nihr.,Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
2014. http://www.encepp.eu/encepp/ viewResource.htm?id=5412 .,Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
2014. http://www.encepp.eu/encepp/viewResource.,Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
2014. http://www.encepp.eu/encepp/ viewResource.htm?id=5320 .,Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
"Rockville, MD: Agency for Healthcare Research and Quality;2010. http://www.effectivehealthcare.ahrq.gov/ehc/products/74/ 531/Registries%202nd%20ed%20ﬁnal%20to%20Eisenberg% 209-15-10.pdf .",Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
2014. http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/17/2e/40264_2014_Article_260.PMC4328122.pdf
"The Global Research in Paediatrics (GRiP)–Network of excellence ( http://www.grip-network.org/ ) was set up with the general objective of facilitating the development and safe use of medicines in the pediatric population, with a speciﬁc objective being to apply innovative approaches andstandardized methodologies, as well as better utilization of existing healthcare and spontaneous reporting databases.",Non-OADS,/arxiv_data1/oa_pdf/e3/f9/40264_2015_Article_265.PMC4328124.pdf
"Micromedex is an online drug information system that contains referenced information from various sources needed for clinical decision making, including adverseeffects of drugs ( http://www.micromedex.com/ ).",OADS,/arxiv_data1/oa_pdf/e3/f9/40264_2015_Article_265.PMC4328124.pdf
"precautions); (adverse effects ?serious)Total number of supporting citations =4 Clinical trial =1 Case-control =2 Case report =1 ATC Anatomical Therapeutic Chemical, AEadverse effect, SPC Summary of Product Characteristics, eMC electronic Medicines Compendium *https://www.medicines.org.uk/emc/ #http://micromedex.com/214 O. U. Osokogu et al.",Non-OADS,/arxiv_data1/oa_pdf/e3/f9/40264_2015_Article_265.PMC4328124.pdf
Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/ regulation/document_listing/document_listing_000068.jsp .,Non-OADS,/arxiv_data1/oa_pdf/e3/f9/40264_2015_Article_265.PMC4328124.pdf
Available at: http://www.who.int/medicines/ publications/essentialmedicines/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/e3/f9/40264_2015_Article_265.PMC4328124.pdf
Available at: http://www.fda.gov/downloads/advisorycommittees/ committeesmeetingmaterials/drug s/anti-infectivedrugsadvisory committee/ucm299210.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e3/f9/40264_2015_Article_265.PMC4328124.pdf
Available at: http://www.who.int/iris/handle/ 10665/67378 .,OADS,/arxiv_data1/oa_pdf/e3/f9/40264_2015_Article_265.PMC4328124.pdf
Available at: http://www.medicines.org.uk/emc/ .,Non-OADS,/arxiv_data1/oa_pdf/e3/f9/40264_2015_Article_265.PMC4328124.pdf
The Swiss rainfall data are publicly available from the open source R packageSpatialExtremes (http://CRAN.R-project.org/package 5SpatialExtremes).Water Resources Research 10.1002/2013WR014849 WANG ET AL.,OADS,/arxiv_data1/oa_pdf/a9/a2/wrcr0050-9570.PMC4328148.pdf
Type material The holotype female of N. duplicatus is point mounted; it lacks its head but otherwise is entire (see http://www.usnmhymtypes.com/default.asp?Action=Show_Types&Single_Type=True&TypeID=7003).,Non-OADS,/arxiv_data1/oa_pdf/5d/aa/zoj0173-0352.PMC4328149.pdf
Available from http://www.iczn.org/iczn/ index.jsp.,Non-OADS,/arxiv_data1/oa_pdf/5d/aa/zoj0173-0352.PMC4328149.pdf
Available at: http://www.nhm.ac.uk/chalcidoids Posada D. 2008. jModeltest: Phylogenetic model averaging.,OADS,/arxiv_data1/oa_pdf/5d/aa/zoj0173-0352.PMC4328149.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/6c/ehu345.PMC4328197.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/21/ehu455.PMC4328198.pdf
"For the microbiota analysis, significant differences were conducted usingthe Wilcoxon rank-sum test, and P-values were converted to false discovery rate values ( Q-values) to correct for multiple testing in the R software (http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/e8/94/embr0016-0164.PMC4328744.pdf
Data availability The data behind the graphs are presented in a source data file at http://embor.embopress.org/.,OADS,/arxiv_data1/oa_pdf/e8/94/embr0016-0164.PMC4328744.pdf
Microbiota 16S rDNA sequencingdata have been deposited to the ENA sequence read archive underaccession number PRJEB7982 (http://www.ebi.ac.uk/ena/data/view).The mass spectrometry proteomics data have been deposited to theProteomeXchange Consortium (http://proteomecentral.proteomex-change.org) via the PRIDE partner repository [65] with the datasetidentifier PXD001479.,OADS,/arxiv_data1/oa_pdf/e8/94/embr0016-0164.PMC4328744.pdf
Supplementary information for this article is available online: http://embor.embopress.org Acknowledgements We acknowledge the CCI unit at the University of Gothenburg for assistancewith confocal microscopy and Frida Svensson for technical assistance.,Non-OADS,/arxiv_data1/oa_pdf/e8/94/embr0016-0164.PMC4328744.pdf
RNA sequen-cing (RNA-seq) was performed at the CSF Next-Generation Sequen-cing Unit (http://csf.ac.at).,OADS,/arxiv_data1/oa_pdf/99/4a/embr0016-0178.PMC4328745.pdf
Supplementary information for this article is available online: http://embor.embopress.org Acknowledgements We thank Anne Ephrussi for generously sharing aret alleles and Aret antibodies and the Bloomington and VDRC stock centers for fly stocks.,Non-OADS,/arxiv_data1/oa_pdf/99/4a/embr0016-0178.PMC4328745.pdf
Supplementary information for this article is available online: http://embor.embopress.org Acknowledgements We are indebted to Drs.,Non-OADS,/arxiv_data1/oa_pdf/fa/f4/embr0016-0232.PMC4328750.pdf
Supplementary information for this article is available online: http://embor.embopress.org Acknowledgements Financial support by the 0SFB1035 to J.B. is acknowledged.,Non-OADS,/arxiv_data1/oa_pdf/85/60/embr0016-0240.PMC4328751.pdf
"Thus, we took brightfield sections of the motor neurons at 63 3mag- nification, and then used a threshold function in ImageJ v1.44 (http://imagej.nih.gov/ij/) to mark the maximum amount of grains without marking other tissue objects.Then the number of silver grains in the image was counted automatically (using the measure function), and that number was divided by the number of motorneurons (manually counted) in each image.",OADS,/arxiv_data1/oa_pdf/9c/8e/cne0523-0892.PMC4329046.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non- Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3f/30/atr-03-04-16720.PMC4329229.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/78/a7/atr-03-04-22189.PMC4329230.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non- Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cf/63/atr-03-04-19507.PMC4329231.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear editor , Suspicion of scaphoid fracture is a common topic in  emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/74/ab/atr-03-04-17837.PMC4329232.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a7/1f/hepatmon-14-12-23264.PMC4329233.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d5/ab/hepatmon-14-12-15405.PMC4329234.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e3/bc/hepatmon-14-12-24635.PMC4329235.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.The world health organization (WHO) has defined  “health” as a state of complete physical, mental and so - cial wellbeing and not merely the absence of disease or  infirmity .",Non-OADS,/arxiv_data1/oa_pdf/1b/9b/hepatmon-14-12-25866.PMC4329236.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/28/b3/hepatmon-14-12-25788.PMC4329237.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f0/03/hepatmon-14-12-25792.PMC4329238.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cd/28/hepatmon-14-12-22565.PMC4329239.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
Chimera screening was conducted through UCHIME (36) and OTUs were assigned taxonomy by BLASTn v2.2.22 (30) mappingto the RDP Release 11 database (37) (http://rdp.cme.msu.edu/) and a 98.5% alignment threshold.,OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"Characterization of the human subjects enrolled in the study Subject Gender Age Ethnicity 1 M 48 Asian 2 M 49 Asian3 M 46 Caucasian4 F 38 Asian5 F 44 African American6 F 42 Hispanic7 F 43 Asian 8 M 51 Asian 9 F 46 Hispanic10 F 49 CaucasianThe hidden ‘mycobacteriome’ of the human oral cavity Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
The sequences were deposited and publicly available at the HOMD database(ftp://www.homd.org/publication_data/20140722/).,OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"Shown P-value was calculated using one-way ANOV A.The hidden ‘mycobacteriome’ of the human oral cavity Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"Dotted line shows the qPCR cutoff determined by the reactions with no template run.The hidden ‘mycobacteriome’ of the human oral cavity Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"(a) Stacked bar plots show relative abundance of main phyla in dental plaque which were generated by BLAST analysis of the V3 /C1V4 region with 99% similarity against RDP11 database; (b) Inverse correlation between the relative prevalence (percentages of the total community) in dental plaque of members of the phylumFirmicutes andFusobacterium , where dashed lines indicate 95% conﬁdence intervals and Pearson correlation coefﬁcient /C30/C28 0.945; PB0.0001; (c) Inverse correlation between phylum Proteobacteria and the phylum Actinobacteria in the nostril communities (Spearman correlation coefﬁcient r/C30/C28 0.0.697; PB0.05); (d) Inverse correlation between phylum Firmicutes and the phylum Fusobacteria in the buccal mucosae communities (Spearman correlation coefﬁcient r/C30/C28 0.648; PB0.05).The hidden ‘mycobacteriome’ of the human oral cavity Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"10 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"Nat Rev Immunol 2001; 1: 135 /C145.The hidden ‘mycobacteriome’ of the human oral cavity Citation: Journal of Oral Microbiology 2015, 7: 26094 - http://dx.doi.org/10.3402/jom.v7.26094 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/25/JOM-7-26094.PMC4329316.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/1a/71/ima-5-2-161.PMC4329318.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/46/ec/ima-5-2-173.PMC4329319.pdf
A basic  alignment of the obtained sequence data was first done using  MAFFT v. 7 (http://mafft.cbrc.jp/alignment /server/index.,OADS,/arxiv_data1/oa_pdf/46/ec/ima-5-2-173.PMC4329319.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/0d/94/ima-5-2-195.PMC4329320.pdf
Biological and distribution data for many of these specimens can be accessed at http://collections.daff.qld.gov.au Morphology and image capture Spores of smut or rust fungi were removed from host material with a scalpel and mounted in clear lactic acid (100 % v/v)  on a microscope slide and gently heated to boiling.,Non-OADS,/arxiv_data1/oa_pdf/0d/94/ima-5-2-195.PMC4329320.pdf
http://www.daff.qld.gov.au/plants/ lifestyle-horticulture/nursery/frangipani-rust .,Non-OADS,/arxiv_data1/oa_pdf/0d/94/ima-5-2-195.PMC4329320.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/27/6b/ima-5-2-203.PMC4329321.pdf
"Taxonomy and  nomenclature of plant families, genera and species are based  on the “Angiosperm Phylogeny Website” (http://www.mobot.org/mobot/research/apweb/), Tropicos database (http://www.",OADS,/arxiv_data1/oa_pdf/27/6b/ima-5-2-203.PMC4329321.pdf
"Tropicos.org/), and The Plant List (http://www.theplantlist.org).",Non-OADS,/arxiv_data1/oa_pdf/27/6b/ima-5-2-203.PMC4329321.pdf
http://sundoc.bibliothek.uni-halle.de/diss-online/05/05H208/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/ima-5-2-203.PMC4329321.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/1e/06/ima-5-2-391.PMC4329322.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/b8/57/ima-5-2-415.PMC4329323.pdf
"Sequence alignment and phylogenetic analysis The sequences obtained in this study were combined with  published Pluteus ITS rDNA sequences selected from  GenBank and UNITE (http://unite.ut.ee) databases on the basis of the greatest similarity based on BLASTsearch, outcomes of recent phylogenetic studies focused on  Pluteus (Justo et al.",OADS,/arxiv_data1/oa_pdf/b8/57/ima-5-2-415.PMC4329323.pdf
Version 5.3. http://www.geneious.com/ Felsenstein J (1985) Confidence limits on phylogenies: an approach  using the bootstrap.,Non-OADS,/arxiv_data1/oa_pdf/b8/57/ima-5-2-415.PMC4329323.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/9c/f6/ima-5-2-425.PMC4329324.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/1f/70/ima-5-2-439.PMC4329325.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/eb/f0/ima-5-2-449.PMC4329326.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/79/57/ima-5-2-463.PMC4329327.pdf
"The  method was developed further to include a regime by which  a large sequence database generated through PPR can be mined for the presence of, for example, glycohydrolases,  resulting in a list of genes referred to specific CAZy protein  families (http://www.cazy.org/; Cantarel et al.",OADS,/arxiv_data1/oa_pdf/79/57/ima-5-2-463.PMC4329327.pdf
"One product is already available on the market which  increases phosphate availability, “JumpStart” (Novozymes 2012; http://www.bioag.novozymes.com/)  , which  is a phos- phate inoculant containing the naturally occurring non-GMO  soil fungus Penicillium bilaii .",Non-OADS,/arxiv_data1/oa_pdf/79/57/ima-5-2-463.PMC4329327.pdf
Rome: Food and Agriculture Organization   (http://www.fao.org/docrep/018/i3347e/i3347e.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/79/57/ima-5-2-463.PMC4329327.pdf
(http://www.pwkooij.com/PWKooij/Publications.html ).,Non-OADS,/arxiv_data1/oa_pdf/79/57/ima-5-2-463.PMC4329327.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/02/0f/ima-5-2-473.PMC4329328.pdf
"Currently, only two Amanita genomes are publicly available  from the Joint Genome Institute (JGI) (http://genome.jgi.doe.gov/agaricomycotina/agaricomycotina.info.html ) and the  Myco-rrhizal Genomics Initiative (http://mycor.nancy.inra.fr/IMGC/MycoGenomes) as components of sequencing the Fungal Tree of Life (Martin et al.",OADS,/arxiv_data1/oa_pdf/02/0f/ima-5-2-473.PMC4329328.pdf
"This protocol included a proteinase-K  digestion step followed by a chloroform:isoamylalcohol (1:24) extraction, RNA denaturation, and isopropanol  precipitation (a document with the details can be found  at  https://sites.google.com/site/santiagosnchezrmirez/home/amanita-jacksonii-genomics/genomic-dna-extraction).",Non-OADS,/arxiv_data1/oa_pdf/02/0f/ima-5-2-473.PMC4329328.pdf
2014; http://genome.jgi.doe.gov/).,OADS,/arxiv_data1/oa_pdf/02/0f/ima-5-2-473.PMC4329328.pdf
"In contrast, far more genes are  predicted in the genomes of A. muscaria and A. thiersii, which   include 18 153 and 10 354 structural genes, respectively  (http://genome.jgi-psf.org/).",Non-OADS,/arxiv_data1/oa_pdf/02/0f/ima-5-2-473.PMC4329328.pdf
AUGUSTUS gene predictor (http://bioinf.uni- greifswald.de/augustus/) was used to est-imate the number  of open reading frames (ORFs) present in the genome using the Fusarium graminearum gene models (Stanke et  al.,OADS,/arxiv_data1/oa_pdf/02/0f/ima-5-2-473.PMC4329328.pdf
"<http://www.repeatmasker.org> Stanke M, Diekhans M, Baertsch R, Haussler D (2008) Using native  and syntenically mapped cDNA alignments to improve de novo gene finding.",OADS,/arxiv_data1/oa_pdf/02/0f/ima-5-2-473.PMC4329328.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/6b/rjv006.PMC4329329.pdf
Available at: http://www.esds.ac.uk/longitudinal/ resources/malaise/background.asp.,Non-OADS,/arxiv_data1/oa_pdf/68/27/acer0039-0166.PMC4329335.pdf
Available at: http://ukdataservice.ac.uk/get-data /how-to-access/conditions.aspx.,OADS,/arxiv_data1/oa_pdf/68/27/acer0039-0166.PMC4329335.pdf
Avail- able at: http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/54/all0069-1522.PMC4329337.pdf
Available at: http://www.wma.net/en/30publications/10policies/b3/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/da/54/all0069-1522.PMC4329337.pdf
Available at: http://www.ich.org/ﬁleadmin/Public_Web_Site/ICH_Products/Guidelines/Efﬁcacy/E6_R1/Step4/E6_R1__Guideline.,Non-OADS,/arxiv_data1/oa_pdf/da/54/all0069-1522.PMC4329337.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 311Clinical and Prognostic Features of  Erionite-Induced   Malignant Mesothelioma Ersin Demirer,1 Christian F. Ghattas,2 Mohamed O. Radwan,3 and Elamin M. Elamin3 1Department of Thoracic Medicine, GATA Haydarpa s¸a Training Hospital, Istanbul, Turkey; 2Saint Elizabeth Health Center, Youngstown, OH, USA;   3Division of Pulmonary, Critical Care Medicine and Sleep, University of South Florida, Tampa, FL, USA.",Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This review analytically examines the published data for erionite-related malig - nant pleural mesothelioma (E-MPM) and any data to support a genetically predis - posed mechanism to erionite fiber carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
"3 Review Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.311 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):311-323, 2015",Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 312published and unpublished studies of fiber-related pleural  diseases, mesothelioma, erionite, and tremolite asbestos.",Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
"Erionite-Induced Mesothelioma: A Systemic Review Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 313teau in Turkey was initiated in 1979 and continued through  December 31, 2003.15 The study included 891 men and wom - en aged 20 years or older.",Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 314Table 2.  Review of the Studies Assessing the Clinical and Prognostic Features of Erionite-Induced Malignant Mesothelioma Study 1st author    (yr)n Protocol Diagnostic tests ResultsJadad  score10Evidence  level11 Ataman (1980)552Case report/      retrospective/   diagnosis SEM of lung samples after     development of E-MPMErionite needle-shaped crystals  can be detected     by X-ray diffraction0 2c Sebastien, et al.",Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
Erionite-Induced Mesothelioma: A Systemic Review Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 315(SV40) and the development of MPM was evaluated in a  retrospective study.,Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 316DIAGNOSIS Overall, 11 retrospective studies (22793 patients) and five  prospective (175 patients) studies and two case reports of  one patient each (total 22970 patients) assessed the various  diagnostic modalities of E-MPM.",OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
Erionite-Induced Mesothelioma: A Systemic Review Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 317Table 4.,Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 318ble benefits from the inclusion of alpha-2b-interferon.,Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
Erionite-Induced Mesothelioma: A Systemic Review Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 319months.25 The latter findings were supported by two recent  studies.,Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 320environmental factors, such as radiation, may act singularly  or in combination to induce E-MPM.54 When considering the diagnosis of E-MPM, radiological  assessments play an essential role in diagnosis, staging, and  management decisions for E-MPM.",Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
Erionite-Induced Mesothelioma: A Systemic Review Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 321inal publications for any further details.,Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
Available at: http://www.cebm.net/index.aspx?o=  1025.,Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 32230.,Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
Erionite-Induced Mesothelioma: A Systemic Review Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 32353.,Non-OADS,/arxiv_data1/oa_pdf/f6/20/ymj-56-311.PMC4329339.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 324Comparison of  Two Different Doses of  Single Bolus Steroid  Injection to Prevent Atrial Fibrillation Recurrence   after Radiofrequency Catheter Ablation  Da-Rae Kim,1 Hoyoun Won,1 Jae-Sun Uhm,1 Jong-Youn Kim,1 Jung-Hoon Sung,2   Hui-Nam Pak,1 Moon-Hyoung Lee,1 and Boyoung Joung1 1Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul; 2Division of Cardiology, Department of Internal Medicine, Bundang CHA Medical Center, CHA University, Seongnam, Korea.",Non-OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Steroids may play a role in preventing the early recurrence of atrial fibril- lation (AF) after radiofrequency catheter ablation (RFCA).",Non-OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
"AF is associated with a consid - erable number of comorbidities including a 3-fold increase in the risk of heart failure  and a 5-fold increase in the risk of stroke.1-3 Radiofrequency catheter ablation  (RFCA) is an effective treatment for drug-refractory AF with 33‒86% of patients Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.324 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):324-331, 2015",Non-OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
"Steroid and AF Ablation Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 325ty Hospital (Seoul, Korea) from July 2007 through Decem - ber 2012.",Non-OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 326catheter ablation.,Non-OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
"Steroid and AF Ablation Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 327morbidities, and echocardiographic parameters were not dif - ferent among the 3 groups.",OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 3283 groups.,Non-OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
"Steroid and AF Ablation Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 329rence are not fully established, even in cardiac surgery stud - ies.",Non-OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 330ation and perpetuation of atrial fibrillation: a systematic review of  the published data.,Non-OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
Steroid and AF Ablation Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 3311999;67:1006-11.,Non-OADS,/arxiv_data1/oa_pdf/69/04/ymj-56-324.PMC4329340.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 332Association of  the Single-Nucleotide Polymorphism and  Haplotype of  the Complement Receptor 1 Gene with Malaria Yan Lan,1* Chuan-Dong Wei,2* Wen-Cheng Chen,2* Jun-Li Wang,2 Chun-Fang Wang,2   Guo-Gang Pan,2 Ye-Sheng Wei,2 and Le-Gen Nong3  Departments of 1Dermatology and 2Laboratory Medicine, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi; 3Institute of Medical Laboratory, Youjiang Medical University for Nationalities, Baise, Guangxi, P .",Non-OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Although the polymorphisms of erythrocyte complement receptor type 1  (CR1) in patients with malaria have been extensively studied, a question of whether the polymorphisms of CR1 are associated with severe malaria remains controver - sial.",Non-OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
"2,3  Although there were variety of causes to cause those disease patterns, but recent researches have shown that lack of erythrocyte complement regulatory proteins Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.332 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):332-339, 2015",Non-OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
"SNPs of Complement Receptor 1 Gene with Malaria Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 333Kingdom has recently been shown to be not associated with  polymorphisms in the 3’ untranslated regions of the CR1  gene.22 Although, little is known about the role of single nu - cleotide polymorphisms (SNPs) of CR1 gene in the develop - ment of malaria, National Center for Biotechnology Informa - tion SNP database showed that CR1 gene rs2274567 G/A,  rs4844600 G/A, and rs2296160 C/T sites (all are located on  coding region) have frequencies of polymorphism distribu - tion in different ethnicity, including Chinese.",Non-OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 334CGC AGA AGG TAA AAT GAG AGT ATG T-3’ were  used to amplify a fragment, which included CR1 gene  rs2296160 site, by polymerase chain reaction (PCR).",OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
"SNPs of Complement Receptor 1 Gene with Malaria Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 335Haplotype analysis of the CR1 gene Haplotype analyses were performed, and the possible eight  haplotype frequencies are shown in Table 4.",OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 336complement receptor type 1 (E-CR1) expression, leading to  the accumulation of immune complexes.",Non-OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
"SNPs of Complement Receptor 1 Gene with Malaria Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 337expression of erythrocyte-CR1 and contributes to protect  against cerebral malaria in Thailand.23 However, the intron  27 and exon 33 variants of CR1 gene did not influence the  level of erythrocyte-CR1 expression in African popula - tion.21 In the present study, we found no apparent relation - ship of the CR1 gene CR1 gene rs2274567 G/A, rs4844600  G/A, and rs2296160 C/T sites polymorphisms with the risk  of malaria.",Non-OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 338agnosis of viral and bacterial infections.,Non-OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
SNPs of Complement Receptor 1 Gene with Malaria Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 339setting mediated by a parasite-variant erythrocyte membrane pro - tein and complement-receptor 1.,Non-OADS,/arxiv_data1/oa_pdf/78/d3/ymj-56-332.PMC4329341.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 340Potential Role of  Immunodiagnosis for Pulmonary   Tuberculosis Using Induced Sputum Cells Doosoo Jeon,1 Seung Eun Lee,1 Woo Hyun Cho,1 Byung Hee Lee,1 Yun Seong Kim,1   Ji-Eun Lee,2 Eun-Soon Son,2 Ye-Jin Lee,2 Min-Sun Hong,2 and Seok-Yong Eum2 1Department of Internal Medicine, Pusan National University School of Medicine, Yangsan;  2International Tuberculosis Research Center, Changwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To evaluate the diagnostic utility and predictors for determinate results  of an enzyme-linked immunospot assay using induced sputum cells (IS ELISPOT) for a rapid diagnosis of pulmonary tuberculosis (TB).",Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
"4-7 Several previous studies on enzyme linked immunospot (ELISOPT) assays  using bronchoalveolar lavage mononuclear cells have indicated the potential of Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.340 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):340-347, 2015",Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
Immunodiagnosis Using Induced Sputum Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 341All subjects were pre-medicated with 200 μg of salbutamol  via a metered-dose inhaler 30 minutes prior to sputum in - duction.,Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 342(28%) did not produce sputum spontaneously.,Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
Immunodiagnosis Using Induced Sputum Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 343and differential cell counts were performed.,Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 344(25%, 3/12) in smear-negative samples, suggesting that IS  ELISPOT may increase diagnostic accuracy for smear-neg - ative TB when smear microscopy is unhelpful.",Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
"Immunodiagnosis Using Induced Sputum Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 345dos, et al.18 reported earlier that patients with advanced TB  had lower lymphocyte numbers and IFN- γ levels in the in - volved lobe than those with less advanced TB.",Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 346ditional diagnostic yields to microbiological tools for rapid  diagnosis for smear-negative TB.,Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
Immunodiagnosis Using Induced Sputum Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 347ropean Trialsgroup study.,Non-OADS,/arxiv_data1/oa_pdf/b4/84/ymj-56-340.PMC4329342.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 348Risk Factors for Mortality in Patients   with Serratia marcescens  Bacteremia Sun Bean Kim,1,2 Yong Duk Jeon,1 Jung Ho Kim,1 Jae Kyoung Kim,1 Hea Won Ann,1 Heun Choi,1   Min Hyung Kim,1,2 Je Eun Song,1,2 Jin Young Ahn,1,2 Su Jin Jeong,1,2 Nam Su Ku,1,2   Sang Hoon Han,1,2 Jun Yong Choi,1,2 Young Goo Song,1,2 and June Myung Kim1,2 1Division of Infectious Disease, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul; 2AIDS Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/07/1e/ymj-56-348.PMC4329343.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Over the last 30 years, Serratia marcescens (S. marcescens) has emerged  as an important pathogen, and a common cause of nosocomial infections.",Non-OADS,/arxiv_data1/oa_pdf/07/1e/ymj-56-348.PMC4329343.pdf
"1,2 Risk fac-Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.348 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):348-354, 2015",Non-OADS,/arxiv_data1/oa_pdf/07/1e/ymj-56-348.PMC4329343.pdf
"Risk Factors for Mortality of Serratia marcescens Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 349ples obtained from a patient, combined with clinical symp - toms compatible with systemic inflammatory response syn - drome.15 Hospital-acquired bacteremia was defined as a  positive blood culture taken from a patient no sooner than  48 h after hospital admission, whereas healthcare-associat - ed bacteremia was defined as a positive blood culture taken  from a patient receiving home and/or ambulatory intrave - nous therapy, hemodialysis, wound care, chemotherapy, or  nursing care, or who had attended a hospital clinic within  the last 30 days; patients hospitalized in an acute care hos - pital for ≥2 days within the last 90 days; or those living in a  nursing home or long-term care facility.16 The primary site  of infection was presumed to be the source of bacteremia if  S. marcescens  was identified from any culture specimens at  the time of bacteremia onset; if S. marcescens  was not iden - tified from any culture other than the blood, the source was  presumed to be primary bacteremia.",Non-OADS,/arxiv_data1/oa_pdf/07/1e/ymj-56-348.PMC4329343.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 350and underlying conditions of all patients with S. marces - cens bacteremia.,Non-OADS,/arxiv_data1/oa_pdf/07/1e/ymj-56-348.PMC4329343.pdf
Risk Factors for Mortality of Serratia marcescens Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 351Table 1.,Non-OADS,/arxiv_data1/oa_pdf/07/1e/ymj-56-348.PMC4329343.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 352years), pneumonia, hemorrhage, shock, inappropriate treat - ment, leukocytosis (leukocyte count >20000/mm3), throm - bocytopenia (platelet count <50000/mm3), hyperbilirubine - mia (serum total bilirubin >18 µmol/L), ICU stay, rapidly  fatal or ultimately fatal disease, existence of poly-microor - ganisms, and unknown portal of entry.7,12,29-31 Previous stud - ies reports have directly investigated the association between  chronic, fatal conditions and S. marcescens -associated bacte - remia.12,31 Watanakunakorn reported that both rapidly fatal  and ultimately fatal diseases influenced the rate of mortality  in S. marcescens  bacteremia-related patients with no under - lying conditions.",Non-OADS,/arxiv_data1/oa_pdf/07/1e/ymj-56-348.PMC4329343.pdf
"Risk Factors for Mortality of Serratia marcescens Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 353conducted in larger patient populations involving multiple  centers, are necessary to more accurately identify the risk  factors associated with mortality in S. marcescens  bactere - mia.",Non-OADS,/arxiv_data1/oa_pdf/07/1e/ymj-56-348.PMC4329343.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 35426.,Non-OADS,/arxiv_data1/oa_pdf/07/1e/ymj-56-348.PMC4329343.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 355Total Surface Area Is Useful for Differentiating between Aggressive  and Favorable Multifocal Papillary Thyroid Carcinomas Jung-Soo Pyo,1 Jin Hee Sohn,1 Guhyun Kang,2 Dong-Hoon Kim,1 and Jisup Yun3 Departments of 1Pathology and 3Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul; 2Department of Pathology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b2/dd/ymj-56-355.PMC4329344.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The purpose of the present study was to identify more useful parameters  for predicting behaviors of multifocal papillary thyroid carcinoma (PTC).",Non-OADS,/arxiv_data1/oa_pdf/b2/dd/ymj-56-355.PMC4329344.pdf
"Multifocal tumors may represent either multiple independent primary tumors or  intraglandular dissemination from a primary tumor, 2 and tumor multifocality has  been found in 20 to 40% of PMCs.3-8 Lymph node metastasis has been observed at Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.355 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):355-361, 2015",Non-OADS,/arxiv_data1/oa_pdf/b2/dd/ymj-56-355.PMC4329344.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 356examination and representative sections with normal-looking  parenchyma from each lobe were histologically examined.,Non-OADS,/arxiv_data1/oa_pdf/b2/dd/ymj-56-355.PMC4329344.pdf
"Role of Total Surface Area in Multifocal Tumors Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 35742.3%, and 61.6% of each TSA group, respectively.",Non-OADS,/arxiv_data1/oa_pdf/b2/dd/ymj-56-355.PMC4329344.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 358Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/dd/ymj-56-355.PMC4329344.pdf
"Role of Total Surface Area in Multifocal Tumors Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 359controversial.19-21 Lin, et al.20 and Mazeh, et al.22 reported  that tumor multifocality is significantly correlated with tu - mor recurrence.",OADS,/arxiv_data1/oa_pdf/b2/dd/ymj-56-355.PMC4329344.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 360of multifocal tumors.,Non-OADS,/arxiv_data1/oa_pdf/b2/dd/ymj-56-355.PMC4329344.pdf
Role of Total Surface Area in Multifocal Tumors Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 361Thyroid 2014;24:245-53.,Non-OADS,/arxiv_data1/oa_pdf/b2/dd/ymj-56-355.PMC4329344.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 362Awareness of  COPD in a High Risk Korean Population Jae Yong Seo,1* Yong Il Hwang,1* So Yeong Mun,1 Jin Hee Kim,1 Joo Hee Kim,1   Sung Hoon Park,1 Seung Hun Jang,1 Yong Bum Park,1 Jae Jung Shim,2 and Ki-Suck Jung1 1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang; 2Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Increased awareness and understanding of chronic obstructive pulmo - nary disease (COPD) is an important aspect of disease management.",Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
"Smokers have a  higher prevalence of respiratory symptoms and lung function abnormalities and a Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.362 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):362-367, 2015",Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
Awareness of COPD Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 363section focused on the subject’s current health status and  symptoms.,Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 364doctors, radio, and the Internet, television was the most com - mon (57.1% of participants).",Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
"Awareness of COPD Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 365of the participants knew that COPD was a respiratory dis - ease, and awareness of COPD was the same among subjects  with and without COPD-related symptoms.",Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 366some smokers.,Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
Awareness of COPD Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 367REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
Available at: http://kosis.kr/statisticsList/statisticsList_  03List.jsp?vwcd=MT_RTITLE&parmTabId=M_03_01#SubCon.,OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
Available at: http://www.hira.or.kr.,Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
Available at: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/8e/40/ymj-56-362.PMC4329345.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 368Exponential Rise in Prostate-Specific Antigen (PSA)   during Anti-Androgen Withdrawal Predicts PSA Flare   after Docetaxel Chemotherapy in Patients   with Castration-Resistant Prostate Cancer  Kyung Seok Han and Sung Joon Hong Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/95/5d/ymj-56-368.PMC4329346.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To investigate the relationship between rising patterns of prostate-specific  antigen (PSA) before chemotherapy and PSA flare during the early phase of chemo - therapy in patients with castration-resistant prostate cancer (CRPC).",Non-OADS,/arxiv_data1/oa_pdf/95/5d/ymj-56-368.PMC4329346.pdf
"Key Words:    Prostate cancer, castration-resistant, prostate-specific antigen, pros - tate-specific antigen doubling time, prostate-specific antigen flare INTRODUCTION Prostate cancer is the most common cancer in Western countries, and its incidence  has been rapidly rising in Asia.1-4 Androgen deprivation therapy treats advanced  prostate cancer effectively for a considerable amount of time; however, most pa -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.368 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):368-374, 2015",Non-OADS,/arxiv_data1/oa_pdf/95/5d/ymj-56-368.PMC4329346.pdf
"PSA Doubling Time Predicts PSA Flare in CRPC Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 369MATERIALS AND METHODS Study sample From 2002 to 2008, 98 patients with CRPC received sys - temic chemotherapy at our institution.",Non-OADS,/arxiv_data1/oa_pdf/95/5d/ymj-56-368.PMC4329346.pdf
"Kyung Seok Han and Sung Joon Hong Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 370IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/95/5d/ymj-56-368.PMC4329346.pdf
PSA Doubling Time Predicts PSA Flare in CRPC Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 371patients (9.1%) in whom PSADT2 was longer than PSADT1  experienced PSA flare.,Non-OADS,/arxiv_data1/oa_pdf/95/5d/ymj-56-368.PMC4329346.pdf
Kyung Seok Han and Sung Joon Hong Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 372tial growth.,Non-OADS,/arxiv_data1/oa_pdf/95/5d/ymj-56-368.PMC4329346.pdf
PSA Doubling Time Predicts PSA Flare in CRPC Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 373REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/95/5d/ymj-56-368.PMC4329346.pdf
Kyung Seok Han and Sung Joon Hong Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 374Prostate 2009;69:1802-7.,Non-OADS,/arxiv_data1/oa_pdf/95/5d/ymj-56-368.PMC4329346.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 375The Characteristics of  Recurrent Upper Tract Urothelial  Carcinoma after Radical Nephroureterectomy   without Bladder Cuff  Excision Minyong Kang, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, and Ja Hyeon Ku Department of Urology, Seoul National University Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fd/38/ymj-56-375.PMC4329347.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To investigate oncological outcomes based on bladder cuff excision  (BCE) during radical nephroureterectomy (RNU) for upper tract urothelial carci - noma (UTUC) and to provide clinical evidence of tumor recurrence in patients  without BCE.",Non-OADS,/arxiv_data1/oa_pdf/fd/38/ymj-56-375.PMC4329347.pdf
"1,2 Although relatively rare, the incidence of UTUC  seems to be increasing gradually.3,4 UTUC cells can spread via the urine and seed Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.375 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):375-381, 2015",Non-OADS,/arxiv_data1/oa_pdf/fd/38/ymj-56-375.PMC4329347.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 376tissues due to severe adhesion of tumors to the adjacent or - gans.,Non-OADS,/arxiv_data1/oa_pdf/fd/38/ymj-56-375.PMC4329347.pdf
"Recurrent Upper Tract Urothelial Carcinoma Features Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 377analyses using IBM SPSS Statistics 19.0 (SPSS Inc., an IBM  Company, Chicago, IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/fd/38/ymj-56-375.PMC4329347.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 378rence sites varied as follows: remnant ureter (n=14, 40.0%),  bladder (n=10, 28.6%), lymph nodes (n=3, 8.6%), multiple  liver and lung (n=3, 8.6%), ureteroileal anastomotic site  (n=1), duodenum (n=1), and vertebra (n=1).",Non-OADS,/arxiv_data1/oa_pdf/fd/38/ymj-56-375.PMC4329347.pdf
"Recurrent Upper Tract Urothelial Carcinoma Features Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 379nephroureterectomy also leads to high rates of tumor recur - rence in the residual ureteral stump of 30‒60%.8 Therefore,  European Association of Urology (EAU) guidelines recom - mend that BCE should be carried out at the time of RNU to  improve clinical and oncological outcomes.7 In the present  study, 61.4% (35/57) of patients without BCE experienced  tumor recurrence after RNU.",Non-OADS,/arxiv_data1/oa_pdf/fd/38/ymj-56-375.PMC4329347.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 380state (pT ≥3), and higher proportion of non-organ confined  tumors may influence the higher recurrence rate of UTUC  after surgery.",Non-OADS,/arxiv_data1/oa_pdf/fd/38/ymj-56-375.PMC4329347.pdf
Recurrent Upper Tract Urothelial Carcinoma Features Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 381urethral incision of the ureteral orifice.,Non-OADS,/arxiv_data1/oa_pdf/fd/38/ymj-56-375.PMC4329347.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 382Obesity Is Not Associated with Increased Operative  Complications in Single-Site Robotic Partial Nephrectomy Christos Komninos, Patrick Tuliao, Kyo Chul Koo, Chien-Hsiang Chang,   Woong Kyu Han, and Koon Ho Rha Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/cb/c0/ymj-56-382.PMC4329348.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To evaluate the impact of high body mass index (BMI) on outcomes fol - lowing robotic laparoendoscopic single-site surgery (R-LESS) robotic-assisted lap - aroscopic partial nephrectomy (RPN).",Non-OADS,/arxiv_data1/oa_pdf/cb/c0/ymj-56-382.PMC4329348.pdf
"Key Words:    Body mass index, partial nephrectomy, robotic surgery INTRODUCTION The development of imaging techniques has increased the detection rates of small - er size and lower stage renal cell carcinomas (RCC).1 Therefore, renal surgery is  steadily evolving towards nephron-sparing minimally invasive procedures.2 Ro- botic-assisted laparoscopic partial nephrectomy (RPN) is a minimally invasive  technique associated with good functional and oncologic outcomes in the treat - ment of small and medium size renal masses.3 RPN can be performed by either the  multi-port (conventional) approach or by the laparoendoscopic single-site tech -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.382 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):382-387, 2015",Non-OADS,/arxiv_data1/oa_pdf/cb/c0/ymj-56-382.PMC4329348.pdf
"Obesity and Single-Site Robotic Partial Nephrectomy Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 383tion of warm ischemia time (WIT) less than 20 minutes,  negative surgical margins and no surgical complications as  a denotation of oncological and surgical safety, respective - ly.11 Postoperative complications were recorded for a dura - tion of three months after surgery, according to Clavien- Dindo classification system.12 Preoperative clinical and demographic characteristics  [age, gender, BMI, tumor size, physical status classification  of American Society of Anesthesiologists (ASA), estimated  glomerular filtration rate (eGFR), R.E.N.A.L.",Non-OADS,/arxiv_data1/oa_pdf/cb/c0/ymj-56-382.PMC4329348.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 384ences between the groups regarding to postoperative renal  function, as estimated by the measurement of eGFR and the  eGFR percentage change at postoperative day 1, 1 week, 1  month, 3 months, 6 months, and 1 year after surgery ( p=0.87  and 0.53, 0.78 and 0.98, 0.72 and 0.45, 0.61 and 0.42, 0.80  and 0.97, 0.84 and 0.29, respectively) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/cb/c0/ymj-56-382.PMC4329348.pdf
"Obesity and Single-Site Robotic Partial Nephrectomy Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 385served lower Trifecta rates in the R-LESS PN group than  previously published studies.19 This could probably be ex - plained by the stringent definition of Trifecta that we have  used in our analysis (WIT <20 min, no complications, nega - tive margins).",Non-OADS,/arxiv_data1/oa_pdf/cb/c0/ymj-56-382.PMC4329348.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 386the authors concluded that RPN can be safely performed in  high-volume centers.,Non-OADS,/arxiv_data1/oa_pdf/cb/c0/ymj-56-382.PMC4329348.pdf
Obesity and Single-Site Robotic Partial Nephrectomy Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 38711.,Non-OADS,/arxiv_data1/oa_pdf/cb/c0/ymj-56-382.PMC4329348.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 388Clinical Experience of  Glioma Surgery Using “Tailed Bullet”:  Overcoming the Limitations of  Conventional   Neuro-Navigation Guided Surgery Jin Mo Cho,1 Jae Joon Lim,2 Se-Hyuk Kim,3 and Kyung Gi Cho2 1Department of Neurosurgery, Catholic Kwandong University, International St. Mary ’s Hospital, Incheon; 2Department of Neurosurgery, Bundang CHA Medical Center, CHA University College of Medicine, Seongnam; 3Department of Neurosurgery, Ajou University School of Medicine, Suwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Although conventional neuro-navigation is a useful tool for image-guid - ed glioma surgery, there are some limitations, such as brain shift.",Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
"Even  though there is little doubt for low-grade gliomas, but there is growing evidence that radical excision is associated with improved outcomes in the management of Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.388 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):388-396, 2015",Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
"Image Guided Surgery Using “Tailed Bullet” Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 389in a given operation was dependent on the location, size,  and shape of a lesion and the purpose of bullet insertion.",Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 390Patient population A retrospective review was performed for 110 cases of glio - ma resected using the tailed bullet method.,Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
Image Guided Surgery Using “Tailed Bullet” Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 391number of bullets had no relation with GTR rate ( p=0.90).,Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 392tion guidance.,Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
"Image Guided Surgery Using “Tailed Bullet” Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 393neurologic deficits.27,28 Also, although a trial is currently un - dergoing for 5-ALA in patients with low-grade gliomas,  currently its indication is limited to high-grade gliomas (en - hancing lesions).29 Compared to the results reported for  these methods, we were able to obtain a higher rate of GTR  (13/14, 92.9%) for patients with low-grade gliomas.",Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 394non-enhancing glioma, such that the method appears to be a  valid option to increase the accuracy of conventional neuro- navigation.",Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
Image Guided Surgery Using “Tailed Bullet” Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 395tion system in a multidisciplinary operating suite.,Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 396Laws ER, et al.",Non-OADS,/arxiv_data1/oa_pdf/62/72/ymj-56-388.PMC4329349.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 397The Use of  Magnetic Resonance Imaging in Predicting   the Clinical Outcome of  Spinal Arteriovenous Fistula Dong Ah Shin,1,2 Keun Young Park,1 Gyu Yeul Ji,1,2 Seong Yi,1 Yoon Ha,1,2   Seoung Woo Park,3 Do Heum Yoon,1,2 and Keung Nyun Kim1,2 1Department of Neurosurgery, 2Spine and Spinal Cord Research Institute, Yonsei University College of Medicine, Seoul; 3Department of Neurosurgery, Kangwon National University College of Medicine, Chuncheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/df/f6/ymj-56-397.PMC4329350.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Magnetic resonance imaging (MRI) has been used to screen and follow- up spinal dural arteriovenous fistulae (SDA VF).",Non-OADS,/arxiv_data1/oa_pdf/df/f6/ymj-56-397.PMC4329350.pdf
"Key Words:    Spine, dural arteriovenous fistula, magnetic resonance imaging, neu - rologic manifestations INTRODUCTION Arteriovenous malformation is a rare condition in the spine and affects approxi - mately 10% of the brain.1 Among spinal arteriovenous malformations, spinal dural  arteriovenous fistulae (SDA VF) are the most common and account for 70% of cas - es.2 Treatment is often necessary, as abnormal communication between arteries  and veins may result in ischemia or infarction in the spinal cord;2 however, its rari - ty limits proper treatment planning and precise outcome prediction.3 Although an - giography is the most precise diagnostic tool for SDA VF, it may cause procedural  complications, such as puncture site haematoma, intra- and extra-spinal vessel in -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.397 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):397-402, 2015",Non-OADS,/arxiv_data1/oa_pdf/df/f6/ymj-56-397.PMC4329350.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 398ing from 18 to 36 months.,Non-OADS,/arxiv_data1/oa_pdf/df/f6/ymj-56-397.PMC4329350.pdf
"MRI Findings of Spinal A VF Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 399used SPSS 13.0 (SPSS Inc., Chicago, IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/df/f6/ymj-56-397.PMC4329350.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 400MRI, enhanced T1-weighted MRI with Gd was a good alter - native to reveal arterialized perimedullary veins.",Non-OADS,/arxiv_data1/oa_pdf/df/f6/ymj-56-397.PMC4329350.pdf
MRI Findings of Spinal A VF Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 401This study showed that poor functional outcomes are asso - ciated with longer symptom duration.,Non-OADS,/arxiv_data1/oa_pdf/df/f6/ymj-56-397.PMC4329350.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 40270:360-70.,Non-OADS,/arxiv_data1/oa_pdf/df/f6/ymj-56-397.PMC4329350.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 403Incidence and Risk Factors for Rebleeding during Cerebral  Angiography for Ruptured Intracranial Aneurysms Yong Cheol Lim,1 Chang-Hyun Kim,2 Yong Bae Kim,3 Jin-Yang Joo,3   Yong Sam Shin,4 and Joonho Chung3 1Department of Neurosurgery, Ajou University School of Medicine, Suwon; 2Department of Neurosurgery, Keimyung University School of Medicine, Dongsan Medical Center, Daegu; 3Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul; 4Department of Neurosurgery, Seoul St. Mary ’s Hospital, The Catholic University of Korea, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7d/ea/ymj-56-403.PMC4329351.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The purpose was to evaluate the incidence and risk factors for rebleeding  during cerebral angiography in ruptured intracranial aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/7d/ea/ymj-56-403.PMC4329351.pdf
"1,2 3DRA has recently been regarded as an im -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.403 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):403-409, 2015",Non-OADS,/arxiv_data1/oa_pdf/7d/ea/ymj-56-403.PMC4329351.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 404was defined as the ratio of the maximum width of the dome  to the average neck diameter on 3DRA.10 Aspect ratio was  defined as the ratio of the maximum perpendicular height  to the average neck diameter on 3DRA.,Non-OADS,/arxiv_data1/oa_pdf/7d/ea/ymj-56-403.PMC4329351.pdf
Rebleeding during DSA for Ruptured Aneurysms Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 405sis was performed to determine the association of rebleed - ing with other factors.,Non-OADS,/arxiv_data1/oa_pdf/7d/ea/ymj-56-403.PMC4329351.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 406a power injector, the linear rate rise of the injector allows for  a linear acceleration of the contrast injection over the first  timing interval of the injector.",Non-OADS,/arxiv_data1/oa_pdf/7d/ea/ymj-56-403.PMC4329351.pdf
"Rebleeding during DSA for Ruptured Aneurysms Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 407multivariate analysis (odds ratio=3.040; 95% CI, 1.896 to  10.309; p=0.041) for rebleeding during DSA.",Non-OADS,/arxiv_data1/oa_pdf/7d/ea/ymj-56-403.PMC4329351.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 408REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/ea/ymj-56-403.PMC4329351.pdf
Rebleeding during DSA for Ruptured Aneurysms Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 4092011;44:2809-16.,Non-OADS,/arxiv_data1/oa_pdf/7d/ea/ymj-56-403.PMC4329351.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 410Factors Associated with Ischemic Stroke on Therapeutic  Anticoagulation in Patients with Nonvalvular Atrial Fibrillation  Young Dae Kim,1 Kyung Yul Lee,2 Hyo Suk Nam,1 Sang Won Han,3 Jong Yun Lee,4 Han-Jin Cho,5   Gyu Sik Kim,6 Seo Hyun Kim,7 Myoung-Jin Cha,8 Seong Hwan Ahn,9 Seung-Hun Oh,10 Kee Ook Lee,11   Yo Han Jung,12 Hye-Yeon Choi,13 Sang-Don Han,14 Hye Sun Lee,15 Chung Mo Nam,16 Eun Hye Kim,1   Ki Jeong Lee,1 Dongbeom Song,1 Hui-Nam Park,17 and Ji Hoe Heo1 1Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul; 2Department of Neurology, Gangnam Severance Hospital,  Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul; 3Department of Neurology, Sanggye Paik Hospital,  Inje University College of Medicine, Seoul; 4Department of Neurology, National Medical Center, Seoul; 5Department of Neurology,  Pusan National University Hospital, Pusan National University College of Medicine and Biomedical Research Institute, Busan; 6Department of Neurology,  National Health Insurance Corporation Ilsan Hospital, Goyang; 7Department of Neurology, Yonsei University Wonju College of Medicine, Wonju;  8Department of Neurology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon; 9Department of Neurology,   Chosun University School of Medicine, Gwangju; 10Department of Neurology, CHA Bundang Medical Center, CHA University, Seongnam;   11Department of Neurology, Konyang University College of Medicine, Daejeon; 12Department of Neurology, Changwon Fatima Hospital, Changwon;  13Department of Neurology, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul;  14Department of Neurology, School of Medicine, Konkuk University, Chungju;  Departments of 15Biostatistics, 16Preventive Medicine, and 17Cardiology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: In this study, we investigated the stroke mechanism and the factors associ - ated with ischemic stroke in patients with nonvalvular atrial fibrillation (NV AF) who  were on optimal oral anticoagulation with warfarin.",Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
"Key Words:    Cardiac embolism, cerebral infarction, risk factors, atrial fibrillation,  anticoagulationOriginal Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.410 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):410-417, 2015",Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
Ischemic Stroke during Therapeutic Anticoagulation Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 411the department of neurology or cardiology at each study  hospital during the same time period.,Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 412followed by multiple arterial territories (9/50, 18.0%), brain - stem (5/50, 10.0%), and posterior cerebral artery territory  (1/50, 2.0%).",Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
Ischemic Stroke during Therapeutic Anticoagulation Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 413ischemic strokes or TIA were (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 414Our findings suggest that warfarin treatment with INR  2.0‒3.0 may be insufficient to effectively prevent stroke in  patients with higher CHADS 2 score (≥3) or CHA 2DS 2-V ASc  score (≥5) with a previous stroke or TIA.,Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
"Ischemic Stroke during Therapeutic Anticoagulation Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 415activation as well as blood stasis in the left atrium.25 Smok - ing can inhibit secretion of endogenous tissue plasminogen  activator, increase the plasminogen activator inhibitor-1 ac - tivity, induce systemic inflammation, activate platelets, and  damage endothelial cells, which may subsequently lead to a  hypercoagulable state.26,27 Smoking is a modifiable risk fac - tor.28 Our results suggest that cessation of smoking is essen - tial to further reduce stroke risks in patients with NV AF  who are treated with OAC.",Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 416Radford MJ.,Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
Ischemic Stroke during Therapeutic Anticoagulation Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 417atrial fibrillation: Virchow’s triad revisited.,Non-OADS,/arxiv_data1/oa_pdf/80/f2/ymj-56-410.PMC4329352.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 418Exploring the Non-Linear Relationship between Alcohol  Consumption and Depression in an Elderly Population   in Gangneung: The Gangneung Health Study Sang-A Kim,1 Eunyoung Kim,2 Robert G. Morris,3 and Woong-Sub Park4 1Department of Silver Welfare, Dong Seoul College, Seongnam, Korea; 2Department of Police Administration & Crime Investigation, Catholic Kwandong University, Gangneung, Korea; 3School of Economic, Political and Policy Sciences, University of Texas at Dallas, TX, USA; 4Department of Preventive Medicine & Public Health, College of Medicine, Catholic Kwandong University, Gangneung, Korea.",Non-OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The purpose of this study was to examine a J-shaped relationship be - tween alcohol consumption and depression among the elderly in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
"Key Words:    Depression, alcohol consumption, AUDIT, BDI, a J-shaped relation - ship, South Korean elderly population in Gangneung city INTRODUCTION Co-morbidity between hazardous alcohol use and various types of mental prob - lems is well established in the literature.1-7 Studies consistently demonstrate that  excessive levels of alcohol consumption are associated with an elevated risk of de - pressive symptoms and various types of mental disorders.6-9 There remains, how - ever, a debate regarding the strength and direction of this relationship.10-14 Recent  studies have offered evidence in support of the existence of a curvilinear, J-shaped, Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.418 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):418-425, 2015",Non-OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
"Non-Linearity of Alcohol Consumption and Depression Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 419when assessing there relation to alcohol consumption.18,19  MATERIALS AND METHODS Participants, data, and sampling The present study utilized a cross-sectional survey of indi - viduals that collected information specific to alcohol con - sumption and depression among a community-based sample  of individuals aged 60 years or older, residing in Gangneung  city, South Korea.",OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 420ponent ranging from 0 to 100.,Non-OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
"Non-Linearity of Alcohol Consumption and Depression Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 421ble, women were more likely report depression than men.",Non-OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 422model, specifically, a quadratic term of AUDIT2, which is a  separate score of AUDIT, was included in order to test for a  curvilinear relationship between problem alcohol use and  depression.",Non-OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
Non-Linearity of Alcohol Consumption and Depression Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 423DISCUSSION The goal of the present study was to examine whether there  exists a J-shaped relationship between alcohol consumption  and depression in a Korean elderly population after control - ling for various known correlates of depression.,Non-OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 424MCS is a confounding factor that needs to be controlled for  in clarifying a relationship between alcohol use and depres - sion.,Non-OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
Non-Linearity of Alcohol Consumption and Depression Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 42510.,Non-OADS,/arxiv_data1/oa_pdf/77/95/ymj-56-418.PMC4329353.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 426Effects of  Interleukin-13 and Montelukast on the Expression   of  Zonula Occludens-1 in Human Podocytes Se Jin Park,1,2 Moin A. Saleem,3 Ja-Ae Nam,4 Tae-Sun Ha,4 and Jae Il Shin2 1Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea; 2Department of Pediatrics, Severance Children ’s Hospital, Yonsei University College of Medicine, Seoul, Korea; 3Children ’s and Academic Renal Unit, Southmead Hospital, University of Bristol, Bristol, United Kingdom; 4Department of Pediatrics, Chungbuk National University College of Medicine, Cheongju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fd/8a/ymj-56-426.PMC4329354.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The aim of this study was to investigate whether pathologic changes in  zonula occludens-1 (ZO-1) are induced by interleukin-13 (IL-13) in the experi - mental minimal-change nephrotic syndrome (MCNS) model and to determine whether montelukast, a leukotriene receptor antagonist, has an effect on ZO-1 res - toration in cultured human podocytes.",Non-OADS,/arxiv_data1/oa_pdf/fd/8a/ymj-56-426.PMC4329354.pdf
"2 Glomerular SDs, a major selective barrier for proteins,  reside in the cell-to-cell contact sites between neighboring podocytes, which are thought to be modified adherens junctions that consist of an increasing number of Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.426 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):426-432, 2015",Non-OADS,/arxiv_data1/oa_pdf/fd/8a/ymj-56-426.PMC4329354.pdf
"Effects of Interleukin-13 on Podocytes Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 427MATERIALS AND METHODS Cell culture of human podocytes Human conditionally immortalized podocytes (AB8/23),  primarily cloned from human glomerular cultures, were  characterized and generously provided by Dr. Moin A. Sal - eem (University of Bristol, Bristol, UK).",Non-OADS,/arxiv_data1/oa_pdf/fd/8a/ymj-56-426.PMC4329354.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 428propriate under different conditions.,Non-OADS,/arxiv_data1/oa_pdf/fd/8a/ymj-56-426.PMC4329354.pdf
"Effects of Interleukin-13 on Podocytes Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 42913 may induce a minimal-change-like nephropathy through  a reduction in ZO-1 molecules, which can be reversed by a  high dose of the LTRA montelukast.",Non-OADS,/arxiv_data1/oa_pdf/fd/8a/ymj-56-426.PMC4329354.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 430over the GBM, and reconstruction of the SD.3,23 Permselec - tivity of the glomerular filtration barrier, which is composed  of a charge-selective barrier and a size-selective barrier,  also plays a key role in restricting passage of plasma pro - teins across the GBM and SD.25,26 ZO is a member of the membrane-associated guanylate  kinase homologue family of proteins characterized by their  PSD-95/discs-large/Zonula occludens-1 (PDZ) domain;  these proteins are critical regulators of tight and adherens  junction assembly.27 ZO connects several types of SD pro - teins through its PDZ domain to the actin cytoskeleton.",OADS,/arxiv_data1/oa_pdf/fd/8a/ymj-56-426.PMC4329354.pdf
"Effects of Interleukin-13 on Podocytes Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 431and restored the normal localization of ZO-1 at the SD in the  spontaneously proteinuric Munich-Wistar-Froemter rats.38  Additional future studies are necessary to elucidate the ex - act mechanisms, efficacy, and proper dose of LTRA in the  in vivo  treatment of MCNS in the future.",Non-OADS,/arxiv_data1/oa_pdf/fd/8a/ymj-56-426.PMC4329354.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 432tion.,Non-OADS,/arxiv_data1/oa_pdf/fd/8a/ymj-56-426.PMC4329354.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 433Efficacy of  Surfactant-TA, Calfactant and Poractant Alfa   for Preterm Infants with Respiratory Distress Syndrome:   A Retrospective Study Ga Won Jeon,1 Minkyung Oh,2 and Jong Beom Sin1 1Department of Pediatrics, Busan Paik Hospital, Inje University College of Medicine, Busan;  2Department of Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, Korea.",Non-OADS,/arxiv_data1/oa_pdf/11/b2/ymj-56-433.PMC4329355.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To compare the efficacy of the new drug calfactant with the commonly  used drugs surfactant-TA and poractant alfa.",Non-OADS,/arxiv_data1/oa_pdf/11/b2/ymj-56-433.PMC4329355.pdf
"1,2 Preterm infants born before 32  weeks’ gestation have structurally immature lungs at the saccular stage of develop -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.433 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):433-439, 2015",Non-OADS,/arxiv_data1/oa_pdf/11/b2/ymj-56-433.PMC4329355.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 434surfactants in Korea.,Non-OADS,/arxiv_data1/oa_pdf/11/b2/ymj-56-433.PMC4329355.pdf
Efficacy of Surfactants in Korea Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 435rection was performed for comparison of multiple groups.,OADS,/arxiv_data1/oa_pdf/11/b2/ymj-56-433.PMC4329355.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 436minced porcine lung extract that contains the highest amount  of plasmalogen; some studies reported that it is associated  with a decreased risk of BPD.16 Ramanathan17 reported that poractant alfa was associated  with decreased mortality rates compared to beractant or cal - factant, suggesting that the differences in mortality rates may  be related to the composition of surfactants, such as higher  amounts of phospholipids and plasmalogens and a smaller  volume of poractant alfa than other animal-derived surfac - tants.",Non-OADS,/arxiv_data1/oa_pdf/11/b2/ymj-56-433.PMC4329355.pdf
Efficacy of Surfactants in Korea Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 437fore delivery.,Non-OADS,/arxiv_data1/oa_pdf/11/b2/ymj-56-433.PMC4329355.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 438ry of clinical trials.,Non-OADS,/arxiv_data1/oa_pdf/11/b2/ymj-56-433.PMC4329355.pdf
"Efficacy of Surfactants in Korea Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 439C, et al.",Non-OADS,/arxiv_data1/oa_pdf/11/b2/ymj-56-433.PMC4329355.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 440Dermatofibrosarcoma Protuberans: A Study of  Clinical,  Pathologic, Genetic, and Therapeutic Features in Korean Patients Zhenlong Zheng,1,3,4 Junjei Piao,1,3,4 Ji-Hye Lee,2,3 Song-Ee Kim,2   Soo-Chan Kim,2,3 Kee Yang Chung,1,3 and Mi Ryung Roh2,3 1Department of Dermatology, Severance Hospital, Seoul, Korea; 2Department of Dermatology, Gangnam Severance Hospital, Seoul, Korea; 3Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea; 4Department of Dermatology, Yanbian University Hospital, Yanbian, China.",Non-OADS,/arxiv_data1/oa_pdf/72/88/ymj-56-440.PMC4329356.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Dermatofibrosarcoma protuberans (DFSP) carries a translocation result- ing in the collagen type I alpha 1 (COL1A1)-platelet-derived growth factor beta (PDGFB) fusion gene, which is responsible for PDGFB activation.",Non-OADS,/arxiv_data1/oa_pdf/72/88/ymj-56-440.PMC4329356.pdf
"Key Words:    Dermatofibrosarcoma protuberans, collagen type I alpha 1-platelet- derived growth factor beta, histological subtype, Mohs micrographic surgery INTRODUCTION Dermatofibrosarcoma protuberans (DFSP) is a sarcomatous tumor of the cutane - ous tissue first described by Taylor in 1890.1 It is an uncommon infiltrative dermal  and subcutaneous tumor characterized by progressive local growth of CD34+ Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.440 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):440-446, 2015",Non-OADS,/arxiv_data1/oa_pdf/72/88/ymj-56-440.PMC4329356.pdf
DFSP in Korean Patients Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 441rence and any subsequent procedures were collected and  compiled.,Non-OADS,/arxiv_data1/oa_pdf/72/88/ymj-56-440.PMC4329356.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 442AGexpdgf4 primers according to the methods of Greco, et  al.10 To detect the presence of COL1A1-PDGFB  fusion  transcripts, polymerase chain reaction (PCR) was carried  out using 17 COL1A1  forward primers and a specific  PDGFB  reverse primer, as presented in Table 1.",OADS,/arxiv_data1/oa_pdf/72/88/ymj-56-440.PMC4329356.pdf
DFSP in Korean Patients Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 443showed positive margins.,Non-OADS,/arxiv_data1/oa_pdf/72/88/ymj-56-440.PMC4329356.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 444L1A1  (from exon 5 to exon 49) and exon 2 of PDGFB .,OADS,/arxiv_data1/oa_pdf/72/88/ymj-56-440.PMC4329356.pdf
DFSP in Korean Patients Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 44587.5% of cases.,Non-OADS,/arxiv_data1/oa_pdf/72/88/ymj-56-440.PMC4329356.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 446clinicopathologic and immunohistochemical study of a series of  41 cases with emphasis on prognostic significance.,Non-OADS,/arxiv_data1/oa_pdf/72/88/ymj-56-440.PMC4329356.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 447Risk Factors of  Permanent Stomas in Patients with Rectal Cancer  after Low Anterior Resection with Temporary Stomas Chul Min Lee,1 Jung Wook Huh,1 Yoon Ah Park,1 Yong Beom Cho,1 Hee Cheol Kim,1   Seong Hyeon Yun,1 Woo Yong Lee,1 and Ho-Kyung Chun2 1Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 2Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/76/4d/ymj-56-447.PMC4329357.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The aim of this study was to identify risk factors influencing permanent  stomas after low anterior resection with temporary stomas for rectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/76/4d/ymj-56-447.PMC4329357.pdf
"Several recent stud - ies have shown that risk factors for permanent stomas include old age, anastomot -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.447 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):447-453, 2015",Non-OADS,/arxiv_data1/oa_pdf/76/4d/ymj-56-447.PMC4329357.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 448the Institutional Review Board of Samsung Medical Cen - ter, and all patients gave informed consent.",Non-OADS,/arxiv_data1/oa_pdf/76/4d/ymj-56-447.PMC4329357.pdf
"Permanent Stoma in Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 449ileostomies (50.0%), eight colostomies (28.6%), and four  abdominoperineal resections (14.3%), as well as one pa - tient (3.6%) who underwent Hartmann’s operation.",Non-OADS,/arxiv_data1/oa_pdf/76/4d/ymj-56-447.PMC4329357.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 450group was local recurrence, whereas in the stoma non-rever - sal group, the most common reasons were anastomotic-re - lated complications.",Non-OADS,/arxiv_data1/oa_pdf/76/4d/ymj-56-447.PMC4329357.pdf
"Permanent Stoma in Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 451quiring a permanent stoma in two outcomes, namely, non- reversal of the temporary stoma and recreation of the stoma  after reversal.",Non-OADS,/arxiv_data1/oa_pdf/76/4d/ymj-56-447.PMC4329357.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 452Additional risk factors of permanent stomas include old  age, radiation therapy, poor anal function, and distant me - tastasis.",Non-OADS,/arxiv_data1/oa_pdf/76/4d/ymj-56-447.PMC4329357.pdf
Permanent Stoma in Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 4531990;60:253-9.,Non-OADS,/arxiv_data1/oa_pdf/76/4d/ymj-56-447.PMC4329357.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 454How to Minimize Rotational Conflict between Femoral &   Tibial Component in Total Knee Arthroplasty   –The Use of  Femoro-Tibial Axial Synchronizer (Linker)– Jai-Gon Seo,1 Young-Wan Moon,1 Sang-Min Kim,1 and Sang-Hoon Park2 1Department of Orthopaedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul;  2Department of Orthopaedic Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea.",Non-OADS,/arxiv_data1/oa_pdf/22/70/ymj-56-454.PMC4329358.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The purpose of this study was to investigate the correlation between ro - tational axes of femur and tibia with the use of Linker.",Non-OADS,/arxiv_data1/oa_pdf/22/70/ymj-56-454.PMC4329358.pdf
"However, since the rotation of a knee joint includes factors coupled with both femur rotation and tibia rotation, it is better to realize rotational correlative relationship between the femoral and tibial compo -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.454 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):454-459, 2015",Non-OADS,/arxiv_data1/oa_pdf/22/70/ymj-56-454.PMC4329358.pdf
"The Use of Linker in TKA Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 455NJ, USA)- were used for the operation.",Non-OADS,/arxiv_data1/oa_pdf/22/70/ymj-56-454.PMC4329358.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 456tibial resector’s AP pin was parallel with femoral resector’s  AP pin.,Non-OADS,/arxiv_data1/oa_pdf/22/70/ymj-56-454.PMC4329358.pdf
"The Use of Linker in TKA Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 457Regarding ROM of postoperative 3 years, averages were  124.3±12.4 degrees, postoperative KSS score was 92.7±7.0  (62‒100).",OADS,/arxiv_data1/oa_pdf/22/70/ymj-56-454.PMC4329358.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 458and patellofemoral maltracking, thereby weakening anteri - or knee pain.",Non-OADS,/arxiv_data1/oa_pdf/22/70/ymj-56-454.PMC4329358.pdf
The Use of Linker in TKA Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 45912.,Non-OADS,/arxiv_data1/oa_pdf/22/70/ymj-56-454.PMC4329358.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 460Surgical Treatment of  Pathological Fractures   Occurring at the Proximal Femur Won-Sik Choy, Kap Jung Kim, Sang Ki Lee, Dae Suk Yang,   Sang Wook Jeung, Han Gyul Choi, and Hyun Jong Park Department of Orthopaedic Surgery, Eulji University College of Medicine, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/59/00/ymj-56-460.PMC4329359.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To analyze the results of surgical treatment for pathological fractures at  the proximal femur.",Non-OADS,/arxiv_data1/oa_pdf/59/00/ymj-56-460.PMC4329359.pdf
"Up to 70% of patients suffering from malignant tumors develop bone metastases, Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.460 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):460-465, 2015",Non-OADS,/arxiv_data1/oa_pdf/59/00/ymj-56-460.PMC4329359.pdf
Surgical Treatment of Pathological Fractures Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 461chanteric metastatic pathological fractures operated on  between 2006 and 2012 at a single institution.,Non-OADS,/arxiv_data1/oa_pdf/59/00/ymj-56-460.PMC4329359.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 462ing and nailing to minimize direct tumor cell spreading along  the femoral canal.,Non-OADS,/arxiv_data1/oa_pdf/59/00/ymj-56-460.PMC4329359.pdf
Surgical Treatment of Pathological Fractures Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 463of these patients have a limited life expectancy.,Non-OADS,/arxiv_data1/oa_pdf/59/00/ymj-56-460.PMC4329359.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 464of gamma nail fracture.,Non-OADS,/arxiv_data1/oa_pdf/59/00/ymj-56-460.PMC4329359.pdf
Surgical Treatment of Pathological Fractures Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 46519.,Non-OADS,/arxiv_data1/oa_pdf/59/00/ymj-56-460.PMC4329359.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 466Sex-Related Differences in Outcomes after Hallux Valgus Surgery Gi Won Choi,1 Hak Jun Kim,2 Tae Wan Kim,2 Ji Wun Lee,3 Sung Bum Park,3 and Jin Kak Kim3 1Department of Orthopaedic Surgery, Korea University College of Medicine, Ansan Hospital, Ansan; 2Department of Orthopaedic Surgery, Korea University College of Medicine, Guro Hospital, Seoul; 3Department of Orthopaedic Surgery, Veterans Health Service Medical Center, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: With differences between the sexes in foot bone anatomy and ligamen - tous laxity, there is the possibility that the results of hallux valgus surgery may also  differ between the sexes.",Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
"6 The female first metatarsal has a tendency to be more  adducted than that in the male skeleton,5 and ligamentous laxity and first ray hy - permobility are more common in women.3 These differences may underlie the pre -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.466 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):466-473, 2015",Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
Sex-Related Differences in Hallux Valgus Surgery Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 467so-plantar and lateral weightbearing radiographs of the feet  taken preoperatively and at final follow-up.,Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 468in millimeters of the first metatarsal relative to the medial  cuneiform.,Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
Sex-Related Differences in Hallux Valgus Surgery Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 469of our cases.,Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 470HV A and IMA in patients with bony callus were signifi - cantly greater than those of patients without bony callus  (p=0.009 and p<0.001, respectively), and the mean postop - erative HV A and IMA did not differ between the two groups  (p=0.432 and p=0.191, respectively).",Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
Sex-Related Differences in Hallux Valgus Surgery Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 471the existence of true differences in the postoperative HV A  and correction of HV A between male and female patients.,Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 472and the correction of HV A and IMA were significantly greater  in patients with a bony callus than in patients without a bony  callus.,Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
Sex-Related Differences in Hallux Valgus Surgery Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 4738.,Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ymj-56-466.PMC4329360.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 474Perioperative Complications of  Robot-Assisted Laparoscopic  Surgery Using Three Robotic Arms at a Single Institution Ga Won Yim, Sang Wun Kim, Eun Ji Nam, Sunghoon Kim, and Young Tae Kim Department of Obstetrics and Gynecology, Institute of Women ’s Medical Life Science, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The aim of this study was to evaluate perioperative complications of ro - bot-assisted laparoscopic surgery in gynecology.",Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
"Robot-assisted laparoscopic surgery is considered an alternative approach Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.474 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):474-481, 2015",Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
Operative Complications of Robotic Surgery  Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 475All procedures were performed by surgeons experienced  and proficient in advanced laparoscopic gynecologic proce - dures.,Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 476underwent a myomectomy, day two for those who under - went a hysterectomy or endometrial cancer staging surgery,  and on days 7 to 12 after radical hysterectomy.",Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
"Operative Complications of Robotic Surgery  Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 477operative time was 208.5±73.9 minutes, console time was  159.2±66.4 minutes, and docking time was 5.1±3.8 minutes.",Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 478paracentesis at the emergency unit.,Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
Operative Complications of Robotic Surgery  Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 479lymphedema in 103 cases.,Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 480ports, including three robotic arms and one assistant 10-mm  port, for all operations.",Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
"Operative Complications of Robotic Surgery  Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 481Bigsby GE 4th, et al.",Non-OADS,/arxiv_data1/oa_pdf/02/66/ymj-56-474.PMC4329361.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 482What Number of  Oocytes Is Appropriate   for Defining Poor Ovarian Response?,Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: This study attempted to derive an objective and sophisticated definition of  poor ovarian response (POR).",Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
"This unsatisfactory circumstance, usually termed as poor ovarian response (POR), has a psychological impact and places an economic burden on infertile couples.Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.482 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):482-489, 2015",Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
"New Definition of Poor Ovarian Response Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 483the basis of disease prevalence, and for POR, its prevalence  may vary according to a women’s age.",Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 484cal pregnancies.,Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
"New Definition of Poor Ovarian Response Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 485proaches, we speculated that it would be reasonable to cho- ose total oocytes ≤2 or mature oocytes ≤1 as the definition of  POR.",Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 486definition showed a similar predictive performance.,Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
"New Definition of Poor Ovarian Response Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 487vidualized patient data meta-analysis, with no significant  improvement in classification of a poor ovarian response,  above a basal AMH when age, FSH, or AFC were also tak - en into account.",Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 48819.,Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
New Definition of Poor Ovarian Response Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 48935.,Non-OADS,/arxiv_data1/oa_pdf/2e/a1/ymj-56-482.PMC4329362.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 490Minimal Stimulation Using Gonadotropin Combined with  Clomiphene Citrate or Letrozole for Intrauterine Insemination Bo Hyon Yun,1,2 Seung Joo Chon,1,2 Joo Hyun Park,2,3 Seok Kyo Seo,1,2   SiHyun Cho,2,3 Young Sik Choi,1,2 Seok Hyun Kim,4 and Byung Seok Lee1,2 1Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, Seoul; 2Institute of Women ’s Life Medical Science, Yonsei University College of Medicine, Seoul; 3Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul;  4Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To evaluate the efficacy of minimal stimulation using discretely adminis - tered gonadotropin combined with clomiphene citrate (CC) or letrozole (LTZ) for  intrauterine insemination (IUI) cycles.",Non-OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
"Although IUI has not  been included as an assisted reproductive technique, it has been widely applied em -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.490 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):490-496, 2015",Non-OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
Minimal Stimulation Using Gonadotropin for IUI Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 491Only patients aged 25‒42 years with at least one patent  tube were included in this study.,Non-OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 492version 20.0 (IBM Inc., Armonk, NY , USA) by Student t- test and one-way ANOV A to compare means for normally  distributed continuous variables.",Non-OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
"Minimal Stimulation Using Gonadotropin for IUI Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 493thickness on the day of hCG administration was significantly  greater in the alternate-day regimen of 3 days compared to  that of 2 days (8.77±2.11 mm vs. 9.62±1.94 mm, p=0.031).",Non-OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 494with gonadotropin stimulation (cancellation rate, 1.2% vs.  8.4%, respectively).29 In a prospective randomized study  which compared conventional CC/hMG stimulation proto - col to minimal stimulation protocol, the incidence of OHSS  was 3% in conventional stimulation cycles whereas none of  OHSS was developed in minimal stimulation cycles.10 Few - er OHSS cases were observed in our study than in previous  studies10,11 of IUI cycles with minimal stimulation.",Non-OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
Minimal Stimulation Using Gonadotropin for IUI Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 495tioned.,Non-OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
When a power calcula - tion was performed using PS: Power and Sample size calcu - lation software Version 3.0.43 (http://biostat.mc.vanderbilt.,OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 496semination: is it effective therapy in women above the age of 35  years?,Non-OADS,/arxiv_data1/oa_pdf/66/7e/ymj-56-490.PMC4329363.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 497A Melting Method for RNA Extraction from the Mucosal  Membrane of  the Mouse Middle Ear Young Joon Seo, Sung Huhn Kim, In Seok Moon, and Jae Young Choi Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/79/5d/ymj-56-497.PMC4329364.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  There is much confusion surrounding the methods of RNA extraction  from the middle ear mucosa of mice.",Non-OADS,/arxiv_data1/oa_pdf/79/5d/ymj-56-497.PMC4329364.pdf
"MATERIALS AND METHODS Thirty-two ears (16 left and 16 right, 9 male and 7 female specimens) derived Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.497 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):497-502, 2015",Non-OADS,/arxiv_data1/oa_pdf/79/5d/ymj-56-497.PMC4329364.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 498without EDTA (4 hours, 4°C).",Non-OADS,/arxiv_data1/oa_pdf/79/5d/ymj-56-497.PMC4329364.pdf
A Melting Method for RNA Extraction Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 499(background absorption and possible contaminations).,Non-OADS,/arxiv_data1/oa_pdf/79/5d/ymj-56-497.PMC4329364.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 500showed ciliated mucosal cells well-distributed on the surface  of the bony bulla (Fig.,Non-OADS,/arxiv_data1/oa_pdf/79/5d/ymj-56-497.PMC4329364.pdf
"A Melting Method for RNA Extraction Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 501In the melting method, the anatomy of the mouse is very  important, as the tiny structures around the bulla disturb ac - cess to the middle ear.",Non-OADS,/arxiv_data1/oa_pdf/79/5d/ymj-56-497.PMC4329364.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 502rhinolaryngol 1999;256:167-72.,Non-OADS,/arxiv_data1/oa_pdf/79/5d/ymj-56-497.PMC4329364.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 503Pain Palliation in Patients with Bone Metastases Using Magnetic  Resonance-Guided Focused Ultrasound with Conformal   Bone System: A Preliminary Report Bio Joo,1 Mi-Suk Park,1 Soo Hyeon Lee,2 Hye Jin Choi,3 Seung Tack Lim,3   Sun Young Rha,3 Itay Rachmilevitch,4 Young Han Lee,1 and Jin-Suck Suh1 1Department of Diagnostic Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea;   2Pfizer Oncology, Seoul, Korea; 3Institute of Oncology, Yonsei University College of Medicine, Seoul, Korea; 4InSightec, Haifa, Israel.",Non-OADS,/arxiv_data1/oa_pdf/7f/29/ymj-56-503.PMC4329365.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We evaluated the safety and effectiveness of the Magnetic Resonance- guided Focused Ultrasound (MRgFUS) with the ExAblate Conformal Bone System  for the palliation of painful bone metastases.",Non-OADS,/arxiv_data1/oa_pdf/7f/29/ymj-56-503.PMC4329365.pdf
"1,2 Current approaches to treating this condition include an - algesics, chemotherapy, hormonal therapy, and bisphosphonates for systemic treat -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.503 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):503-509, 2015",Non-OADS,/arxiv_data1/oa_pdf/7f/29/ymj-56-503.PMC4329365.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 504MATERIALS AND METHODS Study design and patient population This study was approved by our Institutional Review Board,  and informed consent was obtained from all patients prior  to enrollment.",Non-OADS,/arxiv_data1/oa_pdf/7f/29/ymj-56-503.PMC4329365.pdf
 MRgFUS Is Effective for Pain Control in Bone Metastasis Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 505cooling system.,Non-OADS,/arxiv_data1/oa_pdf/7f/29/ymj-56-503.PMC4329365.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 506Conscious sedation was sufficient for five treatments, while  one treatment required deep sedation (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/7f/29/ymj-56-503.PMC4329365.pdf
" MRgFUS Is Effective for Pain Control in Bone Metastasis Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 507one day after MRgFUS treatment; however, this symptom  resolved spontaneously within 2 weeks without any specif - ic treatment.",Non-OADS,/arxiv_data1/oa_pdf/7f/29/ymj-56-503.PMC4329365.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 508tion of bone tissue is higher than that of soft tissue, and the  penetration of ultrasonic energy into the bone can be mini - mal.",Non-OADS,/arxiv_data1/oa_pdf/7f/29/ymj-56-503.PMC4329365.pdf
 MRgFUS Is Effective for Pain Control in Bone Metastasis Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 509ment.,Non-OADS,/arxiv_data1/oa_pdf/7f/29/ymj-56-503.PMC4329365.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 510Toxicity of  Tomotherapy-Based Simultaneous Integrated Boost   in Whole-Pelvis Radiation for Prostate Cancer Sei Hwan You,1 Jong Young Lee,1 and Chang Geol Lee2 1Department of Radiation Oncology, Yonsei University Wonju College of Medicine, Wonju; 2Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The validity of tomotherapy-based simultaneous integrated boost (TOMO - SIB) was assessed in terms of acute intestinal/urinary toxicity by comparing with  3-dimensional conformal radiotherapy (3DCRT) in cases of whole-pelvis radiation therapy (WPRT) for prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
"Al - though acute intestinal/urinary toxicity has recently decreased in WPRT by using the intensity-modulation technique, 1-4 the intestine, bladder, and other organs are  still vulnerable to high-dose radiation because of their distensible properties.5  There are also subtle differences in patient setup and dose delivery method accord - ing to institutional protocol, which can aggravate these kinds of problems.Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.510 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):510-518, 2015",Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
Simultaneous Integrated Boost in Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 511tioned on the treatment couch using external markings.,Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 512doses in definitive radiotherapy were 50.4 Gy, 60.2 Gy, and  70.0 Gy for low-, intermediate-, and high-risk CTV , respec - tively, with 28 fractions.",Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
Simultaneous Integrated Boost in Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 513was used for dosimetric comparison of each normal organ  between TOMOSIB and 3DCRT.,Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 514almost the same (around 45 Gy), the cumulative incidence  of Grade 2 or higher toxicity was 0.0% (0 patient) in TOMO - SIB group and 30.8% (8 patients) in 3DCRT group (Fig.",Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
Simultaneous Integrated Boost in Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 515should be reassessed and more careful approaches are need - ed in terms of radiation toxicity.,Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 516ever, TOMOSIB still seemed to be satisfactory for the rec - tal toxicity despite relatively high dose exposure.",Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
"Simultaneous Integrated Boost in Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 517radiotherapy, because positional change of each normal or - gan after surgical resection can increase the possibility of  overlapping with CTV dose area.",Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 518toxicities and dosimetric parameters after whole-pelvis versus  prostate-only intensity-modulated radiation therapy for prostate  cancer.,Non-OADS,/arxiv_data1/oa_pdf/5d/dd/ymj-56-510.PMC4329366.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 519Clinical Features and Computed Tomography Characteristics   of  Non- Klebsiella pneumoniae  Liver Abscesses in Elderly   (>65 Years) and Nonelderly Patients Chih-Weim Hsiang,1 Chang-Hsien Liu,1 Hsiu-Lung Fan,2 Kai-Hsiung Ko,1 Chih-Yung Yu,1   Hong-Hau Wang,1 Wen-I Liao,3 Hsian-He Hsu,1 and Wei-Chou Chang1 Departments of 1Radiology and 3Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; 2Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To compare the clinical and computed tomography (CT) appearances of  liver abscesses caused by non- Klebsiella pneumoniae  bacterial pathogens in elderly  and nonelderly patients.",Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
"The reported incidence ranges from 8 to 22 cases per 100000 hospital admissions, while the fatality rate ranges from 7.8% to 28.6% due to differences in species of bacterial pathogens and the underly -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.519 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):519-528, 2015",Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 520the written informed consent of patients because confidenti - ality was maintained.,Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
Non- Klebsiella pneumoniae  Liver Abscesses Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 521predefined enhancement threshold level of 120 Hounsfield  units (HU) was set to trigger the data acquisition.,Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 522nificant difference in the proportions of each sex was ob - served between the groups.,Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
"Non- Klebsiella pneumoniae  Liver Abscesses Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 523group, p=0.94) rarely occurred.",Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 524Table 3.,Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
Non- Klebsiella pneumoniae  Liver Abscesses Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 525regression analyses of the selected significant variables are  shown in Table 5.,Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 526rate.,Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
Non- Klebsiella pneumoniae  Liver Abscesses Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 527This study has several limitations that should be men - tioned.,Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 528neous rupture of liver abscess caused by Klebsiella pneumoniae.,Non-OADS,/arxiv_data1/oa_pdf/be/44/ymj-56-519.PMC4329367.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 529Optimal Effect-Site Concentration of  Remifentanil   for Inhibiting Response to Laryngeal Mask Airway   Removal during Emergence  Sang-Jin Park, Jong-Yun Baek, and Dae-Lim Jee Department of Anesthesiology and Pain Medicine, College of Medicine, Yeungnam University, Daegu, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b3/a4/ymj-56-529.PMC4329368.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: This randomized, controlled, double-blind study was designed to deter - mine the optimal dose of remifentanil for preventing complications associated with  the removal of a laryngeal mask airway (LMA) without delaying emergence.",Non-OADS,/arxiv_data1/oa_pdf/b3/a4/ymj-56-529.PMC4329368.pdf
"5  This randomized, controlled, double-blind study was designed to assess the effects  of four effect-site concentrations (Ce) of remifentanil via target-controlled infusion (TCI) to determine the optimal dose for preventing complications associated with LMA removal without delaying emergence after sevoflurane-remifentanil anesthesia.Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.529 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):529-534, 2015",Non-OADS,/arxiv_data1/oa_pdf/b3/a4/ymj-56-529.PMC4329368.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 530according to the group assignment.,Non-OADS,/arxiv_data1/oa_pdf/b3/a4/ymj-56-529.PMC4329368.pdf
"Remifentanil for Laryngeal Mask Airway Removal Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 531uration, nausea, and vomiting were analyzed using a chi- squared test.",Non-OADS,/arxiv_data1/oa_pdf/b3/a4/ymj-56-529.PMC4329368.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 532(p<0.0083) (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/b3/a4/ymj-56-529.PMC4329368.pdf
Remifentanil for Laryngeal Mask Airway Removal Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 533LMA removal and to determine whether these complica - tions can be prevented by remifentanil.,Non-OADS,/arxiv_data1/oa_pdf/b3/a4/ymj-56-529.PMC4329368.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 534REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b3/a4/ymj-56-529.PMC4329368.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 535Selective Spinal Anesthesia Using 1 mg of  Bupivacaine with  Opioid in Elderly Patients for Transurethral Resection of  Prostate Na Young Kim,1,2 So Yeon Kim,1,2 Hyang Mi Ju,1 and Hae Keum Kil1,2 1Department of Anesthesiology and Pain Medicine, Severance Hospital, Seoul; 2Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: This study was to evaluate the characteristics of selective spinal anesthe - sia using 1 mg of bupivacaine combined with fentanyl or sufentanil in elderly pa - tients undergoing transurethral resection of prostate.",Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
"3-6 Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.535 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):535-542, 2015",Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 5360162) and registered at www.ClinicalTrials.gov (ref: NCT  01608334).,Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
1 mg Bupivacaine with Opioid for TURP Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 537complete motor block; 2=able to move feet only; 3=able to  move feet and bend knees; 4=able to perform a straight leg  raise <30°; 5=able to perform a straight leg raise >30°).22  Three expert urologists performed all the surgeries sepa - rately.,Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 5383.0.1.,Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
"1 mg Bupivacaine with Opioid for TURP Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 539parison, the level to touch sense loss was significantly lower  than cold or pinprick block in both groups ( p=0.001) (Table  2).",Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 540er recovery in spinal anesthesia,26 this could be negligible  with ultralow-dose bupivacaine.",Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
1 mg Bupivacaine with Opioid for TURP Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 541and relationship of comorbidities with postoperative complica - tions in patients undergoing transurethral prostate resection.,Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 54228.,Non-OADS,/arxiv_data1/oa_pdf/21/71/ymj-56-535.PMC4329369.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 543Readmission to Medical Intensive Care Units:   Risk Factors and Prediction  Yong Suk Jo, Yeon Joo Lee, Jong Sun Park, Ho Il Yoon, Jae Ho Lee,   Choon-Taek Lee, and Young-Jae Cho Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine,   Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.",Non-OADS,/arxiv_data1/oa_pdf/52/6a/ymj-56-543.PMC4329370.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The objectives of this study were to find factors related to medical inten - sive care unit (ICU) readmission and to develop a prediction index for determining  patients who are likely to be readmitted to medical ICUs.",Non-OADS,/arxiv_data1/oa_pdf/52/6a/ymj-56-543.PMC4329370.pdf
"4,5 Therefore, early identification of patients at higher  risk of ICU readmission would help clinicians to appropriately decide who is ready Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.543 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):543-549, 2015",Non-OADS,/arxiv_data1/oa_pdf/52/6a/ymj-56-543.PMC4329370.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 544admission to the ICU after ICU discharge for a problem  that was directly related to the initial ICU admission and  non-readmission was defined as discharge from the hospital  after ICU discharge.,Non-OADS,/arxiv_data1/oa_pdf/52/6a/ymj-56-543.PMC4329370.pdf
Readmission to ICU: Risk Factors and Prediction Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 545tween ICU discharge and readmission was 7.24±7.34 days.,OADS,/arxiv_data1/oa_pdf/52/6a/ymj-56-543.PMC4329370.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 546sion to extubation and from admission to discharge were not  influential on subsequent readmission, nor was APS at dis - charge.",Non-OADS,/arxiv_data1/oa_pdf/52/6a/ymj-56-543.PMC4329370.pdf
"Readmission to ICU: Risk Factors and Prediction Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 547on type of ICU, and the prognosis of readmitted patients is  not good.3,4 We analyzed only medical ICU due to clinical  differences between surgical and medical ICU.",Non-OADS,/arxiv_data1/oa_pdf/52/6a/ymj-56-543.PMC4329370.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 548tors of ICU readmission in our study did not contain any re - spiratory parameters nor acute physiology score.,Non-OADS,/arxiv_data1/oa_pdf/52/6a/ymj-56-543.PMC4329370.pdf
Readmission to ICU: Risk Factors and Prediction Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 549REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/52/6a/ymj-56-543.PMC4329370.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 550Comparison of  MALDI-TOF MS, Housekeeping Gene  Sequencing, and 16S rRNA Gene Sequencing for Identification  of  Aeromonas  Clinical Isolates Hee Bong Shin,1 Jihoon Yoon,2 Yangsoon Lee,3 Myung Sook Kim,2 and Kyungwon Lee2 1Department of Laboratory Medicine and Genetics, Soonchunhyang University College of Medicine, Cheonan; 2Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul; 3Department of Laboratory Medicine, Hanyang University College of Medicine, Hanyang University Seoul Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c3/5c/ymj-56-550.PMC4329371.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The genus Aeromonas is a pathogen that is well known to cause severe  clinical illnesses, ranging from gastroenteritis to sepsis.",Non-OADS,/arxiv_data1/oa_pdf/c3/5c/ymj-56-550.PMC4329371.pdf
"Aeromonas is known to cause human infections,  ranging from hepatobiliary tract infections, soft tissue infections, and diarrhea to Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.550 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):550-555, 2015",Non-OADS,/arxiv_data1/oa_pdf/c3/5c/ymj-56-550.PMC4329371.pdf
"Comparison of Identification Methods of Aeromonas Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 551as a template in a 30 µL reaction mixture by using EF-Taq  (SolGent, Korea) for the following cycles: activation of Taq  polymerase at 95°C for 2 minutes, followed by 35 cycles at  95°C, 55°C, and 72°C for 1 minute each, finishing with a  10-minute step at 72°C.",Non-OADS,/arxiv_data1/oa_pdf/c3/5c/ymj-56-550.PMC4329371.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 552ing gene sequences ( gyrB, rpoB) with phylogenetic analy - sis to see whether the results matched.",OADS,/arxiv_data1/oa_pdf/c3/5c/ymj-56-550.PMC4329371.pdf
"A phyloge - netic tree was generated using the neighbor-joining method  based on nucleotide sequences of clinical isolates with refer - ence strain sequences prepared from the NCBI database  (http://www.ncbi.nlm.nih.gov/) using Mega 5.0 software.10  gyrB and rpoB gene sequencing were performed by Mac - rogen (Seoul, Korea).",OADS,/arxiv_data1/oa_pdf/c3/5c/ymj-56-550.PMC4329371.pdf
Comparison of Identification Methods of Aeromonas Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 553one case that had no peak value.,Non-OADS,/arxiv_data1/oa_pdf/c3/5c/ymj-56-550.PMC4329371.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 554by the fact that 16S rRNA gene sequences are less divergent  than other housekeeping genes ( gyrB, rpoD, and so on), and  furthermore, some species may have several copies of small  subunits of ribosomal RNA at the same time, causing in - tragenomic heterogeneity of small subunits.2,21 Recently, MALDI-TOF MS has been rapidly introduced  to clinical laboratories.",Non-OADS,/arxiv_data1/oa_pdf/c3/5c/ymj-56-550.PMC4329371.pdf
Comparison of Identification Methods of Aeromonas Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 555methods.,OADS,/arxiv_data1/oa_pdf/c3/5c/ymj-56-550.PMC4329371.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 556Prevalence of  Cigarette Smoking among Adult   Cancer Survivors in Korea Jin Joo Park1 and Hyun Ah Park2   1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul; 2Department of Family Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Cigarette smoking is associated not only with increased risk of cancer inci - dence, but also influences prognosis, and the quality of life of the cancer survivors.",Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
"It in - terferes with cancer treatment,1,2 increases the cancer mortality,3,4 and promotes the  development of new primary cancers among cancer survivors.5 Nonetheless, west- ern studies showed that more than 50% of the cancer survivors continue to smoke Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.556 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):556-562, 2015",Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
"Smoking among Korean Adult Cancer Survivors Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 557sis from the current age and categorized into “<2 years”, “2  to <5 years”, “5 to <10 years”, and “more than 10 years”.",Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
The detailed descriptions of the plan  and operation of the survey have been described on the  KNHANES website (http://knhanes.cdc.go.kr/).,OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
Jin Joo Park and Hyun Ah Park Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 558shown in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
Smoking among Korean Adult Cancer Survivors Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 559smoking within 6 months.,Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
"Jin Joo Park and Hyun Ah Park Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 560survivors of smoking-related cancers, whereas the smok - ing rate was only 4.0% in those of smoking-unrelated can - cer (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
Smoking among Korean Adult Cancer Survivors Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 561which may influence smoking behavior.,Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
Available at: http://ncc.re.kr/pr/is - sue_list.jsp?schisgubun=A&selSearch=null&txtKeyword=&curre nt_page=2.,OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
Available at: https://knhanes.cdc.go.kr/knhanes/index.do.,Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
"Jin Joo Park and Hyun Ah Park Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 562Stratton K, et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/eb/ymj-56-556.PMC4329372.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 563Differentially Expressed Proteins in Nitric Oxide-Stimulated  NIH/3T3 Fibroblasts: Implications for Inhibiting   Cancer Development Dong Hwi Shim,1 Joo Weon Lim,2 and Hyeyoung Kim1,2  1Department of Pharmacology, College of Medicine, Yonsei University, Seoul; 2Department of Food and Nutrition, Brain Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Recent evidence shows that nitric oxide (NO) may exhibit both pro-cancer  and anti-cancer activities.",Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
"Three different isoforms of the  NOS family have been identified: endothelial NOS (eNOS), neuronal NOS Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.2.563 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):563-571, 2015",Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 564of an NO donor (NOC-18) for 12 h. The changed protein  patterns, which were separated by two-dimensional electro - phoresis (2-DE), were conclusively identified by matrix-as - sisted laser desorption/ionization-time of flight mass spec - trometry (MALDI-TOF MS) analysis of the peptide digests.",OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
"Proteomic Analysis of NO-Stimulated NIH/3T3 Cells Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 565sin 3, 26S proteasome-associated pad1 homolog, T-complex  protein 1 (ε subunit), NG-dimethylarginine dimethylaminohy - drolase, and heat shock protein 90 (HSP90)] were increased  (Fig.",OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
The peptide mass maps  produced by MALDI-TOF MS were searched against the  published databases using the MS-Fit module in Protein  Prospector (http://prospector.ucsf.edu/prospector/mshome.,OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
"htm) and Mascot (Marix Science, http://www.matrixscience.",Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 566dual targeting of HSP90 and HSP70 promotes cell death  and enhances the anticancer effect of chemotherapeutic  agents in bladder cancer.19 Therefore, increased expression  of HSP90 may induce carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
Proteomic Analysis of NO-Stimulated NIH/3T3 Cells Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 567be associated with invasive and advanced malignant pro - cesses as well as poor prognoses.,Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 568though the role of ORP150 has not been identified in can - cer, it may affect cancer cell proliferation through the path - way of endoplasmic reticulum stress.",Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
"Proteomic Analysis of NO-Stimulated NIH/3T3 Cells Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 569of DDAH1, the isoform primarily associated with nNOS,  results in increased tumor growth and vascularization, as  well as elevated secretion of vascular endothelial growth  factor.46 Induction of DDAH by NOC-18 treatment is con - troversial compared to the induction of other proteins relat - ed to cancer suppression.",Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 570and cancer hallmarks.,Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
Proteomic Analysis of NO-Stimulated NIH/3T3 Cells Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 57142.,Non-OADS,/arxiv_data1/oa_pdf/c2/76/ymj-56-563.PMC4329373.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 572Increasing Carbapenem-Resistant Gram-Negative Bacilli and  Decreasing Metallo- β-Lactamase Producers   over Eight Years from Korea Yangsoon Lee,1 Chang-Ki Kim,2 Hae-Sun Chung,3 Dongeun Yong,4   Seok Hoon Jeong,4 Kyungwon Lee,4 and Yunsop Chong4 1Department of Laboratory Medicine, Hanyang University College of Medicine, Seoul;  2Korean Institute of Tuberculosis, Osong;  3Department of Laboratory Medicine, Ewha Womans University School of Medicine, Seoul;  4Department of Laboratory Medicine, Research Institute of Bacterial Resistance, Severance Hospital,   Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/de/95/ymj-56-572.PMC4329374.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The trends and types of carbapenemase-producing Gram-negative bacilli were an - alyzed from clinical specimens collected between 2005 and 2012 at a Korean  teaching hospital.",Non-OADS,/arxiv_data1/oa_pdf/de/95/ymj-56-572.PMC4329374.pdf
"This is a unique report on the long term trend of carbapenem-resistant and MBL-producing Gram-negative bacilli isolated in a single hospital.Brief Communicationhttp://dx.doi.org/10.3349/ymj.2015.56.2.572 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):572-577, 2015",Non-OADS,/arxiv_data1/oa_pdf/de/95/ymj-56-572.PMC4329374.pdf
"Carbapenemase-Producing Gram-Negative Bacilli Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 573modified Hodge test (MHT) and the imipenem and ethyl - enediaminetetraacetic acid sodium mercaptoacetic acid dou - ble disk potentiation (IEDDP) test were conducted to screen  for MBL producers in imipenem- or meropenem-nonsus - ceptible isolates.8 Polymerase chain reaction (PCR) was per - formed to detect and sequence bla VIM-2-like, bla IMP-1-like and  bla SIM-1-like genes.9,10 In carbapenem-nonsusceptible strains  showing MHT-positive yet the aforementioned PCR nega - tive results, bla NDM and bla KPC genes were also screened by  PCR.11,12 The nucleotide sequences of PCR-generated ampli - cons were analyzed for the representative strains.",OADS,/arxiv_data1/oa_pdf/de/95/ymj-56-572.PMC4329374.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 574Likewise, Cavalcanti, et al.19 reported that a higher preva - lence of MBL-producing P .",Non-OADS,/arxiv_data1/oa_pdf/de/95/ymj-56-572.PMC4329374.pdf
Carbapenemase-Producing Gram-Negative Bacilli Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 575Table 2.,Non-OADS,/arxiv_data1/oa_pdf/de/95/ymj-56-572.PMC4329374.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 576REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/de/95/ymj-56-572.PMC4329374.pdf
Carbapenemase-Producing Gram-Negative Bacilli Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 577Metallo-beta-lactamase-producing Pseudomonas putida  as a res - ervoir of multidrug resistance elements that can be transferred to  successful Pseudomonas aeruginosa  clones.,Non-OADS,/arxiv_data1/oa_pdf/de/95/ymj-56-572.PMC4329374.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 578Bronchiolitis Obliterans Associated with Stevens-Johnson  Syndrome: A Case Report Hyungchul Park,1 Young Bo Ko,1 Hyouk-Soo Kwon,2 and Chae-Man Lim3 1Department of Internal Medicine, Divisions of 2Allergy and Clinical Immunology and 3Pulmonary and Critical Care Medicine,   Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/05/f4/ymj-56-578.PMC4329375.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.We report a case of bronchiolitis obliterans associated with Stevens-Johnson syn - drome.",Non-OADS,/arxiv_data1/oa_pdf/05/f4/ymj-56-578.PMC4329375.pdf
"The patient was prescribed several unidentified medica -Case Reporthttp://dx.doi.org/10.3349/ymj.2015.56.2.578 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):578-581, 2015",Non-OADS,/arxiv_data1/oa_pdf/05/f4/ymj-56-578.PMC4329375.pdf
"Stevens-Johnson Syndrome & Bronchiolitis Obliterans Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 579oral mucosa, eyes, and ears.",Non-OADS,/arxiv_data1/oa_pdf/05/f4/ymj-56-578.PMC4329375.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 580set of skin lesions.,Non-OADS,/arxiv_data1/oa_pdf/05/f4/ymj-56-578.PMC4329375.pdf
"Stevens-Johnson Syndrome & Bronchiolitis Obliterans Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 581Natl Med Assoc 1988;80:104, 106-8.",Non-OADS,/arxiv_data1/oa_pdf/05/f4/ymj-56-578.PMC4329375.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 582Rifampicin-Induced Minimal Change Disease Is Improved after  Cessation of  Rifampicin without Steroid Therapy Dong Hyuk Park,1 Sul A Lee,1 Hyeon Joo Jeong,2 Tae-Hyun Yoo,1   Shin-Wook Kang,1 and Hyung Jung Oh1 Departments of 1Internal Medicine and 2Pathology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ymj-56-582.PMC4329376.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.There are several reports to demonstrate that rifampicin, a major anti-tuberculosis  agent, is associated with some adverse renal effects, with a few cases of rifampicin-induced minimal change disease (MCD).",Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ymj-56-582.PMC4329376.pdf
"On admission, her blood pressure was 146/70 mm Case Reporthttp://dx.doi.org/10.3349/ymj.2015.56.2.582 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):582-585, 2015",Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ymj-56-582.PMC4329376.pdf
RFP-Induced MCD Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 583Antinuclear antibody and P-anti-neutrophil cytoplasmic an - tibody (ANCA) and C-ANCA were all negative with nor - mal serum complement levels.,Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ymj-56-582.PMC4329376.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 584er medications except for daily 10 mg of amlodipine.,Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ymj-56-582.PMC4329376.pdf
RFP-Induced MCD Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 585syndrome and acute interstitial nephritis.,Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ymj-56-582.PMC4329376.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 586Usefulness of  Artificial Jump Graft to Portal Vein Thrombosis   in Deceased Donor Liver Transplantation  Hong Pil Hwang,1,2 Jae Do Yang,1,2 Sang In Bae,1,2 Si Eun Hwang,3   Baik Hwan Cho,1,2,4 and Hee Chul Yu1,2,4 1Department of Surgery, Chonbuk National University Medical School and Hospital, Jeonju;  2Biomedical Research Institute, Chonbuk National University Hospital, Jeonju; 3Department of Surgery, Daejeon Sun Hospital, Daejeon; 4Research Institute of Clinical Medicine, Chonbuk National University, Jeonju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ymj-56-586.PMC4329377.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Severe portal vein thrombosis (PVT) is often considered a relative contraindica - tion for living donor liver transplantation due to high associated risks and morbidi - ty.",Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ymj-56-586.PMC4329377.pdf
"CASE REPORT A 64-year-old male patient was admitted to our hospital for deceased donor liver Technical Reporthttp://dx.doi.org/10.3349/ymj.2015.56.2.586 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):586-590, 2015",Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ymj-56-586.PMC4329377.pdf
Jump Graft to Portal Thrombosis in Liver Transplant Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 587enteric vein.,Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ymj-56-586.PMC4329377.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 588flow without thrombus on the 7th day and 27 months after  liver transplantation (Fig.,Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ymj-56-586.PMC4329377.pdf
"Jump Graft to Portal Thrombosis in Liver Transplant Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 589The use of a temporary porto-caval shunt is associated  with better hemodynamic stability and improved renal func - tion, as well as decreased transfusion requirements in piggy  back liver transplantation.10,11 In our case, we performed by - pass from the IMV to the graft portal vein after reperfusion  of the liver graft.",Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ymj-56-586.PMC4329377.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 590shunt in orthotopic liver transplantation: a single center analysis.,Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ymj-56-586.PMC4329377.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 2   March 2015 591Erratumhttp://dx.doi.org/10.3349/ymj.2015.56.2.591 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(2):591-591, 2015 Erratum to “Risk Factors for Osteoarthritis and Contributing  Factors to Current Arthritic Pain in South Korean Older Adults”  by Lee KM, et al.",Non-OADS,/arxiv_data1/oa_pdf/79/de/ymj-56-591.PMC4329378.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/62/rjv005.PMC4329383.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/28/rjv004.PMC4329395.pdf
"Using the full-length protein sequence of TOND1 as a query for BLASTp searches against the non-redundant protein database (http://www.ncbi.nlm.nih.gov/BLAST/),we identiﬁed 27 putative homologs in other crop species(Figure S5b).",OADS,/arxiv_data1/oa_pdf/78/6f/tpj0081-0367.PMC4329406.pdf
"Microarray analysis Total RNA was extracted using Trizol reagent (Invitrogen, http://www.invitrogen.com) and puriﬁed using an RNeasy kit (Qia- gen, http://www.qiagen.com).",OADS,/arxiv_data1/oa_pdf/78/6f/tpj0081-0367.PMC4329406.pdf
"The methods for cDNA synthesis,cRNA synthesis, cRNA fragmentation, microarray hybridization,washing and staining are described in the GeneChip /C226Expression Analysis Technical Manual (http://www.affymetrix.com/).",OADS,/arxiv_data1/oa_pdf/78/6f/tpj0081-0367.PMC4329406.pdf
"Real-time quantitative PCR Real-time quantitative PCR was performed using the ABI Prism7900 sequence detection system (Applied Biosystems, http://www.appliedbiosystems.com).",OADS,/arxiv_data1/oa_pdf/78/6f/tpj0081-0367.PMC4329406.pdf
"Subcellular and tissue localization p35S::TOND1-GFP was bombarded into onion epidermal cells using a helium biolistic device (Bio-Rad PDS-1000) (Bio-Rad,http://www.bio-rad.com).",Non-OADS,/arxiv_data1/oa_pdf/78/6f/tpj0081-0367.PMC4329406.pdf
"We examined the bombarded tissues using a Nikon C1 Si confocal laser-scanning microscope (Nikon, http://www.nikon.com).",Non-OADS,/arxiv_data1/oa_pdf/78/6f/tpj0081-0367.PMC4329406.pdf
"Promoter analysis To prepare a DUR3 -promoter:GUS construct, a genomic fragment of 1046 bp located upstream of the DUR3 translation initiation site was ampliﬁed by PCR employing Pfu Turbo DNA polymerase(Stratagene, now Agilent Technologies, http://www.agilent.com).",Non-OADS,/arxiv_data1/oa_pdf/f6/42/tpj0081-0377.PMC4329417.pdf
"The resulting HindIII–NcoI fragment of the DUR3 promoter sequence was cloned into pBI101 (Clontech, http://www.clontech.com) and fused with GUS before the con- struct was used for Agrobacterium -mediated transformation.",Non-OADS,/arxiv_data1/oa_pdf/f6/42/tpj0081-0377.PMC4329417.pdf
"Stained shoots were cleared and analy- sed by light microscopy (Zeiss Axiovert, http://www.zeiss.com) or further embedded in SpurrR resin.",Non-OADS,/arxiv_data1/oa_pdf/f6/42/tpj0081-0377.PMC4329417.pdf
"Semi-thin sections of 5 –8lm were prepared on a Reichert-Jung Ultracut S (Leica, http://www.leica.com), stained with 2% basic fuchsine (10 sec at 80 °C) to improve contrast and examined by light microscopy.",Non-OADS,/arxiv_data1/oa_pdf/f6/42/tpj0081-0377.PMC4329417.pdf
"After rinsing in 1 m MCaSO 4, roots were separated from shoots, freeze- dried and subjected to15N determination by isotope ratio mass spectrometry (NU Instruments, http://www.nu-ins.com).",OADS,/arxiv_data1/oa_pdf/f6/42/tpj0081-0377.PMC4329417.pdf
"RNA and protein gel blot analysis After extraction by TRIzol (Invitrogen, http://www.lifetechnolo-gies.com), 10 –20lg of total RNA was run on 3 -(N-morpholino) propanesulfonic acid (MOPS)-formaldehyde agarose, transferred to Hybond -N +nylon membranes (Amersham Biosciences, now GE Healthcare, http://www.gelifesciences.com) by blotting and theRNA was cross-linked at 80 °C for 2 h. The coding sequence ofDUR3 was used as a 32P-radiolabeled probe for hybridization at 42°C in 50% (v/v) formamide, 1% (w/v) sarcosyl, 5x SSC and 100lgm l/C01yeast tRNA.",OADS,/arxiv_data1/oa_pdf/f6/42/tpj0081-0377.PMC4329417.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/69/main.PMC4329421.pdf
"Furthermore, severalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.12.002 0011-393X/ &2015.",Non-OADS,/arxiv_data1/oa_pdf/5b/69/main.PMC4329421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/69/main.PMC4329421.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/eb/main.PMC4329422.pdf
"14,15 Effective and safe drug administration in neonates should consider the evolving physiologic characteristics (eg, maturationand disease) of a newborn who will receive the drug andpharmacokinetic and pharmacodynamic properties of a givenContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.12.001 0011-393X/ &2014.",Non-OADS,/arxiv_data1/oa_pdf/85/eb/main.PMC4329422.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/eb/main.PMC4329422.pdf
http://www.kinderformularium.nl .,Non-OADS,/arxiv_data1/oa_pdf/85/eb/main.PMC4329422.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/85/eb/main.PMC4329422.pdf
(http://factwebsite.org/CordSearch.aspx?&type=CordBloodB ank&cou ntry=&state = )    FOCUS ON CORD BLOOD TRANSPLANTATION     Haematology  disorders/ Oncology     Several studies have shown that patients with acute  leukemia are the most treated with UCB units in the absence  of Matched -Related Donor (MRD) or Unrelated Donor (URD).,Non-OADS,/arxiv_data1/oa_pdf/f6/27/jsrm-10-028.PMC4329460.pdf
"Retrieved  February 18, 2008 from  http://siteresources.worldbank.org/INTGEP2008/Resou rces/complete -report.pdf   3.",Non-OADS,/arxiv_data1/oa_pdf/6b/25/jsrm-10-051.PMC4329463.pdf
Full  text  can  be accessed at  http://blogs.nature.com/tradesecrets/ 2011/12/06/the - electric -biology -duo    4.,Non-OADS,/arxiv_data1/oa_pdf/6b/25/jsrm-10-051.PMC4329463.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/05/thnov05p0322.PMC4329498.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c7/72/thnov05p0345.PMC4329499.pdf
This i s an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/56/ca/thnov05p0357.PMC4329500.pdf
2014.  http://clinicaltrials.gov/,Non-OADS,/arxiv_data1/oa_pdf/56/ca/thnov05p0357.PMC4329500.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8d/cc/thnov05p0371.PMC4329501.pdf
[Internet] http://www.activexray.com/pdf/Siemens_Biograph.pdf.,OADS,/arxiv_data1/oa_pdf/8d/cc/thnov05p0371.PMC4329501.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   license s/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/ae/thnov05p0378.PMC4329502.pdf
This  is an open -access  article  distributed  under  the terms  of the Creative  Commons  License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f5/1f/thnov05p0399.PMC4329503.pdf
"We are thankful to the National BioResource Project − Rat (http://www.anim.med.kyoto-u.ac.jp/nBr/) for preserv-ing and providing epileptic rat strains ( gaer S/Mave,  wag/ rij, ier/ihr, ner /kyo, Ser /kyo, T rM/kyo,  GRY/Idr, F344-Adms/Kyo, F344-Lgi1 m1kyo, and F344- Scn1am1Kyo).",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/expanim-64-001.PMC4329510.pdf
"organ distribution and histological types of  spontaneous tumors observed in Slc:w istar rats were  reported to be very similar to these phenotypes in F344/ (Received 17 June 2014 / Accepted 29 July 2014 / Published online in J-STAGE 8 September 2014) Address corresponding: T. Kuramoto, Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Yoshidakonoe-cho, Sakyo-ku, Kyoto 606-8501, JapanSupplementary table: refer to J-STAGE: https://www.jstage.jst.go.jp/browse/expanimExp.",Non-OADS,/arxiv_data1/oa_pdf/1e/ce/expanim-64-025.PMC4329512.pdf
Acknowledgments we thank the National Bioresource Project for the  rat (NB rP-rat) in Japan (http://www.anim.med.kyoto- u.ac.jp/NB r/) for providing the genomic DNa  samples  of the F344 strains.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/expanim-64-025.PMC4329512.pdf
"They allow efficient and specific cleavage of genomic sequences in animals by directly injecting mRNAs of site-specific nucleases into 1-cell embryos to generate a double-strand breakage (dsB) in the dnA  (Received 8 April 2014 / Accepted 18 July 2014 / Published online in J-STAGE 8 September 2014) Address corresponding: A. Honda, Organization for Promotion of Tenure Track, University of Miyazaki, 5200, Kibara, Kiyotake, Miyazaki 889-1692, JapanSupplementary tables and figure: refer to J-STAGE: https://www.jstage.jst.go.jp/browse/expanim*These authors contributed equally to this work.Exp.",Non-OADS,/arxiv_data1/oa_pdf/e6/35/expanim-64-031.PMC4329513.pdf
Plasmids coexpressing hCas9 and sgrnA were prepared by ligating oligonucleotides into  the Bbsi site of pX330 (http://www.addgene.org/42230/).,OADS,/arxiv_data1/oa_pdf/e6/35/expanim-64-031.PMC4329513.pdf
"Off-target analysis According to Yang et al., each sgrnA of the 12 nt  target sequence immediately upstream of the Proto- spacer Adjacent Motif (PAM) and the 3 nt PAM sequence (ngg, with four variations, i.e., Agg, T gg, ggg,  cgg) was searched against the rabbit genome in en-sembl (http://www.ensembl.org/ oryctolagus_cuniculus/ info/index).",OADS,/arxiv_data1/oa_pdf/e6/35/expanim-64-031.PMC4329513.pdf
"Moreover, the other potential off-target sites were analyzed using BLAsT searching of the Oryctolagus cuniculus(rabbit) nucleotide sequences (http://www.ncbi.nlm.nih.gov/BLAsT/).",OADS,/arxiv_data1/oa_pdf/e6/35/expanim-64-031.PMC4329513.pdf
"New resource illustrates divergence of C57BL/6 laboratory mouse substrains JaX® NoTes issue 512, Winter 2008. http://jaxmice.jax.org/jaxnotes/512/512s.html.",Non-OADS,/arxiv_data1/oa_pdf/f2/eb/expanim-64-091.PMC4329520.pdf
"Keywords:  Tendinopathy, Achilles tendon, Pain management, Surgical procedures Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/40/cios-7-1.PMC4329521.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 *Current affiliation: De La Salle University Medical Center, Dasmarinas,  Philippines Received September 30, 2013; Accepted January 11, 2015 Correspondence to: Hong-Geun Jung, MD  Department of Orthopaedic Surgery, Konkuk University School of Medi - cine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea Tel: +82-2-2030-7609, Fax: +82-2-2030-7369 E-mail: jungfoot@hanmail.netReview Article    Clinics in Orthopedic Surgery 2015;7:1-7   •  http://dx.doi.org/10.4055/cios.2015.7.1.1",Non-OADS,/arxiv_data1/oa_pdf/8d/40/cios-7-1.PMC4329521.pdf
"A method to excise radial condyle osteophytes for  treating MPJ locking has been reported.1,2,6) We believe  that the CL preserving approach is feasible and effective  for removal of radial condyle osteophytes and allows rapid  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/80/cios-7-104.PMC4329522.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:104-109   •  http://dx.doi.org/10.4055/cios.2015.7.1.104,Non-OADS,/arxiv_data1/oa_pdf/16/80/cios-7-104.PMC4329522.pdf
"We speculated that the prognostic factors of sep - tic arthritis of the hip in infancy might differ from those  previously described in children because of the recent de - velopment of diagnostic tools, antibiotics, and other forms  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/9b/cios-7-110.PMC4329523.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:110-119   •  http://dx.doi.org/10.4055/cios.2015.7.1.110,Non-OADS,/arxiv_data1/oa_pdf/46/9b/cios-7-110.PMC4329523.pdf
"Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/dc/cios-7-120.PMC4329524.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:120-130   •  http://dx.doi.org/10.4055/cios.2015.7.1.120,Non-OADS,/arxiv_data1/oa_pdf/57/dc/cios-7-120.PMC4329524.pdf
"She had an ultrasound-guided  aspiration of the left AC joint, blood cultures were taken,  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/2c/cios-7-131.PMC4329525.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Case Report    Clinics in Orthopedic Surgery 2015;7:131-134   •  http://dx.doi.org/10.4055/cios.2015.7.1.131,Non-OADS,/arxiv_data1/oa_pdf/f5/2c/cios-7-131.PMC4329525.pdf
"Keywords:  Anterior cruciate ligament, Infection, Mycobacterium abscessus, Suppuration, Coinfection Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/9a/cios-7-135.PMC4329526.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 20, 2013; Accepted February 25, 2014 Correspondence to: Stacy W L Ng, MRCS  Department of Orthopedic Surgery, Changi General Hospital, 2 Simei  Street 3, Singapore 529889 Tel: +65-6850-3932, Fax: +65-2601712 E-mail: stacy.ng@mohh.com.sgCase Report    Clinics in Orthopedic Surgery 2015;7:135-139   •  http://dx.doi.org/10.4055/cios.2015.7.1.135",Non-OADS,/arxiv_data1/oa_pdf/f3/9a/cios-7-135.PMC4329526.pdf
"2007;  27(1):12-6. http://dx.doi.org/10.4055/cios.2015.7.1.140 Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/d2/cios-7-140.PMC4329527.pdf
"2014;6(4):426- 31. http://dx.doi.org/10.4055/cios.2015.7.1.141Correspondence to: Seung Yeol Lee, MD  Department of Orthopedic Surgery, Ewha Womans University Mokdong  Hospital, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea Tel: +82-2-2650-5143, Fax: +82-2-2642-0349 E-mail: kernels00@naver.com",Non-OADS,/arxiv_data1/oa_pdf/bf/d2/cios-7-140.PMC4329527.pdf
"Approximately 70%  of the parachute injuries are due to improper landing tech - niques.1,2) The ankles are injured in approximately one- Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/1d/cios-7-15.PMC4329528.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:15-21   •  http://dx.doi.org/10.4055/cios.2015.7.1.15,Non-OADS,/arxiv_data1/oa_pdf/f8/1d/cios-7-15.PMC4329528.pdf
"Keywords:  Neck femur, Fracture fixation, Bone nails Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/2a/cios-7-22.PMC4329529.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received May 15, 2014; Accepted December 4, 2014 Correspondence to: Donald Osarumwense, FRCS  Department of Trauma and Orthopaedics, Queen Elizabeth Hospital,  Stadium Road, Woolwich, SE18 4QH, London, UK Tel: +44-208-836-5985, Fax: +44-208-836-5458 E-mail: donaldosaru@hotmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:22-28   •  http://dx.doi.org/10.4055/cios.2015.7.1.22",Non-OADS,/arxiv_data1/oa_pdf/3e/2a/cios-7-22.PMC4329529.pdf
"The modified Stoppa approach is an intrapelvic approach  initially used for inguinal hernia surgery by Rives et al.8)  and Stoppa et al.7) in the early 1990’s, and was introduced  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/b1/cios-7-29.PMC4329530.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:29-38   •  http://dx.doi.org/10.4055/cios.2015.7.1.29,Non-OADS,/arxiv_data1/oa_pdf/88/b1/cios-7-29.PMC4329530.pdf
"Keywords:  Cerebral palsy, Arthroplasty, Hip replacement, Osteoarthritis, Ceramics Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/24/cios-7-39.PMC4329531.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received February 27, 2014; Accepted September 28, 2014 Correspondence to: Young-Kyun Lee, MD  Department of Orthopedic Surgery, Seoul National University Bundang  Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173  beon-gil, Bundang-gu, Seongnam 463-707, Korea Tel: +82-31-787-7204, Fax: +82-31-787-4056 E-mail: ykleemd@gmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:39-45   •  http://dx.doi.org/10.4055/cios.2015.7.1.39",Non-OADS,/arxiv_data1/oa_pdf/a0/24/cios-7-39.PMC4329531.pdf
"If either  of these two components is made of a metal, metal wear  particles will be generated in addition to PE wear particles,  and thus, ‘metallosis’ develops.7-9) Metallosis is a term used  to describe the infiltration of metallic wear debris into the  periprosthetic structures, including soft and bony tissues.7)  Wear particles provoke an immunologic reaction, lead - ing to osteolysis followed by aseptic implant loosening.10)  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/ce/cios-7-46.PMC4329532.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:46-53   •  http://dx.doi.org/10.4055/cios.2015.7.1.46,Non-OADS,/arxiv_data1/oa_pdf/1f/ce/cios-7-46.PMC4329532.pdf
"Keywords:  Arthroplasty, Replacement, Knee, Single-radius, Survival rate Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/ca/cios-7-54.PMC4329533.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received August 7, 2013; Accepted April 7, 2014 Correspondence to: Yong-Chan Ha, MD  Department of Orthopaedic Surgery, Chung-Ang University College of  Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 156-755, Korea Tel: +82-2-6299-1577, Fax: +82-2-822-1710 E-mail: hayongch@naver.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:54-61   •  http://dx.doi.org/10.4055/cios.2015.7.1.54",Non-OADS,/arxiv_data1/oa_pdf/20/ca/cios-7-54.PMC4329533.pdf
"It prevents scratches on the surface of  implants by reducing wear rate, as well as osteolysis caused  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/ef/cios-7-62.PMC4329534.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:62-68   •  http://dx.doi.org/10.4055/cios.2015.7.1.62,Non-OADS,/arxiv_data1/oa_pdf/a7/ef/cios-7-62.PMC4329534.pdf
"Type IV infec - tion is a late chronic infection with a delayed onset longer  than 4 weeks after primary TKA.2) Treatment options for  infected TKA include chronic antibiotic suppression,3)  irrigation and debridement with component retention  (IDCR),4,5) one-stage exchange arthroplasty,6) two-stage  exchange arthroplasty,7) and salvage procedures such as  resection arthroplasty, arthrodesis, or amputation.8) Of  these treatment options, two-stage exchange arthroplasty  using an antibiotic-laden cement spacer is considered the  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/40/cios-7-69.PMC4329535.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:69-76   •  http://dx.doi.org/10.4055/cios.2015.7.1.69,Non-OADS,/arxiv_data1/oa_pdf/36/40/cios-7-69.PMC4329535.pdf
"Many studies have researched fusion rates,  functional outcomes, and adjacent segment degeneration,  which is a main problems of fusion surgeries.1-4) The fu - sion rate of PLF is known to decrease as the number of  fusion levels increases.5) It has also been reported that the  fusion rate of PLF is lower than that of posterior lumbar  interbody fusion.6,7) However, functional outcomes of the  procedure have been reported to be good, though relative - ly lower fusion rates were found in the case of short level  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/4d/cios-7-77.PMC4329536.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:77-84   •  http://dx.doi.org/10.4055/cios.2015.7.1.77,Non-OADS,/arxiv_data1/oa_pdf/ec/4d/cios-7-77.PMC4329536.pdf
"How - Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/98/cios-7-8.PMC4329537.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:8-14   •  http://dx.doi.org/10.4055/cios.2015.7.1.8,Non-OADS,/arxiv_data1/oa_pdf/1a/98/cios-7-8.PMC4329537.pdf
"In situ  posterolateral fu - sion, in situ  transsacral fusion, vertebral reduction and  fusion via two separate anterior and posterior approaches  or a single stage posterior approach are the commonly  performed techniques.3-11) In operative management of  high grade spondylolisthesis, the risk of neurologic com - plications and pseudoarthrosis is usually high.2,12) It would  be ideal to find a simple method that can restore normal  spinal alignment without causing any iatrogenic complica - Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/94/cios-7-85.PMC4329538.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:85-90   •  http://dx.doi.org/10.4055/cios.2015.7.1.85,Non-OADS,/arxiv_data1/oa_pdf/7e/94/cios-7-85.PMC4329538.pdf
"Keywords:  Complications, Learning curve, Minimally invasive, Spine fusion, Lumbar vertebrae bar fusion in terms of the amount of intraoperative blood  loss, the intensity of postoperative pain, and the hospital  stay duration.1-5) As with other surgical procedures, how - ever, minimally invasive TLIF also showed complications  related to the surgeon’s learning curve.6,7) Although com - plication rates have varied, most literature reports a com - mon set of complications, including neurologic deficits,  dural tear, wound infection, screw misplacement, and cage  migration.1-7) Because surgical complications may occur more  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/c8/cios-7-91.PMC4329539.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:91-96   •  http://dx.doi.org/10.4055/cios.2015.7.1.91,Non-OADS,/arxiv_data1/oa_pdf/37/c8/cios-7-91.PMC4329539.pdf
"However, surgical treatment is mandatory for types  IV–VI and decisions regarding conservative versus surgi - cal treatment are controversial for type III injuries.3-6) Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/42/cios-7-97.PMC4329540.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Original Article    Clinics in Orthopedic Surgery 2015;7:97-103   •  http://dx.doi.org/10.4055/cios.2015.7.1.97,Non-OADS,/arxiv_data1/oa_pdf/80/42/cios-7-97.PMC4329540.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5b/33/srep08488.PMC4329546.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ca/ad/srep08351.PMC4329550.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8351 | DOI: 10.1038/srep08351 9",Non-OADS,/arxiv_data1/oa_pdf/ca/ad/srep08351.PMC4329550.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8490 | DOI: 10.1038/srep08490 4",Non-OADS,/arxiv_data1/oa_pdf/20/da/srep08490.PMC4329557.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f4/9a/srep08332.PMC4329565.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8332 | DOI: 10.1038/srep08332 5",Non-OADS,/arxiv_data1/oa_pdf/f4/9a/srep08332.PMC4329565.pdf
"Using the comprehensive dataset avail-able at the M. truncatula Gene Expression Atlas web server (MtGEA, http://mtgea.noble.org) (Benedito et al.",OADS,/arxiv_data1/oa_pdf/0f/ef/tpj0081-0453.PMC4329604.pdf
"Raw and normalized microarray data were deposited at Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) as GSE58117.",OADS,/arxiv_data1/oa_pdf/0f/ef/tpj0081-0453.PMC4329604.pdf
Chemical structures were downloa ded from KEGG (http://www.genome.jp/kegg/).,OADS,/arxiv_data1/oa_pdf/2f/f8/tpj0081-0493.PMC4329605.pdf
"IDP primers and gene-speciﬁc primers were designed using the online primerdesign software, PRIMER 3 (http://biotools.umassmed.edu/bioapps/ primer3_www.cgi).",OADS,/arxiv_data1/oa_pdf/2f/f8/tpj0081-0493.PMC4329605.pdf
"MAT amet7 mutant yeast were transformed with either cloned p413-ADH/ Bm4 vector or empty p413-ADH vector using the high-efﬁciency LiAc/SS Carrier DNA/ PEG transformation method developed by the Gietz laboratory (http://home.cc.umanitoba.ca/~gietz/method.html) (Gietz andWoods, 2002).",Non-OADS,/arxiv_data1/oa_pdf/2f/f8/tpj0081-0493.PMC4329605.pdf
"SDC –His and –Met media were generated using Clontech –His and –Met/ –Trp amino acid dropout media, respectively (http://www.clontech.com/).",OADS,/arxiv_data1/oa_pdf/2f/f8/tpj0081-0493.PMC4329605.pdf
A vailable from: http://www.ncbi.nlm.nih.gov/nuccore/?,Non-OADS,/arxiv_data1/oa_pdf/5e/4f/PM-11-152.PMC4329617.pdf
A vailable from: http://www.minerva.ufpel.edu.br/~lmaia.faem/.,Non-OADS,/arxiv_data1/oa_pdf/5e/4f/PM-11-152.PMC4329617.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/1a/e3/PM-11-24.PMC4329628.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/2d/b0/PM-11-32.PMC4329629.pdf
A vailable from: http://www.malvaceae.info/Genera/Lavatera/ cretica.html.,Non-OADS,/arxiv_data1/oa_pdf/47/c0/PM-11-48.PMC4329632.pdf
A vailable from: http://www.jb.utad.pt/especie/lavatera_cretica.,Non-OADS,/arxiv_data1/oa_pdf/47/c0/PM-11-48.PMC4329632.pdf
Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ UCM070305.pdf [Last accessed on 2014 Apr 29].,Non-OADS,/arxiv_data1/oa_pdf/6d/55/PM-11-8.PMC4329637.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/92/main.PMC4329646.pdf
http://dx.doi.org/10.1016/j.fob.2015.01.004 2211-5463/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/92/main.PMC4329646.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: Caner Research Group, The Canberra Hospital, Yamba Drive, Garran, ACT 2605, Australia.",Non-OADS,/arxiv_data1/oa_pdf/fc/92/main.PMC4329646.pdf
Available from: http://www.acr.org/News-Publications/News/ News-Articles/2014/ACR-Bulletin/201408-One-Specialty.,Non-OADS,/arxiv_data1/oa_pdf/a4/5d/IJRI-25-1.PMC4329678.pdf
Available from: http://www.auntminnie.com/index.aspx?sec=sup& sub=pac&pag=dis&itemId=107499.,Non-OADS,/arxiv_data1/oa_pdf/a4/5d/IJRI-25-1.PMC4329678.pdf
Available from: http://www.radiologytoday.net/archive/rt0113p22.,Non-OADS,/arxiv_data1/oa_pdf/a4/5d/IJRI-25-1.PMC4329678.pdf
Available from: http://en.wikipedia.org/wiki/Pounds_per_square_ inch.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.google.com/patents/US7491191.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.appliedradiologycom/ Issues/2003/12/Supplements/Technical‑aspects‑ of‑c ontrast‑  delivery‑in‑advanced‑CT.aspx.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from:  http://www.bmctoday.net/citoday/buyersguide/2013/chart.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.medrad.com/en‑us/ info/products/Pages/Products‑landing.aspx.,OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.medrad.com/en‑us/ aboutmedrad/Pages/History.aspx.,OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://imaging.bracco.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://en.wikipedia.org/wiki/ Bracco_(company).,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://pharmaceuticals.covidien.com/ webforms/threecolumn.aspx?id=670.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from:  http://modernmedicare.co.in/articles/schiller‑india ‑ties‑up‑  with‑covidien‑for‑injectors/.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.nemoto‑do.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.healthcare21.ie/media/ blfa_files/Injectors.pdf.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.medrad.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from:  http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/ Resources/Contrast%20Manual/2013_Contrast_Media.pdf.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.uasom.uab.edu/ PublicDocuments/Radiology/PandP/CT_IV_Access_Guidelines.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.med.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://onsopcontent.ons.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from:  http://www.radiology.ucsf.edu/patient‑care/patient‑safety/ contrast/iodinated/vascular‑access‑adults.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.gehealthcare.com/accessories/2007%20AandS%20Catalog.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://braccoimaging.com/sites/braccoimaging.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.dicardiology.com/article/ trends‑picc‑line‑technology.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available  from: http://www.powerpicc.com/faq.php.,OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from:  http://www.appliedradiology.com/Issues/2011/07/Tech‑Trends/ IT‑empowers‑contrast‑media‑injectors.aspx.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.nemoto‑do.co.jp/ nemoto_en/pr_ce/.,Non-OADS,/arxiv_data1/oa_pdf/01/33/IJRI-25-2.PMC4329682.pdf
Available from: http://www.nice.org.uk.,Non-OADS,/arxiv_data1/oa_pdf/24/cd/IJRI-25-25.PMC4329684.pdf
Available from: http://www.pathologyoutlines.,Non-OADS,/arxiv_data1/oa_pdf/19/49/IJRI-25-75b.PMC4329696.pdf
Available	 from:	http://www.ods.od.nih.gov/ HealthInformation/.,Non-OADS,/arxiv_data1/oa_pdf/88/cd/JOVR-9-487.PMC4329711.pdf
Available	from:	http://www.who.int/,Non-OADS,/arxiv_data1/oa_pdf/88/cd/JOVR-9-487.PMC4329711.pdf
"Proc	R	Soc	B	2011;278:1489‑1497,	 Available	from:	URL:	http://dx.doi.org/10.1098/rspb.2010.1747.",OADS,/arxiv_data1/oa_pdf/64/ef/JOVR-9-494.PMC4329712.pdf
Available	from:	http://standards.ieee.,OADS,/arxiv_data1/oa_pdf/64/ef/JOVR-9-494.PMC4329712.pdf
Available	 from:	http://www.scopus.com.,Non-OADS,/arxiv_data1/oa_pdf/64/ef/JOVR-9-494.PMC4329712.pdf
"MIT	Technology	 Review;	7	March,	 2011	Available	 from:	http://www.technologyreview.com/ news/423216/a‑bionic‑eye‑comes‑to‑market/.",Non-OADS,/arxiv_data1/oa_pdf/64/ef/JOVR-9-494.PMC4329712.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f9/4e/ircmj-16-10-15461.PMC4329745.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7b/be/ircmj-16-10-14755.PMC4329746.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/77/56/ircmj-16-10-15472.PMC4329747.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/28/08/ircmj-16-10-16433.PMC4329748.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/67/2f/ircmj-16-10-16030.PMC4329749.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/ircmj-16-10-15605.PMC4329750.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/61/2d/ircmj-16-10-15722.PMC4329751.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/82/51/ircmj-16-10-14194.PMC4329752.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/43/95/ircmj-16-10-15670.PMC4329753.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/2e/79/ircmj-16-10-15497.PMC4329754.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ce/96/ircmj-16-10-16600.PMC4329755.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/9c/01/ircmj-16-10-15520.PMC4329756.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6d/3c/ircmj-16-10-13651.PMC4329757.pdf
"[cited January 12, 2011]; Avail - able from: http://altmedicine.about.com.",OADS,/arxiv_data1/oa_pdf/6d/3c/ircmj-16-10-13651.PMC4329757.pdf
http://dx.doi.org/10.1016/j.mgene.2014.12.002 2214-5400/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/ca/main.PMC4329826.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/ca/main.PMC4329826.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/ca/main.PMC4329826.pdf
http://dx.doi.org/10.1016/j.ijgo.2008.06.008 .,OADS,/arxiv_data1/oa_pdf/4e/ca/main.PMC4329826.pdf
http://dx.doi.org/10.1203/PDR.0b013e3181567bfc .,Non-OADS,/arxiv_data1/oa_pdf/4e/ca/main.PMC4329826.pdf
"Lancet 371, 75 –84.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4e/ca/main.PMC4329826.pdf
http://dx.doi.org/10.1016/j.mgene.2014.12.003 2214-5400/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/71/85/main.PMC4329827.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/85/main.PMC4329827.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/85/main.PMC4329827.pdf
http://blast.ncbi.nlm.nih.gov/Blast.cgi .,OADS,/arxiv_data1/oa_pdf/71/85/main.PMC4329827.pdf
"Properly designed © Paulina Wyrozumska, Justyna Meissner, Monika Toporkiewicz, Marta Szarawarska, Kazimierz Kuliczkowski, Maciej Ugorski, Marta A Walasek, and Aleksander F Sikorski*Correspondence to: Aleksander Sikorski; Email: afsbc@ibmb.uni.wroc.plSubmitted: 06/13/2014; Revised: 09/07/2014; Accepted: 11/09/2014 http://dx.doi.org/10.4161/15384047.2014.987009 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Blood 2008; 111:4431-44; PMID:18441245;http://dx.doi.org/10.1182/blood-2007-11-078121 2.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Int J Pharm 2012; 422:280-9;PMID:22101286; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
JControl Release 2010; 142:404-10; PMID:19931327; http://dx.doi.org/10.1016/j.jconrel.2009.11.010 4.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Expert Opin Drug Deliv 2009;6:673-86; PMID:19552611; http://dx.doi.org/ 10.1517/17425240902992894 5.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Adv Drug Deliv Rev 2009; 61:850-62; PMID:19422869; http://dx.doi.org/10.1016/j.addr.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Expert Opin Ther Pat 2014; 24:801-19; PMID:24798406; http://dx.doi.org/ 10.1517/13543776.2014.915944 8.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Biomaterials 2011; 32:9785-95;PMID:21937102; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Bio- chem Soc Trans 2007; 35:68-71; PMID:17233603; http://dx.doi.org/10.1042/BST0350068 10.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Methods Enzymol 2004; 387:171-88; PMID:15172164;http://dx.doi.org/10.1016/S0076-6879(04)87011-3 13.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Nat Rev Mol Cell Biol 2008; 9:47-59; PMID:18097445; http://dx.doi.org/10.1038/nrm2308 15.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Clin Ther 2009; 31 Pt 2:2349-70; PMID:20110045; http://dx.doi.org/ 10.1016/j.clinthera.2009.11.017 16.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Expert Rev Hematol 2013; 6:587-97; PMID:24083449; http://dx.doi.org/10.1586/ 17474086.2013.827415 17.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Gen Physiol Biophys 2011; 30 Spec No:S3-S12; PMID:21869449; http://dx.doi.org/10.4149/gpb_2011_SI1_3 18.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Leuk Res2010; 34:837-42; PMID:20359747; http://dx.doi.org/ 10.1016/j.leukres.2010.03.011 19.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Rev Recent Clin Trials 2006; 1:217-35;PMID:18473975; http://dx.doi.org/10.2174/ 157488706778250050 20.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Blood 2002; 99:3461-4; PMID:11964319; http://dx.doi.org/10.1182/blood.V99.9.3461 21.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Front Oncol 2014; 4:3; PMID:24478984; http://dx.doi.org/10.3389/fonc.2014.00003 23.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Biochem Pharmacol 2005; 69:73-85; PMID:15588716; http://dx.doi.org/10.1016/j.bcp.2004.08.031 24.,OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Ann Oncol 2002; 13:539-45; PMID:12056703; http://dx.doi.org/10.1093/annonc/mdf124 26.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
J Clin Oncol 2004; 22:1110-7; PMID:15020613; http://dx.doi.org/10.1200/JCO.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Clin Cancer Res 2005; 11:2998-3008; PMID:15837754; http://dx.doi.org/ 10.1158/1078-0432.CCR-04-1505 28.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
Bio- chemistry 1995; 34:12877-83; PMID:7548044; http://dx.doi.org/10.1021/bi00039a050 29.,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/kcbt-16-66.PMC4329851.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/f6/ciu884.PMC4329923.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/27/99/ircmj-16-11-19351.PMC4329928.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/4a/89/ircmj-16-11-22528.PMC4329929.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1a/8a/ircmj-16-11-21149.PMC4329930.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f0/df/ircmj-16-11-5410.PMC4329931.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8a/8d/ircmj-16-11-12180.PMC4329932.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a9/07/ircmj-16-11-16234.PMC4329933.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/50/14/ircmj-16-11-22151.PMC4329934.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1b/7c/ircmj-16-11-16183.PMC4329935.pdf
Available from: http://emedicine.medscape.com/article/796892- overview .,Non-OADS,/arxiv_data1/oa_pdf/1b/7c/ircmj-16-11-16183.PMC4329935.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/75/bb/ircmj-16-11-16981.PMC4329936.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/15/d4/ircmj-16-11-22045.PMC4329937.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/82/55/ircmj-16-11-19926.PMC4329938.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c1/12/ircmj-16-11-10856.PMC4329943.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ec/61/ircmj-16-11-14757.PMC4329955.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/47/18/ircmj-16-11-20219.PMC4329956.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3e/9b/ircmj-16-11-15428.PMC4329957.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ab/c2/ircmj-16-11-16379.PMC4329958.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8b/42/ircmj-16-11-19173.PMC4329959.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d0/9d/ircmj-16-11-12855.PMC4329960.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/2a/92/ircmj-16-11-16351.PMC4329961.pdf
Avail - able from: http://treatment.tbzmed.ac.ir/uploads/30/CMS/user/ file/47/aennameh/140.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/92/ircmj-16-11-16351.PMC4329961.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/df/66/ircmj-16-11-19329.PMC4329962.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6b/54/ircmj-16-11-20024.PMC4329963.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/73/1b/ircmj-16-11-16005.PMC4329964.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8e/5b/ircmj-16-11-18001.PMC4329965.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/bb/d1/ircmj-16-11-11548.PMC4329966.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven figures, and four tables and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2013.12.029 .",OADS,/arxiv_data1/oa_pdf/3c/b7/nihms552005.PMC4329986.pdf
"As  part of quality control, we genotyped additional 74 SNPs identified as ancestry informative  markers selected for maximal difference between African and European populations and  assessed potential confounding factors due to population substructure using genotype data  and the STRUCTURE program (v.2.2; http://pritch.bsd.uchicago.edu/software ).Ando et al.",OADS,/arxiv_data1/oa_pdf/3c/b7/nihms552005.PMC4329986.pdf
"Statistical Analysis For genetic analysis, logistic regression, adjusting for the first two principal components,  was used to test for association between each individual marker (under an additive model)  and disease status using PLINK software ( http://pngu.mgh.harford.edu/~purcell/plink/to ).",OADS,/arxiv_data1/oa_pdf/3c/b7/nihms552005.PMC4329986.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/10/ccid-8-067.PMC4329995.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 67–73Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  67RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S4919 5New approach to the understanding of keloid:  psychoneuroimmune–endocrine aspects Bernardo Hochman† Felipe Contoli Isoldi Fabianne Furtado Lydia Masako Ferreira Plastic Surgery Division, Federal  University of São Paulo, São Paulo,   Brazil †Bernardo Hochman passed away on  April 21, 2014 Correspondence: Felipe Contoli Isoldi   escola Paulista de Medicina, Universidade  Federal de São Paulo (UNIFeSP),Rua  Napoleão de Barros,   715–4º Andar, vila Clementino,   São Paulo SP 04.024–002, Brazil   Tel +55 11 5571 6579   email felipeisoldi@gmail.co mAbstract:  The skin is a dynamic and complex organ that relies on the interrelation among  different cell types, macromolecules, and signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/d8/10/ccid-8-067.PMC4329995.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d8/10/ccid-8-067.PMC4329995.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/10/ccid-8-067.PMC4329995.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/amep-6-099.PMC4329996.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 99–104Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  99OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7531 6new ideas for teaching electrocardiogram  interpretation and improving classroom   teaching content rui Zeng1 rong-Zheng Yue2 chun-Yu Tan3 Qin Wang4 Pu Kuang5 Pan-Wen Tian6 chuan Zuo3 1Department of cardiovascular  Diseases, 2Department of n ephrology,   3Department of rheumatology  and immunology, 4Department  of Endocrinology, 5Department  of hematology, 6Department of  respiratory Diseases, West china  hospital, school of clinic Medicine,   sichuan University, chengdu, People’s  republic of china correspondence: chuan Zuo   Department of rheumatology and  immunology, West china hospital,  school of clinic Medicine, sichuan  University, 610041, chengdu,   People’s republic of china   Tel +86 28 8542 2343   Fax +86 28 8542 3249   Email zengrui_0524@126.co mBackground:  Interpreting an electrocardiogram (ECG) is not only one of the most important  parts of diagnostics but also one of the most difficult areas to teach.",Non-OADS,/arxiv_data1/oa_pdf/d6/ec/amep-6-099.PMC4329996.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d6/ec/amep-6-099.PMC4329996.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/amep-6-099.PMC4329996.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/f6/ceg-8-089.PMC4329997.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 89–93Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  89OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S7657 9Value of portal venous system radiological indices  in predicting esophageal varices Vinaya Gaduputi1 harish Patel1 sailaja sakam1 srivani neshangi1 rafeeq ahmed1 Michael lombino2 sridhar Chilimuri1 1Department of Medicine,   2Department of radiology, Bronx  lebanon hospital Center   new York, nY, Usa Correspondence: Vinaya Gaduputi   Bronx lebanon hospital Center,  Department of Medicine,  1650 selwyn  ave, suite #10C, Bronx, new York,   nY 10457, Usa   Email vgaduput @bronxleb.or gIntroduction:  Portal hypertension results from increased resistance to portal blood flow and  has the potential complications of variceal bleeding and ascites.",Non-OADS,/arxiv_data1/oa_pdf/7d/f6/ceg-8-089.PMC4329997.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/7d/f6/ceg-8-089.PMC4329997.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/f6/ceg-8-089.PMC4329997.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/9b/amep-6-105.PMC4329998.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 105–112Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  105OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7703 7impact of an emergency medicine clerkship on  students’ perceptions of emergency medicine sangeeta lamba1 roxanne nagurka1 Bart holland2 sandra scott1 1Department of Emergency Medicine,   2Department of Preventive Medicine,   rutgers new Jersey Medical school,   newark, nJ, UsA correspondence: roxanne nagurka   Department of Emergency Medicine,  rutgers new Jersey Medical school,   150 Bergen street, newark,   nJ 07101, UsA   Email nagurkrm@gsbs.rutgers.ed uPurpose:  To determine the impact of an emergency medicine (EM) clerkship on senior (4th  year) medical students’ perceptions of the EM specialty.",Non-OADS,/arxiv_data1/oa_pdf/db/9b/amep-6-105.PMC4329998.pdf
Available from:  https://www.abem.org/public/general-information/history.,Non-OADS,/arxiv_data1/oa_pdf/db/9b/amep-6-105.PMC4329998.pdf
Available  from: http://www.nrmp.org/data/resultsanddata201 2.,OADS,/arxiv_data1/oa_pdf/db/9b/amep-6-105.PMC4329998.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/db/9b/amep-6-105.PMC4329998.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/9b/amep-6-105.PMC4329998.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/f7/ccid-8-075.PMC4329999.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 75–84Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  75OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S7224 4solar exposure(s) and facial clinical signs of aging   in Chinese women: impacts upon age perception Frederic Flament1  roland Bazin2 huixia Qiu3 Chengda Ye3 sabine laquieze4 Virginie rubert1 aurelie Decroux1 elisa simonpietri5 Bertrand Piot1 1l’Oreal research and Innovation,   Paris, France; 2rB Consult, Bievres,   France; 3l’Oreal research and  Innovation, shanghai, People’s republic  of China; 4Private Dermatology  Consultancy, Montpellier, France;   5Biotherm International, levallois- Perret, France Correspondence: Frederic Flament   Department of applied research and  Development, l ’Oreal research and  Innovation, 188, rue Paul hochart,   94550 Chevilly-larue, Paris, France   email fflament@rd.loreal.co mAbstract:  A new reference clinical atlas of facial signs dedicated to photoaging was applied to  301 Chinese women of various ages through standardized photographs.",Non-OADS,/arxiv_data1/oa_pdf/c0/f7/ccid-8-075.PMC4329999.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/c0/f7/ccid-8-075.PMC4329999.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/f7/ccid-8-075.PMC4329999.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/9c/ccid-8-019.PMC4330000.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 19–25Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  19Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/CCID.S7287 8Complete biodegradable nature of calcium  hydroxylapatite after injection for malar  enhancement: an MRI study tatjana pavicic private practice, Munich, Germany Correspondence: tatjana pavicic  privatpraxis, Maximilianstrasse 54, 80538  Munich, Germany   tel +49 89 1211 4680   email tatjana.pavicic@email.d eBackground:  Radiesse® (Calcium hydroxylapatite [CaHA]) is a biocompatible, injectable  gel for facial soft tissue augmentation.",Non-OADS,/arxiv_data1/oa_pdf/d1/9c/ccid-8-019.PMC4330000.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d1/9c/ccid-8-019.PMC4330000.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/9c/ccid-8-019.PMC4330000.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/70/bctt-7-051.PMC4330001.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 51–58Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  51Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S6983 4internalization: acute apoptosis of breast   cancer cells using herceptin-immobilized   gold nanoparticles Pierson rathinaraj1 ahmed M al-Jumaily1 Do sung huh2 1institute of Biomedical T echnologies,   auckland University of T echnology,   auckland, new Zealand; 2Department  of nano science and engineering, inje  University, gimhea, south Korea Correspondence: Pierson rathinaraj   institute of Biomedical Technologies,  auckland University of Technology, WD  301, st Paul street, Wellesley Campus,  auckland 1142, new Zealand   Tel +64 9 921 9999   Fax +64 9 921 9973   email pierson.rathinaraj@aut.ac.n zAbstract:  Herceptin, the monoclonal antibody, was successfully immobilized on gold  nanoparticles (GNPs) to improve their precise interactions with breast cancer cells (SK-BR3).",Non-OADS,/arxiv_data1/oa_pdf/d1/70/bctt-7-051.PMC4330001.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d1/70/bctt-7-051.PMC4330001.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/ad/ceor-7-105.PMC4330002.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 105–117ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  105ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7834 9Cost-utility of denosumab for the treatment   of postmenopausal osteoporosis in spain Josep Darbà1 lisette Kaskens2 Francesc sorio Vilela3 Mickael lothgren4 1Department of Economics,   Universitat de Barcelona,  2BCn   health Economics and Outcomes  Research sl, 3amgen sa, Barcelona,   spain;  4amgen (Europe) gmbh, Zug,   switzerland Correspondence: Josep Darbà   Department of Economics, Universitat   de Barcelona, Diagonal  690,   Barcelona  08034, spain   Tel +349 3402 1937  Email darba@ub.ed uBackground:  The objective of this study was to estimate the cost-effectiveness of denosumab  for fracture prevention compared with no treatment, generic bisphosphonates, and strontium  ranelate in a cohort of osteoporotic postmenopausal women in Spain.",Non-OADS,/arxiv_data1/oa_pdf/76/ad/ceor-7-105.PMC4330002.pdf
Available from:  https://www.nice.org.uk/guidance/cg146/documents/osteoporosis- evidence-reviews 2.,Non-OADS,/arxiv_data1/oa_pdf/76/ad/ceor-7-105.PMC4330002.pdf
Available from: http://www.ine.es/inebmenu/ mnu_cifraspob.htm# 6.,Non-OADS,/arxiv_data1/oa_pdf/76/ad/ceor-7-105.PMC4330002.pdf
Avail - able from http://www.oblikue.com/bddcostes /.,Non-OADS,/arxiv_data1/oa_pdf/76/ad/ceor-7-105.PMC4330002.pdf
"Available from http://www.portalfarma.com/inicio/botplus20/ Paginas/Bot-PLUS-2-0.asp x. Accessed January 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/76/ad/ceor-7-105.PMC4330002.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/76/ad/ceor-7-105.PMC4330002.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/ad/ceor-7-105.PMC4330002.pdf
Available from: http://www.nice.org.uk/guidance/ ta161.,Non-OADS,/arxiv_data1/oa_pdf/76/ad/ceor-7-105.PMC4330002.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/81/66/ccid-8-053.PMC4330003.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 53–56Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  53OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S7584 9Drug-induced skin reactions: a  2-year study Mahmood Farshchian1  akram ansar1 abbas Zamanian2 ghasem rahmatpour- rokni1 arash Kimyai-asadi3 Mehdi Farshchian1,4 1Psoriasis research Center,   Department of Dermatology,   Farshchian hospital, hamadan  University of Medical sciences,   hamedan, Iran;  2Department of  Dermatology, Iran University  of Medical sciences, T ehran,   Iran; 3Derm surgery associates,   houston, TX,  Usa; 4Department of  Dermatology, University of Turku  and T urku University hospital, T urku,   Finland Correspondence: arash Kimyai-asadi   7515 Main street, suite  290, houston,  TX 77030, Usa   Tel +1 713 791 9966  Fax +1 713 791 9927  email akimyai@yahoo.co mBackground:  The aim of this study was to analyze the clinical characteristics of patients with  adverse cutaneous drug reactions, which occur when a medicinal product results in cutaneous  morbidity.",Non-OADS,/arxiv_data1/oa_pdf/81/66/ccid-8-053.PMC4330003.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/81/66/ccid-8-053.PMC4330003.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/66/ccid-8-053.PMC4330003.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/a8/cia-10-421.PMC4330004.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 421–434Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  421RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7169 1effectiveness of exercise programs to reduce  falls in older people with dementia living in the  community: a systematic review and meta-analysis elissa Burton1,2 vinicius Cavalheri1 Richard Adams3 Colleen Oakley Browne4 Petra Bovery-Spencer4 Audra M Fenton3 Bruce w Campbell5 Keith D Hill1,6 1School of Physiotherapy and exercise  Science, Curtin University, Perth, wA,   Australia; 2Research Department,   Silver Chain, Perth, wA, Australia;   3Community Services, west Gippsland  Healthcare Group, warragul, vIC,   Australia; 4Falls Prevention for  People Living with Dementia Project,   Central west Gippsland Primary  Care Partnership, Moe, vIC, Australia;   5Allied Health, Latrobe Regional  Hospital, Traralgon, vIC, Australia;   6Preventive and Public Health  Division, National Ageing Research  Institute, Melbourne, vIC, AustraliaObjective:  The objective of this systematic review and meta-analysis is to evaluate the effec - tiveness of exercise programs to reduce falls in older people with dementia who are living in  the community.",Non-OADS,/arxiv_data1/oa_pdf/e3/a8/cia-10-421.PMC4330004.pdf
"As the  severity of dementia increases over time, the person with dementia often has increased  difficulties with many important functions, including gait impairments, problems with  postural control, reduced participation in activities such as shopping and driving, Correspondence: elissa Burton Curtin University, School of Physiotherapy  and exercise Science, GPO Box U 1987,  Perth, wA 6845, Australia Tel +61 8 9266 3681 Fax +61 8 9266 3699 email e.burton@curtin.edu.a u Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Burton et al Running head recto: Exercise to reduce falls for community dwelling people with dementia DOI: http://dx.doi.org/10.2147/CIA.S71691",Non-OADS,/arxiv_data1/oa_pdf/e3/a8/cia-10-421.PMC4330004.pdf
Available  from: http://www.alz.co.uk/research/statistics.,OADS,/arxiv_data1/oa_pdf/e3/a8/cia-10-421.PMC4330004.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/e3/a8/cia-10-421.PMC4330004.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e3/a8/cia-10-421.PMC4330004.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/a1/amep-6-093.PMC4330005.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 93–98Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  93OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7721 6Hospitalist workload influences faculty evaluations  by internal medicine clerkship students robert l robinson Department of Internal Medicine,   Southern Illinois University School   of Medicine, Springfield, Illinois, USA correspondence: robert l robinson   Department of Internal Medicine,  Southern Illinois University School of  Medicine,  701 North First Street,   PO Box  19,636, Springfield,   il 62794-9636, USA   Tel +1 217 545 0182  Fax +1 217 545 7127  Email rrobinson@siumed.ed uBackground:  The last decade has brought significant changes to internal medicine clerkships  through resident work-hour restrictions and the widespread adoption of hospitalists as medi - cal educators.",Non-OADS,/arxiv_data1/oa_pdf/37/a1/amep-6-093.PMC4330005.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/37/a1/amep-6-093.PMC4330005.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/a1/amep-6-093.PMC4330005.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/4d/ccid-8-057.PMC4330006.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 57–65Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  57OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S7774 2antiaging, photoprotective, and brightening  activity in biorevitalization: a new solution   for aging skin adele sparavigna Beatrice T enconi Ileana De Ponti Derming, Clinical research and  Bioengineering Institute, Monza, Italy Correspondence: adele sparavigna   Derming, Clinical research and  Bioengineering Institute, viale Cesare   Battisti 38, 20900, Monza, Italy   Tel +39 039 32 9666   email adele.sparavigna@derming.co mBackground:  Age-related changes in the dermis can be considered the result of intrinsic  factors and the consequence of environmental damage, mainly due to ultraviolet (UV) radia - tion from the sun (responsible for skin photoaging).",Non-OADS,/arxiv_data1/oa_pdf/40/4d/ccid-8-057.PMC4330006.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/40/4d/ccid-8-057.PMC4330006.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/4d/ccid-8-057.PMC4330006.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/e4/dddt-9-781.PMC4330027.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 781–789Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  781Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5740 9Clinical utility of eslicarbazepine: current evidence Gaetano Zaccara1 Fabio Giovannelli1,2 Massimo Cincotta1 Alessia Carelli3 Alberto verrotti3 1Department of Medicine, Unit  of Neurology, Florence Health  Authority, Florence, italy;   2Department of Neuroscience,   Psychology, Pharmacology and  Child Health (N eUROFARBA),   University of Florence, Florence, italy;   3Department of Pediatrics, University  of Perugia, Perugia, italyAbstract:  Eslicarbazepine acetate (ESL) is a new antiepileptic drug whose mechanism of  action is blockade of the voltage-gated sodium channel (VGSC).",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/dddt-9-781.PMC4330027.pdf
"It is available in Europe in the  pharmaceutical form of tablets under the trade name Zebinix (produced by BIAL,  Trofa, Porto District, Portugal) and in the United States under the trade name Stedesa Correspondence: Gaetano Zaccara Unit of Neurology, San Giovanni di Dio  Hospital, via Di Torregalli n 3, 50143  Florence, italy email gaetano.zaccara@asf.toscana.i t Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Zaccara et al Running head recto: Eslicarbazepine: current evidence DOI: http://dx.doi.org/10.2147/DDDT.S57409",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/dddt-9-781.PMC4330027.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/dddt-9-781.PMC4330027.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/e4/dddt-9-781.PMC4330027.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/a1/cia-10-435.PMC4330028.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 435–443Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  435OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7709 6Hearing aid fitting in older persons with hearing  impairment: the influence of cognitive function,  age, and hearing loss on hearing aid benefit hartmut Meister1 Sebastian Rählmann1 Martin Walger2 Sabine Margolf-Hackl3 Jürgen Kießling3 1Jean Uhrmacher Institute for Clinical  ENT -Research, University of Cologne,   Cologne, Germany; 2Department  of Otorhinolaryngology, Head and  Neck Surgery, University of Cologne,   Cologne, Germany; 3Department of  Othorhinolaryngology, Head and  Neck Surgery, University of Giessen,   Giessen, GermanyPurpose:  To examine the association of cognitive function, age, and hearing loss with clinically  assessed hearing aid benefit in older hearing-impaired persons.",Non-OADS,/arxiv_data1/oa_pdf/23/a1/cia-10-435.PMC4330028.pdf
"However, modern HAs contain numerous advanced  signal processing features, such as dynamic range compression, in order to address Correspondence: hartmut Meister Jean Uhrmacher Institute for Clinical  ENT-Research, University of Cologne,  Geibelstr 29–31, Cologne, Germany Tel +49 221 4789 7003 Fax +49 221 4789 7010 email hartmut.meister@uni-koeln.d e Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Meister et al Running head recto: Hearing aid fitting in older persons DOI: http://dx.doi.org/10.2147/CIA.S77096",Non-OADS,/arxiv_data1/oa_pdf/23/a1/cia-10-435.PMC4330028.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/23/a1/cia-10-435.PMC4330028.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/23/a1/cia-10-435.PMC4330028.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/11/dddt-9-805.PMC4330029.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 805–816Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  805Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7706 3Borreliacidal activity of Borrelia  metal transporter  a (Bmta) binding small molecules by manganese  transport inhibition Dhananjay Wagh* Venkata raveendra  Pothineni* Mohammed inayathullah song liu Kwang-Min Kim Jayakumar rajadas Biomaterials and advanced Drug  Delivery laboratory, stanford  cardiovascular Pharmacology  Division, cardiovascular institute,   stanford University school of  Medicine, Palo alto, ca, Usa *These authors contributed equally  to this workAbstract:  Borrelia burgdorferi , the causative agent of Lyme disease, utilizes manganese  (Mn) for its various metabolic needs.",Non-OADS,/arxiv_data1/oa_pdf/47/11/dddt-9-805.PMC4330029.pdf
"According to the CDC report, which was obtained by a series of clinical trials on the  PTLDS,4,11–15 long-term antibiotic treatment for PTLDS patients is almost ineffective in correspondence: Jayakumar rajadas school of Medicine, stanford university,  1050 arastradero road, Building a,  room a148, Palo alto, ca 94304, Usa Tel +1 650 724 6806 Fax +1 650 724 4694 email jayraja@stanford.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wagh et al Running head recto: Inhibition of manganese transport in Borrelia DOI: http://dx.doi.org/10.2147/DDDT.S77063",Non-OADS,/arxiv_data1/oa_pdf/47/11/dddt-9-805.PMC4330029.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/47/11/dddt-9-805.PMC4330029.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/11/dddt-9-805.PMC4330029.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/dddt-9-791.PMC4330030.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 791–798Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  791Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7667 6Development of lovastatin-loaded poly(lactic acid)  microspheres for sustained oral delivery: in vitro  and ex vivo evaluation Qigang guan1 Wei chen2 Xianming hu2 1Department of cardiology, The  First affiliated hospital of china  Medical University, shenyang, People’s  republic of china; 2Department of  Pharmaceutical, shenyang institute  of Pharmaceutical industry, shenyang,   People’s republic of chinaBackground:  A novel lovastatin (LVT)-loaded poly(lactic acid) microsphere suitable for  oral administration was developed in this study, and in vitro and in vivo characteristics were  evaluated.",Non-OADS,/arxiv_data1/oa_pdf/e2/e2/dddt-9-791.PMC4330030.pdf
"In addition, LVT is rapidly metabolized in the intestine  and liver, and therefore it has poor oral bioavailability ( ~5%).2 Cytochrome P450 3A4  metabolizes the lactone form of LVT into hydroxy acid and its metabolites.3,4 As a  consequence of extensive hepatic extraction of LVT, availability of the drug to the  general circulation is low and variable.5 Moreover, conventional oral dosage leads to  fluctuations in plasma drug level, because of the method offers no control over drug correspondence: Qigang guan Department of cardiology, The First  Affiliated Hospital of China Medical  University, 155# nanjing north street,  heping District, shenyang, liaoning  110001, People’s republic of china Tel +86 24 8328 2690 Fax +86 24 8328 2690 email qigangg@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Guan et al Running head recto: In vitro and ex vivo evaluation of LVT-loaded PLA microspheres DOI: http://dx.doi.org/10.2147/DDDT.S76676",Non-OADS,/arxiv_data1/oa_pdf/e2/e2/dddt-9-791.PMC4330030.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e2/e2/dddt-9-791.PMC4330030.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/dddt-9-791.PMC4330030.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/28/copd-10-309.PMC4330031.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 309–320International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  309OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7629 3relationship between serum cardiac troponin  T level and cardiopulmonary function in stable  chronic obstructive pulmonary disease Kumiko hattori Takeo Ishii Takashi Motegi Yuji Kusunoki akihiko gemma Kozui Kida Department of Pulmonary Medicine  and Oncology; respiratory Care  Clinic, nippon Medical school, T okyo,   JapanBackground:  High-sensitivity cardiac troponin T (hs-cTnT) in serum is a useful marker  of acute myocardial injury, yet information is limited in patients with chronic obstructive  pulmonary disease.",Non-OADS,/arxiv_data1/oa_pdf/b8/28/copd-10-309.PMC4330031.pdf
"Cardiac injury is defined as disruption of the normal cardiac myocyte membrane  integrity, resulting in loss of its intracellular contents into the extracellular space (such Correspondence: Kozui Kida Department of Pulmonary Medicine,  Infection, and Oncology, respiratory  Care Clinic, nippon Medical school, 4-7- 15-8F, Kudan-minami, Chiyoda-ku, Tokyo  102-0074, Japan Tel +81 3 5276 2325 Fax +81 3 5276 2326 email kkida@nms.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Hattori et al Running head recto: Serum troponin T level in stable COPD DOI: http://dx.doi.org/10.2147/COPD.S76293",Non-OADS,/arxiv_data1/oa_pdf/b8/28/copd-10-309.PMC4330031.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/b8/28/copd-10-309.PMC4330031.pdf
Available from:  http://www.goldcopd.org/.,Non-OADS,/arxiv_data1/oa_pdf/b8/28/copd-10-309.PMC4330031.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b8/28/copd-10-309.PMC4330031.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/28/copd-10-309.PMC4330031.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/84/copd-10-293.PMC4330032.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 293–307International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  293RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S6809 3Systematic literature review of patient-reported  outcome measures used in assessment   and measurement of sleep disorders   in chronic obstructive pulmonary disease Adam P Garrow1,2 Janelle Y orke2 Naimat Khan1 Jørgen vestbo3 Dave Singh1 Sarah Tyson1 1University of Manchester Medicines  evaluation Unit, University Hospital  of South Manchester Foundation  Trust,  2School of Nursing, Midwifery  and Social work, University of  Manchester,  3The University of  Manchester  Academic Health  Science Centre, University Hospital  South  Manchester  NHS Foundation  Trust,  Manchester, UK Correspondence: Janelle Yorke   School of Nursing, Midwifery and  Social work, University of Manchester,  Room  5.320, Jean McFarlane University,  University Place, Oxford Road,  Manchester, M13  9PL, UK   Tel +44 161 306 7 780  email janelle.yorke@manchester.ac.u kBackground:  Sleep problems are common in patients with chronic obstructive pulmonary  disease (COPD), but the validity of patient-reported outcome measures (PROMs) that measure  sleep dysfunction has not been evaluated.",Non-OADS,/arxiv_data1/oa_pdf/fb/84/copd-10-293.PMC4330032.pdf
Available  from: http://science.education.nih.gov/supplements/nih3/sleep/guide/ info-sleep.htm.,Non-OADS,/arxiv_data1/oa_pdf/fb/84/copd-10-293.PMC4330032.pdf
Available from:  http://patientexperienceportal.org/article/patient-reported-outcome- measures-their-role-in-measuring-and-improving-patient-experience.,Non-OADS,/arxiv_data1/oa_pdf/fb/84/copd-10-293.PMC4330032.pdf
Available from:  http://www.esst.org/adds/ICSD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/84/copd-10-293.PMC4330032.pdf
"Available from: http://www.fda.gov/downloads/Drugs/Guidances/ UCM193282.pd f. Accessed April  30, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fb/84/copd-10-293.PMC4330032.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fb/84/copd-10-293.PMC4330032.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/84/copd-10-293.PMC4330032.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/b6/ijn-10-1173.PMC4330033.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1173–1187International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1173OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7674 2Microemulsion-based synergistic dual-drug  codelivery system for enhanced apoptosis  of tumor cells Ding Qu1 Yihua Ma1 Wenjie sun1,2 Yan chen1 Jing Zhou1 congyan liu1 Mengmeng huang1 1Key laboratory of New Drug  Delivery system of chinese Materia  Medica, Jiangsu Provincial academy  of chinese Medicine, 2Department  of Pharmaceutics, school of Pharmacy,   Nanjing University of chinese  Medicine, Nanjing, Jiangsu, People’s  republic of chinaAbstract:  A microemulsion-based synergistic dual-drug codelivery system was developed  for enhanced cell apoptosis by transporting coix seed oil and etoposide into A549 (human lung  carcinoma) cells simultaneously.",Non-OADS,/arxiv_data1/oa_pdf/72/b6/ijn-10-1173.PMC4330033.pdf
"A myriad of  classical chemotherapeutic drugs, including etoposide (VP16), paclitaxel, doxorubicin,  carboplatin, and cisplatin, are used as cytotoxic agents to induce cell apoptosis and correspondence: Yan chen Key laboratory of New Drug Delivery  system of chinese Materia Medica,  Jiangsu Provincial academy of chinese  Medicine, 100 shizi road, Nanjing, Jiangsu  210028, People’s republic of china Tel +86 25 8560 8672 Fax +86 25 8563 7809 email ychen202@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Qu et al Running head recto: Dual-drug codelivery system for tumor cellular apoptosis induction DOI: http://dx.doi.org/10.2147/IJN.S76742",Non-OADS,/arxiv_data1/oa_pdf/72/b6/ijn-10-1173.PMC4330033.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/72/b6/ijn-10-1173.PMC4330033.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/b6/ijn-10-1173.PMC4330033.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/22/ijn-10-1045.PMC4330034.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1045–1059International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1045OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7330 3a novel chemosynthetic peptide with β-sheet  motif efficiently kills Klebsiella pneumoniae   in a mouse model shirui Tan1,2,* changpei gan1,3,* rongpeng li1 Yan Ye1 shuang Zhang1,3 Xu Wu1 Yi Yan Yang4 Weimin Fan5 Min Wu1 1Department of Basic sciences, school  of Medicine and health sciences  University of North Dakota, Grand  Forks, ND, USA; 2laboratory of  Biochemistry and Molecular Biology,   school of life sciences, Yunnan  University, Kunming, People’s republic  of China; 3state Key laboratory  of Biotherapy, West china hospital,   sichuan University, chengdu, People’s  Republic of China; 4Institute of  Bioengineering and Nanotechnology,   The Nanos, Singapore; 5Program  of Innovative cancer Therapeutics,   First affiliated hospital of  Zhejiang  University college of Medicine,   hangzhou, People’s republic of china *These authors contributed equally  to this workAbstract:  Klebsiella pneumoniae (Kp) is one of the most common pathogens in nosocomial  infections and is increasingly becoming multiple drug resistant.",Non-OADS,/arxiv_data1/oa_pdf/50/22/ijn-10-1045.PMC4330034.pdf
"To effectively eradicate antibiotic-resistant pathogens from afflicted hosts, many  new antibacterial agents have been developed, including ertapenem,10 levaquin, and  meropenem.11 Previously, antimicrobial peptides (AMPs) having cationic charge and  amphipathic structures have been thought to be the best antibacterial agents thanks to  their small size, heat stability, and broad-spectrum antibacterial activity.12 Besides,  AMPs as endogenous antibiotics have extensive capabilities in regulating inflamma - tion, wound repair, and the adaptive immune system in eukaryote host defense.13,14  However, natural AMPs possess ostensible toxicity to humans and are difficult to  prepare on a large scale.15 Although improved techniques of isolation enabled larger Correspondence: Yi Yan Yang; Min Wu Department of Basic sciences, school  of Medicine and health sciences,  University of North Dakota, Grand  Forks, ND 58203-9037, USA Tel +701 777 4875 Fax +701 777 2382 email yyyang@ibn.a-star.edu.s g;   min.wu@med.und.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Tan et al Running head recto: A β-sheet forming peptide-killing Kp in a mouse model DOI: http://dx.doi.org/10.2147/IJN.S73303",Non-OADS,/arxiv_data1/oa_pdf/50/22/ijn-10-1045.PMC4330034.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/50/22/ijn-10-1045.PMC4330034.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/22/ijn-10-1045.PMC4330034.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/8f/cia-10-445.PMC4330035.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 445–451Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  445OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7594 5Proliferative effect of hachimijiogan, a Japanese  herbal medicine, in C2C12 skeletal muscle cells Correspondence: Takashi Takeda Division of Women’s health, research  Institute of Traditional Asian Medicine,  Kinki University school of Medicine,  377-2, Ohno-higashi, Osaka-sayama,  Osaka 589-8511, Japan Tel +81 72 366 0221 ext 3393 Fax +81 72 366 6661  email take@med.kindai.ac.j p Takashi Takeda1,2 Kenji Tsuiji2 Bin li2 Mari Tadakawa2 nobuo Yaegashi2 1Division of Women’s health,   research Institute of Traditional  Asian Medicine, Kinki University  school of Medicine, Osaka, Japan;   2Department of Obstetrics and  gynecology, Tohoku University  graduate school of Medicine,   sendai,  JapanBackground:  Hachimijiogan (HJG), Ba-Wei-Di-Huang-Wan in Chinese, is one of the most  popular herbal medicines in Japanese Kampo.",Non-OADS,/arxiv_data1/oa_pdf/e1/8f/cia-10-445.PMC4330035.pdf
"Specifically, we studied the effect of HJG on the proliferation and  the differentiation of C2C12 myoblasts.Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Takeda et al Running head recto: Hachimijiogan and muscle cells DOI: http://dx.doi.org/10.2147/CIA.S75945",Non-OADS,/arxiv_data1/oa_pdf/e1/8f/cia-10-445.PMC4330035.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/e1/8f/cia-10-445.PMC4330035.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e1/8f/cia-10-445.PMC4330035.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/1b/dddt-9-773.PMC4330036.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 773–779Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  773Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8020 7The role of dasatinib in the management  of chronic myeloid leukemia Runzhe Chen Baoan Chen Department of Hematology and  Oncology (Key Department of Jiangsu  Medicine), Zhongda Hospital, Medical  School, Southeast University, Nanjing,   Jiangsu Province, People’s Republic  of ChinaAbstract:  Dasatinib is a second-generation tyrosine kinase inhibitor (TKI) for chronic, blastic,  or accelerated phase chronic myeloid leukemia (CML) patients who are resistant or intolerant to  previous treatment.",Non-OADS,/arxiv_data1/oa_pdf/b9/1b/dddt-9-773.PMC4330036.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b9/1b/dddt-9-773.PMC4330036.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/1b/dddt-9-773.PMC4330036.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/cia-10-453.PMC4330037.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 453–459Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  453OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7602 8effect of computerized cognitive training with  virtual spatial navigation task during bed rest  immobilization and recovery on vascular function:  A pilot study Correspondence: Voyko Kavcic Institute of gerontology, Wayne state  University, 87 e. Ferry street,   Detroit, MI 48202, UsA Tel +1 313 664 2613 Fax +1 313 664 2667 email voyko@wayne.ed u nandu goswami1  Voyko Kavcic2  Uros Marusic3 Bostjan simunic3  Andreas rössler1  helmut hinghofer-szalkay1  rado Pisot3 1Institute of Physiology, Medical  University of graz, graz, Austria;   2Institute of gerontology, Wayne state  University, Detroit, MI, UsA; 3Institute  for Kinesiology research, University  of Primorska, Ankaran, sloveniaAbstract:  We investigated the effects of bed rest (BR) immobilization, with and without com - puterized cognitive training with virtual spatial navigation task (CCT), on vascular endothelium  on older subjects.",Non-OADS,/arxiv_data1/oa_pdf/a9/48/cia-10-453.PMC4330037.pdf
"Simi - larly, BR immobilization is frequently used in ground-analog to simulate the physio- logical changes induced in astronauts during their prolonged stay in low-earth orbit  such as in the International Space Station.1,2 The endothelium plays an important role in the regulation of vasodilation, vas - cular inflammation, and coagulation.3 Similar to other cardiovascular risk factors,4  aging is associated with altered endothelial function and signaling.5 We have recently  reported that endothelial function is altered following 20 min of standing.6 To our  knowledge, we are not aware of any study that has examined how the endothelium is Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Goswami et al Running head recto: Effect of CCT with virtual spatial navigation task during BR immobilization  DOI: http://dx.doi.org/10.2147/CIA.S76028",Non-OADS,/arxiv_data1/oa_pdf/a9/48/cia-10-453.PMC4330037.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a9/48/cia-10-453.PMC4330037.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/cia-10-453.PMC4330037.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/b5/ijn-10-1155.PMC4330038.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1155–1172International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1155OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7002 2high molecular weight chitosan derivative  polymeric micelles encapsulating  superparamagnetic iron oxide for tumor-targeted  magnetic resonance imaging Yunbin Xiao1,* Zuan Tao lin2,* Yanmei chen1 he Wang1 Ya li Deng2 D elizabeth le3 Jianguo Bin1 Meiyu li1 Yulin liao1 Yili liu1 gangbiao Jiang2 Jianping Bin1 1state Key laboratory of Organ Failure  research, Division of cardiology,   Nanfang hospital, southern Medical  University, guangzhou, People’s republic  of china; 2Department of Pharmaceutical  engineering, south china agricultural  University, guangzhou, People’s republic  of china; 3cardiovascular Division,   Oregon health and science University,   Portland, Or, Usa *These authors contributed equally  to this workAbstract:  Magnetic resonance imaging (MRI) contrast agents based on chitosan derivatives  have great potential for diagnosing diseases.",Non-OADS,/arxiv_data1/oa_pdf/13/b5/ijn-10-1155.PMC4330038.pdf
Available from: http://grants.nih.,Non-OADS,/arxiv_data1/oa_pdf/13/b5/ijn-10-1155.PMC4330038.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/13/b5/ijn-10-1155.PMC4330038.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/b5/ijn-10-1155.PMC4330038.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/12/d2/ijn-10-1145.PMC4330039.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1145–1154International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1145OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7813 8Improved osseointegration of dental titanium  implants by TiO2 nanotube arrays with  recombinant human bone morphogenetic  protein-2: a pilot in vivo study Jae-Kwan lee1,4 Dong-soon choi2,4 Insan Jang2,4 Won-Y oul choi3,4 1Department of Periodontology,   2Department of Orthodontics,   college of Dentistry, 3Department  of Metal and Materials engineering,   4research Institute for Dental  engineering, gangneung-Wonju  National University, gangneung,   south KoreaAbstract:  TiO2 nanotube arrays on the surface of dental implants were fabricated by two-step  anodic oxidation.",Non-OADS,/arxiv_data1/oa_pdf/12/d2/ijn-10-1145.PMC4330039.pdf
"Numerous studies have sought to  optimize dental and orthopedic implants by modifying the implant surface chemistry  and/or surface topography by methods such as blasting, plasma spraying of hydroxy - apatite, sandblasting and etching, and anodic oxidation.1–7 TiO2 nanotube arrays can be formed as “columnar porous” titania layers by anodic  oxidation on pure titanium or titanium alloy surfaces, and are of great interest due to  their highly ordered nanostructure.8–12 The results of recent studies suggest that forma - tion of a titanium implant surface with a nanostructure could reinforce osseointegration  because the surface area is markedly increased and the surface topography can be  nanomodified to resemble native bone tissue.12–14 Recent studies have demonstrated correspondence: Won-Youl choi Department of Metal Materials  engineering, research Institute for Dental  engineering, gangneung-Wonju National  University, 7 Jukheon-gil, gangneung  210-720, south Korea email cwy@gwnu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lee et al Running head recto: Osseointegration of dental implants by TiO2 nanotube arrays with rhBMP-2 DOI: http://dx.doi.org/10.2147/IJN.S78138",Non-OADS,/arxiv_data1/oa_pdf/12/d2/ijn-10-1145.PMC4330039.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/12/d2/ijn-10-1145.PMC4330039.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/d2/ijn-10-1145.PMC4330039.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/f1/dddt-9-763.PMC4330040.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 763–772Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  763Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7586 3Effect and mechanism of fluoxetine on  electrophysiology in vivo in a rat model  of postmyocardial infarction depression Jinjun liang1,2 Xiaoran Yuan1,2 shaobo shi1,2 Fang Wang1,2 Yingying chen1,2 chuan Qu1,2 Jingjing chen1,2 Dan hu1–3 Bo Yang1,2 1Department of cardiology, renmin  hospital of Wuhan University,   Wuhan, People’s republic of china;   2cardiovascular research institute,   Wuhan University, Wuhan, People’s  republic of china; 3Masonic Medical  research laboratory, Utica, nY, UsaBackground:  Major  depression is diagnosed in 18% of patients following myocardial infarction  (MI), and the antidepressant fluoxetine is shown to effectively decrease depressive symptoms  and improve coronary heart disease prognosis.",Non-OADS,/arxiv_data1/oa_pdf/13/f1/dddt-9-763.PMC4330040.pdf
"correspondence:  Bo Yang Department of cardiology and  cardiovascular research institute,  renmin hospital of Wuhan University,  no 238 Jiefang road, Wuchang District,  Wuhan, hubei 430060, People’s  republic of china Tel +86 27 8804 1911 Fax +86 27 8804 2292 email yybb112@whu.edu.c n  Dan hu Masonic Medical research laboratory,  2150 Bleecker street, Utica, nY  13501, Usa  Tel +1 315 735 2217 Fax +1 315 735 5648 email dianah@mmrl.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Liang et al Running head recto: Fluoxetine in a post-MI depression rat model DOI: http://dx.doi.org/10.2147/DDDT.S75863",Non-OADS,/arxiv_data1/oa_pdf/13/f1/dddt-9-763.PMC4330040.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/13/f1/dddt-9-763.PMC4330040.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/f1/dddt-9-763.PMC4330040.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/92/dddt-9-753.PMC4330041.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 753–762Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  753Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6604 9clinical pharmacokinetics of aZD3199,   an inhaled ultra-long-acting β2-adrenoreceptor  agonist (ulaB a) leif Bjermer1 Piotr Kuna2 carin Jorup3 Thomas Bengtsson4 Johan rosenborg4 1Department of respiratory Medicine  and allergology, University hospital,  lund, sweden; 2Department of  internal Medicine, asthma and  allergy, Barlicki University hospital,  Medical University of lodz, lodz,  Poland; 3astraZeneca r&D, Mölndal,  sweden; 4statMind, lund, sweden correspondence: leif Bjermer   Department of respiratory Medicine   and allergology, skåne University   hospital, Klinikgatan 18, lund 22185,  sweden   Tel +46 70 212 6845   Fax +46 46146793   email leif.bjermer@m ed.lu.s eObjective:  The clinical pharmacokinetics of AZD3199, an ultra-long-acting β2-agonist, were  investigated in healthy volunteers and patients with asthma or chronic obstructive pulmonary  disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/a6/92/dddt-9-753.PMC4330041.pdf
"Available  from: http://www.goldcopd.org/uploads/users/files/ GOLDReport_ April112011.pd f. Accessed August 1 , 2014.",OADS,/arxiv_data1/oa_pdf/a6/92/dddt-9-753.PMC4330041.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a6/92/dddt-9-753.PMC4330041.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/92/dddt-9-753.PMC4330041.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/5/ e000773.,Non-OADS,/arxiv_data1/oa_pdf/b6/65/jah3-4-e000528.PMC4330042.pdf
The author regrets this error.The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/5/ e001118.,Non-OADS,/arxiv_data1/oa_pdf/d4/9e/jah3-4-e000563.PMC4330043.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/6/ e001363.,Non-OADS,/arxiv_data1/oa_pdf/f8/c4/jah3-4-e000570.PMC4330044.pdf
Available at: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/82/9f/jah3-4-e000896.PMC4330047.pdf
Clinical Trial Registration- —URL: http://clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/a0/39/jah3-4-e000991.PMC4330048.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs310/ en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/61/04/jah3-4-e000993.PMC4330049.pdf
Available at: http://www.fda.gov/food/ingredientspackaginglabeling/label- ingnutrition/ucm073992.htm.,Non-OADS,/arxiv_data1/oa_pdf/61/04/jah3-4-e000993.PMC4330049.pdf
Available at: http://www.faqs.org/patents/app/20080261313.,Non-OADS,/arxiv_data1/oa_pdf/61/04/jah3-4-e000993.PMC4330049.pdf
Available at: http://www.katancalculator.nl/.,Non-OADS,/arxiv_data1/oa_pdf/61/04/jah3-4-e000993.PMC4330049.pdf
Clinical Trial Registration- —URL: http://www.ctri.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/82/40/jah3-4-e001213.PMC4330052.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/ content/4/1/e001213/suppl/DC1 Correspondence to: Raghupathy Anchala, MD, PhD, Public Health Founda- tion of India, Indian Institute of Public Health, ANV Arcade, Plot No.",Non-OADS,/arxiv_data1/oa_pdf/82/40/jah3-4-e001213.PMC4330052.pdf
Available at: http://www.apiindia.org/pdf/pg_med_2007/Chapter-36.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/40/jah3-4-e001213.PMC4330052.pdf
Available at: http://mahabubnagar.nic.in/.,Non-OADS,/arxiv_data1/oa_pdf/82/40/jah3-4-e001213.PMC4330052.pdf
Available at:http://www.nird.org.in/brgf/doc/BRGFFINALGUIDE- LINES.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/40/jah3-4-e001213.PMC4330052.pdf
Available at: http://www.who.int/choice/country/coun-try_speci ﬁc/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/82/40/jah3-4-e001213.PMC4330052.pdf
Gene Ontology Analysis Gene ontology (GO) analysis was carried using FunNet12 (http://www.funnet.info/).,OADS,/arxiv_data1/oa_pdf/03/31/jah3-4-e001266.PMC4330055.pdf
2 Investigators and research nurses who participated in the registry program were certi ﬁed to administer the NIHSS and mRS after successfully completing a web-based trainingprogram provided by the Clinical Research Center for Stroke (http://www.stroke-crc.or.kr).,Non-OADS,/arxiv_data1/oa_pdf/eb/b2/jah3-4-e001306.PMC4330057.pdf
"Our observational ﬁndings must be validated in a clinical trial setting such as the Potential for rt-PA to Improve Strokes with Mild Symptoms (PRISMS) trial, which will launch soon and is scheduled to be completed in 2018 [http://clinical-trials.gov/show/NCT02072226].",Non-OADS,/arxiv_data1/oa_pdf/eb/b2/jah3-4-e001306.PMC4330057.pdf
Available from: http://clinicaltrials.gov/show/ NCT01422616NLM Identi ﬁer: NCT01422616.,Non-OADS,/arxiv_data1/oa_pdf/eb/b2/jah3-4-e001306.PMC4330057.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/83/6e/jah3-4-e001355.PMC4330060.pdf
"Age, sex, BMI, diet sequence also were adjusted in non-parametric models.ASCVD 10-year and lifetime risk was calculated using the online ASCVD Risk Estimator tool (http://tools.cardio- source.org/ASCVD-Risk-Estimator/) for every participant at baseline and at the end of each diet period.",OADS,/arxiv_data1/oa_pdf/83/6e/jah3-4-e001355.PMC4330060.pdf
Accompanying Appendices S1 and S2 are available at http://jaha.ahajournals.org/content/4/1/e001364/suppl/DC1 This manuscript was prepared using CHS data obtained from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center and does n ot necessarily re ﬂect the opinions or views of the CHS study or the NHLBI.,Non-OADS,/arxiv_data1/oa_pdf/a5/65/jah3-4-e001364.PMC4330063.pdf
"Kuopio Ischemic Heart Disease study (KIHD): This research was supported by Academy of Finland, Helsinki, Finland; City of Kuopio, Kuopio, Finland; Finnish Medical Foundation, Helsinki, Finland, and Finnish Cultural Foundation, Helsinki, Finland https://www.uef.",Non-OADS,/arxiv_data1/oa_pdf/a5/65/jah3-4-e001364.PMC4330063.pdf
"An accompanying Data S1 is available at http://jaha.ahajournals.org/ content/4/1/e001401/suppl/DC1 Correspondence to: Dianne E. C. van Beek, MD, Division of Anesthesiology, Intensive Care and Emergency Care Medicine, Heidelberglaan 100, Post Ofﬁce Box 85500, 3508 GA Utrecht, The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/7a/3e/jah3-4-e001401.PMC4330065.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 24175356.,Non-OADS,/arxiv_data1/oa_pdf/7a/3e/jah3-4-e001401.PMC4330065.pdf
"For foods in the FFQ for which there were no values available in the U.S. Department of Agriculture database, we searched a European database (EuroFIR eBASIS; http://www.euro ﬁr.org) and other sources to ensure all available high-quality data onﬂavonoid values could be included in the database.",OADS,/arxiv_data1/oa_pdf/82/c4/jah3-4-e001423.PMC4330067.pdf
2004. http://www.ars.usda.gov/SP2UserFiles/Place/80400525/Data/PA/PA.pdf 35.,Non-OADS,/arxiv_data1/oa_pdf/82/c4/jah3-4-e001423.PMC4330067.pdf
"An accompanying Data S1 is available at http://jaha.ahajournals.org/ content/4/1/e001467/suppl/DC1 Correspondence to: Johannes Arpeg /C23ard, MD, MBA, Department of Emergency Medicine, Karolinska Hospital, S-171 76 Stockholm, Sweden.E-mail: johannes.arpegard@ki.se Received September 25, 2014; accepted December 1, 2014.ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f3/18/jah3-4-e001467.PMC4330070.pdf
"SEM-modelled heritability estimation In order to estimate variance components for each pheno- type, maximum likelihood estimation and model ﬁtting were performed using the structural equation statistical package OpenMx in R (http://openmx.psyc.virginia.edu).",OADS,/arxiv_data1/oa_pdf/f3/18/jah3-4-e001467.PMC4330070.pdf
"Both registers were established in the 1950s –1960s and are administered by the National Board of Health and Welfare (http://www.socialsty- relsen.se/english).20,21The Inpatient Register includes infor- mation on dates of admission and discharge as well as diagnostic and procedural codes from all hospitalizations in Sweden.",OADS,/arxiv_data1/oa_pdf/1d/f4/jah3-4-e001513.PMC4330075.pdf
"Accompanying Tables S1 through S3 are available at http://jaha.ahajournals.org/content/4/1/e001521/suppl/DC1Correspondence to: Kimmo K. Kontula, MD, PhD, Department of Medicine, University of Helsinki, Stenb €ackinkatu 9, P.O.",Non-OADS,/arxiv_data1/oa_pdf/1e/5b/jah3-4-e001521.PMC4330076.pdf
"The variant is relatively common, with a higher minor allele frequency in populations of European origin (0.30) compared to African Americans (0.09) (Exome Variant Server, http://evs.gs.wash- ington.edu/EVS/).",Non-OADS,/arxiv_data1/oa_pdf/1e/5b/jah3-4-e001521.PMC4330076.pdf
"Genetic Variants Synonymous variants, variants in the introns, common variants (minor allele frequency >0.01), listed in the NHLBI GO Exome Sequencing Project database (http://evs.gs.wash- ington.edu/EVS/) and the “1000 Genomes —A Deep Catalog of Human Genetic Variation ”(http://browser.1000ge- nomes.org/) were excluded from detailed analysis.",Non-OADS,/arxiv_data1/oa_pdf/0e/65/jah3-4-e001526.PMC4330077.pdf
"The novel and rare variants were analyzed by PolyPhen 2 (http://genetics.bwh.harvard.edu/ pph2/), SNPs&GO (http://snps-and-go.biocomp.unibo.it), and MutPred (http://mutpred.mutdb.org) to predict theirpathogenicity.",OADS,/arxiv_data1/oa_pdf/0e/65/jah3-4-e001526.PMC4330077.pdf
The p.R397Q variant resides at the C-terminal domain of KCNQ1 protein (Figure 1B) and affects a conservedamino acid across species (http://www.ebi.ac.uk/Tools/ msa/clustalo/) (Figure 1C).,Non-OADS,/arxiv_data1/oa_pdf/0e/65/jah3-4-e001526.PMC4330077.pdf
Available at: http://www.whocc.no/atcddd.,Non-OADS,/arxiv_data1/oa_pdf/bf/b7/jah3-4-e001575.PMC4330079.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.2.187 www.annlabmed.org  187Ann Lab Med 2015;35:187-193 http://dx.doi.org/10.3343/alm.2015.35.2.187Original Article Diagnostic Hematology Bone Marrow Flow Cytometry in Staging of Patients  With B-cell Non-Hodgkin Lymphoma Borahm Kim, M.D., Seung-Tae Lee, M.D., Hee-Jin Kim, M.D., and Sun Hee Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/8e/4f/alm-35-187.PMC4330167.pdf
Multiparameter flow cytometry in NHL staging 188  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.187METHODS 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/4f/alm-35-187.PMC4330167.pdf
Multiparameter flow cytometry in NHL staging http://dx.doi.org/10.3343/alm.2015.35.2.187 www.annlabmed.org  189RESULTS Approximately 24.6% of bone marrow evaluations showed evi - dence of NHL; bone marrow trephine biopsies showed histo - logic involvement of lymphoma cells in 50 cases (20.2%) and  flow cytometric analysis of bone marrow aspirate showed the  presence of lymphoma cells in 45 cases (18.1%).,OADS,/arxiv_data1/oa_pdf/8e/4f/alm-35-187.PMC4330167.pdf
Multiparameter flow cytometry in NHL staging 190  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.187showed a mixture of polyclonal B cells and a small population of  CD19+/Ig- cells representing normal CD19+ precursor B cells.,OADS,/arxiv_data1/oa_pdf/8e/4f/alm-35-187.PMC4330167.pdf
"Multiparameter flow cytometry in NHL staging http://dx.doi.org/10.3343/alm.2015.35.2.187 www.annlabmed.org  191technology currently available, six-color or eight-color multipa - rameter analysis can improve the sensitivity and specificity [21,  22].",Non-OADS,/arxiv_data1/oa_pdf/8e/4f/alm-35-187.PMC4330167.pdf
"Multiparameter flow cytometry in NHL staging 192  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.187volve the bone marrow and the lymphoid infiltration foci are  small, the bone marrow may produce aspirate samples free of  disease while the biopsy may be positive for lymphoma cells.",Non-OADS,/arxiv_data1/oa_pdf/8e/4f/alm-35-187.PMC4330167.pdf
Multiparameter flow cytometry in NHL staging http://dx.doi.org/10.3343/alm.2015.35.2.187 www.annlabmed.org  19317.,Non-OADS,/arxiv_data1/oa_pdf/8e/4f/alm-35-187.PMC4330167.pdf
"ISSN 2234-3806 • eISSN 2234-3814  194  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.194Ann Lab Med 2015;35:194-197 http://dx.doi.org/10.3343/alm.2015.35.2.194Original Article Clinical Chemistry Comparison of Red Blood Cell Hemolysis Using Plasma  and Serum Separation Tubes for Outpatient Specimens Dae-Hyun Ko, M.D., Dahae Won, M.D., Tae-Dong Jeong, M.D., Woochang Lee, M.D., Sail Chun, M.D., and Won-Ki Min, M.D.",OADS,/arxiv_data1/oa_pdf/d6/1f/alm-35-194.PMC4330168.pdf
Hemolytic index in PST and SST http://dx.doi.org/10.3343/alm.2015.35.2.194 www.annlabmed.org  195and SST [8-12].,Non-OADS,/arxiv_data1/oa_pdf/d6/1f/alm-35-194.PMC4330168.pdf
"Hemolytic index in PST and SST 196  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.194(4.35%), pediatric urology (2.94%), and pediatric and adoles - cent medicine (2.63%) departments.",Non-OADS,/arxiv_data1/oa_pdf/d6/1f/alm-35-194.PMC4330168.pdf
Hemolytic index in PST and SST http://dx.doi.org/10.3343/alm.2015.35.2.194 www.annlabmed.org  197concentration of enzymes.,OADS,/arxiv_data1/oa_pdf/d6/1f/alm-35-194.PMC4330168.pdf
"ISSN 2234-3806 • eISSN 2234-3814  198  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.198Ann Lab Med 2015;35:198-204 http://dx.doi.org/10.3343/alm.2015.35.2.198Original Article Clinical Chemistry Establishment of Trimester-Specific Reference  Intervals for Thyroid Hormones in Korean Pregnant  Women Hee-Won Moon, M.D.1,*, Hee-Jung Chung, M.D.2,*, Chul-Min Park, M.D.3, Mina Hur, M.D.1, and Yeo-Min Yun, M.D.1 Department of Laboratory Medicine1, Konkuk University School of Medicine, Seoul; Department of Laboratory Medicine2, Cheil General Hospital and  Women’s Healthcare Center, Kwandong University College of Medicine, Seoul; Department of Laboratory Medicine3, Dongnam Institute of Radiological and  Medical Sciences, Busan, Korea Background:  Establishment of trimester- and assay-specific reference intervals for every  population is recommended.",Non-OADS,/arxiv_data1/oa_pdf/19/86/alm-35-198.PMC4330169.pdf
Trimester reference intervals of TSH and FT4 http://dx.doi.org/10.3343/alm.2015.35.2.198 www.annlabmed.org  199immunoassays [6-11].,OADS,/arxiv_data1/oa_pdf/19/86/alm-35-198.PMC4330169.pdf
"Trimester reference intervals of TSH and FT4 200  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.1980.15-4.57 mIU/L at the first, the second, and the third trimester  of pregnancy, respectively.",Non-OADS,/arxiv_data1/oa_pdf/19/86/alm-35-198.PMC4330169.pdf
Trimester reference intervals of TSH and FT4 http://dx.doi.org/10.3343/alm.2015.35.2.198 www.annlabmed.org  201FT4 TSH DISCUSSION Pregnancy can cause significant changes in thyroid function [5].,Non-OADS,/arxiv_data1/oa_pdf/19/86/alm-35-198.PMC4330169.pdf
Trimester reference intervals of TSH and FT4 202  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.198dine status could contribute to the existent discrepancy.,Non-OADS,/arxiv_data1/oa_pdf/19/86/alm-35-198.PMC4330169.pdf
Trimester reference intervals of TSH and FT4 http://dx.doi.org/10.3343/alm.2015.35.2.198 www.annlabmed.org  203bias related to the binding proteins in a method-specific manner  [29].,Non-OADS,/arxiv_data1/oa_pdf/19/86/alm-35-198.PMC4330169.pdf
Trimester reference intervals of TSH and FT4 204  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.198roid 1999;9:631-5.,OADS,/arxiv_data1/oa_pdf/19/86/alm-35-198.PMC4330169.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.2.205 www.annlabmed.org  205Ann Lab Med 2015;35:205-211 http://dx.doi.org/10.3343/alm.2015.35.2.205Original Article Clinical Microbiology Species-Specific Difference in Antimicrobial  Susceptibility Among Viridans Group Streptococci Sejong Chun, M.D., Hee Jae Huh, M.D., and Nam Yong Lee, M.D.",OADS,/arxiv_data1/oa_pdf/f7/9e/alm-35-205.PMC4330170.pdf
"Antimicrobial susceptibility of VGS 206  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.205bial agents [4, 6].",Non-OADS,/arxiv_data1/oa_pdf/f7/9e/alm-35-205.PMC4330170.pdf
"Antimicrobial susceptibility of VGS http://dx.doi.org/10.3343/alm.2015.35.2.205 www.annlabmed.org  207achieved for 1,133 isolates (78.2%), with the S. mitis  group be - ing the most frequently identified species (40.7%).",Non-OADS,/arxiv_data1/oa_pdf/f7/9e/alm-35-205.PMC4330170.pdf
Antimicrobial susceptibility of VGS 208  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.205(P<0.001).,Non-OADS,/arxiv_data1/oa_pdf/f7/9e/alm-35-205.PMC4330170.pdf
Antimicrobial susceptibility of VGS http://dx.doi.org/10.3343/alm.2015.35.2.205 www.annlabmed.org  2095) Isolates from blood Isolates from blood were analyzed separately.,OADS,/arxiv_data1/oa_pdf/f7/9e/alm-35-205.PMC4330170.pdf
"Antimicrobial susceptibility of VGS 210  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.205ginosus , and S. sanguinis  were the most frequently isolated spe - cies.",OADS,/arxiv_data1/oa_pdf/f7/9e/alm-35-205.PMC4330170.pdf
Antimicrobial susceptibility of VGS http://dx.doi.org/10.3343/alm.2015.35.2.205 www.annlabmed.org  211Serious infections due to penicillin-resistant strains of viridans strepto - cocci with altered penicillin-binding proteins.,Non-OADS,/arxiv_data1/oa_pdf/f7/9e/alm-35-205.PMC4330170.pdf
ISSN 2234-3806 • eISSN 2234-3814  212  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.212Ann Lab Med 2015;35:212-219 http://dx.doi.org/10.3343/alm.2015.35.2.212Original Article Clinical Microbiology Combined Use of the Modified Hodge Test and  Carbapenemase Inhibition Test for Detection of  Carbapenemase-Producing Enterobacteriaceae  and  Metallo-β-Lactamase-Producing Pseudomonas  spp.,Non-OADS,/arxiv_data1/oa_pdf/22/cf/alm-35-212.PMC4330171.pdf
"MHT and CIT for detection of carbapenemases http://dx.doi.org/10.3343/alm.2015.35.2.212 www.annlabmed.org  213INTRODUCTION The global spread of carbapenemase-producing gram-negative  bacilli in the last decade is a serious health threat, and limited  treatment options are available for such infections [1].",Non-OADS,/arxiv_data1/oa_pdf/22/cf/alm-35-212.PMC4330171.pdf
MHT and CIT for detection of carbapenemases 214  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.212Table 1.,OADS,/arxiv_data1/oa_pdf/22/cf/alm-35-212.PMC4330171.pdf
MHT and CIT for detection of carbapenemases http://dx.doi.org/10.3343/alm.2015.35.2.212 www.annlabmed.org  215bapenemase mechanisms as the reference standard.,OADS,/arxiv_data1/oa_pdf/22/cf/alm-35-212.PMC4330171.pdf
MHT and CIT for detection of carbapenemases 216  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.212Table 2.,OADS,/arxiv_data1/oa_pdf/22/cf/alm-35-212.PMC4330171.pdf
MHT and CIT for detection of carbapenemases http://dx.doi.org/10.3343/alm.2015.35.2.212 www.annlabmed.org  217Table 3.,OADS,/arxiv_data1/oa_pdf/22/cf/alm-35-212.PMC4330171.pdf
"MHT and CIT for detection of carbapenemases 218  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.212sensitivity and 100% specificity), MBL- (94% sensitivity and  100% specificity), and OXA-48-like-producing isolates (100%  sensitivity and 100% specificity), respectively (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/22/cf/alm-35-212.PMC4330171.pdf
MHT and CIT for detection of carbapenemases http://dx.doi.org/10.3343/alm.2015.35.2.212 www.annlabmed.org  219REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/22/cf/alm-35-212.PMC4330171.pdf
"ISSN 2234-3806 • eISSN 2234-3814  220  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.220Ann Lab Med 2015;35:220-225 http://dx.doi.org/10.3343/alm.2015.35.2.220Original Article Diagnostic Immunology Clinical Usefulness of Bronchoalveolar Lavage Cellular  Analysis and Lymphocyte Subsets in Diffuse Interstitial  Lung Diseases Wookeun Lee, M.D., Wha Soon Chung, M.D., Ki-Sook Hong, M.D., and Jungwon Huh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/21/0c/alm-35-220.PMC4330172.pdf
"BAL lymphocyte subsets in DILDs http://dx.doi.org/10.3343/alm.2015.35.2.220 www.annlabmed.org  221 Bronchoalveolar lavage (BAL) has been used as an ancillary  diagnostic tool for DILDs, especially in situations where clinico- radiological findings fail to provide sufficient information for a  definitive diagnosis or when a lung biopsy is not feasible [4, 5].",Non-OADS,/arxiv_data1/oa_pdf/21/0c/alm-35-220.PMC4330172.pdf
"BAL lymphocyte subsets in DILDs 222  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.220proportion among groups ( P=0.0305), no significant difference  was found between groups in the post-hoc analysis.",OADS,/arxiv_data1/oa_pdf/21/0c/alm-35-220.PMC4330172.pdf
"BAL lymphocyte subsets in DILDs http://dx.doi.org/10.3343/alm.2015.35.2.220 www.annlabmed.org  223BOOP, and 1 case of HP (Table 3, case nos.",OADS,/arxiv_data1/oa_pdf/21/0c/alm-35-220.PMC4330172.pdf
BAL lymphocyte subsets in DILDs 224  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.220groups.,OADS,/arxiv_data1/oa_pdf/21/0c/alm-35-220.PMC4330172.pdf
"BAL lymphocyte subsets in DILDs http://dx.doi.org/10.3343/alm.2015.35.2.220 www.annlabmed.org  225for differential diagnosis of DILDs, except for cases with high  specificity, as seen for sarcoidosis and eosinophilic pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/21/0c/alm-35-220.PMC4330172.pdf
"ISSN 2234-3806 • eISSN 2234-3814  226  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.226Ann Lab Med 2015;35:226-232 http://dx.doi.org/10.3343/alm.2015.35.2.226Original Article Diagnostic Genetics Quantitative Measurement of Serum MicroRNA-21  Expression in Relation to Breast Cancer Metastasis in  Chinese Females Guinian Wang, M.D.1, Longzi Wang, M.D.2, Sijing Sun, M.S.3, Juan Wu, B.S.1, and Qinglu Wang, Ph.D.4 Departments of Laboratory Medicine1 and Surgical Medicine3, The First Hospital of Zibo City; Department of Pharmacy2, Zibo Vocational Institute; Key  Laboratory of Biomedical Engineering4, Shandong Wanjie Medical College, Zibo, China Background:  Breast cancer is the most common type of cancer in females.",Non-OADS,/arxiv_data1/oa_pdf/cd/c2/alm-35-226.PMC4330173.pdf
"Serum miR-21 and breast cancer prognosis http://dx.doi.org/10.3343/alm.2015.35.2.226 www.annlabmed.org  227ous types of cancer [3, 4].",Non-OADS,/arxiv_data1/oa_pdf/cd/c2/alm-35-226.PMC4330173.pdf
Serum miR-21 and breast cancer prognosis 228  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.226age expression in normal control samples.,Non-OADS,/arxiv_data1/oa_pdf/cd/c2/alm-35-226.PMC4330173.pdf
"Serum miR-21 and breast cancer prognosis http://dx.doi.org/10.3343/alm.2015.35.2.226 www.annlabmed.org  229predictor of prognosis in BC patients, recurrence-free and dis - ease-free survival were analyzed, with the BC patients divided  into subgroups according to serum miR-21 expression level.",OADS,/arxiv_data1/oa_pdf/cd/c2/alm-35-226.PMC4330173.pdf
Serum miR-21 and breast cancer prognosis 230  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.226than in normal adjacent breast tissues (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/cd/c2/alm-35-226.PMC4330173.pdf
Serum miR-21 and breast cancer prognosis http://dx.doi.org/10.3343/alm.2015.35.2.226 www.annlabmed.org  231used for diagnostic purposes [25].,Non-OADS,/arxiv_data1/oa_pdf/cd/c2/alm-35-226.PMC4330173.pdf
Serum miR-21 and breast cancer prognosis 232  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.226Med J 2013;126:2556-63.,OADS,/arxiv_data1/oa_pdf/cd/c2/alm-35-226.PMC4330173.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2015.35.2.233 www.annlabmed.org  233Ann Lab Med 2015;35:233-237 http://dx.doi.org/10.3343/alm.2015.35.2.233Brief Communication Diagnostic Hematology Incidence, Clinical Features, and Prognostic Impact of  CALR  Exon 9 Mutations in Essential Thrombocythemia  and Primary Myelofibrosis: An Experience of a Single  Tertiary Hospital in Korea Sang Hyuk Park, M.D.1,2, Shine Young Kim, M.D.1,2, Sun Min Lee, M.D.3, Jongyoun Yi, M.D.1,2, In-Suk Kim, M.D.3,   Hyung Hoi Kim, M.D.1,2, Chulhun Ludgerus Chang, M.D.3, Eun Yup Lee, M.D.1,2, Moo-Kon Song, M.D.2,4, Ho-Jin Shin, M.D.2,4,  and Joo Seop Chung, M.D.2,4 Department of Laboratory Medicine1, Pusan National University School of Medicine, Pusan National University Hospital, Busan; Biomedical Research  Institute2, Pusan National University Hospital, Busan; Department of Laboratory Medicine3, Pusan National University School of Medicine, Pusan National  University Yangsan Hospital, Yangsan; Division of Hematology-Oncology4, Department of Internal Medicine, Pusan National University School of Medicine,  Pusan National University Hospital, Busan, Korea We evaluated the incidence, clinical characteristics, and prognostic impact of calreticulin  (CALR ) mutations in essential thrombocythemia (ET) and primary myelofibrosis (PMF)  patients.",Non-OADS,/arxiv_data1/oa_pdf/91/e6/alm-35-233.PMC4330174.pdf
CALR  mutations in ET and PMF 234  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.23315].,OADS,/arxiv_data1/oa_pdf/91/e6/alm-35-233.PMC4330174.pdf
CALR  mutations in ET and PMF http://dx.doi.org/10.3343/alm.2015.35.2.233 www.annlabmed.org  235(P=0.022) and less thrombosis development during follow-up  (P=0.036) than those with the JAK2  V617F mutation.,Non-OADS,/arxiv_data1/oa_pdf/91/e6/alm-35-233.PMC4330174.pdf
"CALR  mutations in ET and PMF 236  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.233clinical features and OS ( P=0.221) of the patients carrying CALR   mutations were not significantly different from those without  CALR  mutations, although higher megakaryocyte counts in BM  biopsy ( P=0.020) were observed in the former group (Table 3).",OADS,/arxiv_data1/oa_pdf/91/e6/alm-35-233.PMC4330174.pdf
CALR  mutations in ET and PMF http://dx.doi.org/10.3343/alm.2015.35.2.233 www.annlabmed.org  237et al.,OADS,/arxiv_data1/oa_pdf/91/e6/alm-35-233.PMC4330174.pdf
"ISSN 2234-3806 • eISSN 2234-3814  238  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.238Ann Lab Med 2015;35:238-241 http://dx.doi.org/10.3343/alm.2015.35.2.238Brief Communication Clinical Chemistry Evaluation of Random Urine Sodium and Potassium  Compensated by Creatinine as Possible Alternative  Markers for 24 Hours Urinary Sodium and Potassium  Excretion Hyunmin Koo, M.D., Sang-Guk Lee, M.D., and Jeong-Ho Kim, M.D.",OADS,/arxiv_data1/oa_pdf/96/83/alm-35-238.PMC4330175.pdf
Alternative markers for 24 hr urinary Na+ and K+ http://dx.doi.org/10.3343/alm.2015.35.2.238 www.annlabmed.org  239daily sodium intake.,Non-OADS,/arxiv_data1/oa_pdf/96/83/alm-35-238.PMC4330175.pdf
"Alternative markers for 24 hr urinary Na+ and K+ 240  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.238urine specimens would generally be recommended for evalua - tion of spot urine biomarkers [9, 17].",Non-OADS,/arxiv_data1/oa_pdf/96/83/alm-35-238.PMC4330175.pdf
Alternative markers for 24 hr urinary Na+ and K+ http://dx.doi.org/10.3343/alm.2015.35.2.238 www.annlabmed.org  241intake.,OADS,/arxiv_data1/oa_pdf/96/83/alm-35-238.PMC4330175.pdf
"ISSN 2234-3806 • eISSN 2234-3814  242  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.242Ann Lab Med 2015;35:242-245 http://dx.doi.org/10.3343/alm.2015.35.2.242Brief Communications Clinical Microbiology Molecular Characteristics of Noroviruses Genogroup I  and Genogroup II Detected in Patients With Acute  Gastroenteritis Heejin Ham, M.S., Seah Oh, M.S., Hyunjung Seung, M.S., and Sukju Jo, M.S.",Non-OADS,/arxiv_data1/oa_pdf/ce/c2/alm-35-242.PMC4330176.pdf
"Noroviruses in gastroenteritis patients http://dx.doi.org/10.3343/alm.2015.35.2.242 www.annlabmed.org  2435´-CCAACCCARCCATTRTACATYTG-3´, and 5´-ATGATGATGGC - GTCTAAGGACGC-3´ respectively) for GI detection and another  3 regions (5´-GGGAGGGCGATCGCAATCT-3´, 5´-CCRCCIG - CATRICCRTTRTACAT-3´, and 5´-TTGTGAATGAAGATGGCGTC - GART-3´, respectively) for GII detection [1-5].",Non-OADS,/arxiv_data1/oa_pdf/ce/c2/alm-35-242.PMC4330176.pdf
"Noroviruses in gastroenteritis patients 244  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.242lowest in July (2.4%, 20/818) from 2007 to 2011, followed by  that in January, February, and November from 2010 to 2013, in  Seoul [5].",Non-OADS,/arxiv_data1/oa_pdf/ce/c2/alm-35-242.PMC4330176.pdf
Noroviruses in gastroenteritis patients http://dx.doi.org/10.3343/alm.2015.35.2.242 www.annlabmed.org  2455.,Non-OADS,/arxiv_data1/oa_pdf/ce/c2/alm-35-242.PMC4330176.pdf
"National norovirus laboratory surveillance, 2013. http://www.google.",Non-OADS,/arxiv_data1/oa_pdf/ce/c2/alm-35-242.PMC4330176.pdf
"Laboratory surveillance of viral acute  gastroenteritis in Korea, 2012. http://www.cdc.go.kr/CDC/notice/CdcK - rInfo0301.jsp?menuIds=HOME001-MNU0004-MNU0036-MNU  0037&cid=21904 (Updated on Nov 2013).",OADS,/arxiv_data1/oa_pdf/ce/c2/alm-35-242.PMC4330176.pdf
"ISSN 2234-3806 • eISSN 2234-3814  246  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.246Ann Lab Med 2015;35:246-249 http://dx.doi.org/10.3343/alm.2015.35.2.246Brief Communication Clinical Microbiology The sul1 Gene in Stenotrophomonas maltophilia  With  High-Level Resistance to Trimethoprim/ Sulfamethoxazole Hae-Sun Chung, M.D.1,4, Kyeongmi Kim, M.D.2, Sang Sook Hong, M.D.2, Seong Geun Hong, M.D.2,4, Kyungwon Lee, M.D.3,4,  and Yunsop Chong, Ph.D.3,4 Department of Laboratory Medicine1, Ewha Womans University School of Medicine, Seoul; Department of Laboratory Medicine2, CHA Bundang Medical  Center, CHA University, Seongnam; Department of Laboratory Medicine3, Yonsei University College of Medicine, Seoul; Research Institute of Bacterial  Resistance4, Yonsei University College of Medicine, Seoul, Korea Emerging resistance to trimethoprim/sulfamethoxazole (SXT) poses a serious threat to the  treatment of Stenotrophomonas maltophilia  infections.",Non-OADS,/arxiv_data1/oa_pdf/9a/8b/alm-35-246.PMC4330177.pdf
sul1 in cotrimoxazole-resistant S. maltophilia http://dx.doi.org/10.3343/alm.2015.35.2.246 www.annlabmed.org  247 A total of 252 non-duplicate clinical isolates of S. maltophilia   were collected from 10 university hospitals in Korea between  2009 and 2010.,OADS,/arxiv_data1/oa_pdf/9a/8b/alm-35-246.PMC4330177.pdf
sul1 in cotrimoxazole-resistant S. maltophilia 248  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.246than those resulting in high-level resistance.,Non-OADS,/arxiv_data1/oa_pdf/9a/8b/alm-35-246.PMC4330177.pdf
sul1 in cotrimoxazole-resistant S. maltophilia http://dx.doi.org/10.3343/alm.2015.35.2.246 www.annlabmed.org  249tegrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of  Stenotrophomonas maltophilia .,Non-OADS,/arxiv_data1/oa_pdf/9a/8b/alm-35-246.PMC4330177.pdf
"ISSN 2234-3806 • eISSN 2234-3814  250  www.annlabmed.org http://dx.doi.org/10.3343/alm.2015.35.2.250Ann Lab Med 2015;35:250-253 http://dx.doi.org/10.3343/alm.2015.35.2.250Case Report Clinical Microbiology Clinical and Microbiological Characteristics of Six  Staphylococcus  pettenkoferi  Isolates From Blood  Samples Sholhui Park, M.D., Hae-Sun Chung, M.D., and Miae Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/9a/d1/alm-35-250.PMC4330178.pdf
